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Abstract 
 
The entorhinal cortex (EC) is a vital structure in the mammalian brain, implicated in 
the processes of learning and memory, and a possible site for the generation of 
seizures in temporal lobe epilepsy. Neurones in the EC are constantly bombarded with 
inhibitory and excitatory neurotransmitter. This background activity is thought to 
exert significant control on the excitability and function of neurones in cortical 
networks, with changes in the levels and proportion of background inhibition (IBg) and 
excitation (EBg) driving rhythmic oscillations in membrane potential, and even 
underlying the generation of epileptic seizures. 
 
In this thesis I used a novel approach to quantify levels of background activity in the 
EC, and relate these levels to cellular excitability. The VmD (membrane voltage 
distribution) method (Rudolph et al., J Neurophysiol 91, 2884-96) allows the 
estimation of IBg and EBg, and their respective standard deviations, from intracellular 
recordings in principal neurones. I have applied the VmD method to pyramidal 
neurones in the rat medial EC in an in vitro slice preparation. My experiments have 
provided validation of the VmD method in the mEC by initially using a range of well-
characterised pharmacological tools (e.g. NBQX, 2-AP5) to obtain predictable and 
repeatable measures of IBg and EBg and the effects of receptor or uptake blockade on 
these values. 
 
The VmD method was also used to investigate lamina-specific differences in 
background activity and sensitivity to epileptogenesis in the mEC. Using the VmD 
method and the GABAA antagonist bicuculline I was able to show that there are 
appreciable lamina-specific differences between the ratio of inhibition to excitation 
and sensitivity to GABAA blockade. 
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Additionally, I used the method to characterise two different types of slow wave 
oscillatory activity (seen in highly active cortical networks) in layer III of the mEC, 
and to investigate the mode of action of several anticonvulsant drugs. 
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Introduction 
 
Work in this laboratory has been focussed on the functional synaptic organisation of 
the entorhinal cortex (EC). In particular, in recent years, it has been examining how 
spontaneous release of excitatory (glutamate) and inhibitory (GABA) transmitters is 
controlled, and how this spontaneous release helps to determine overall network 
activity. 
 
The aim of this thesis has been to investigate the link between cortical network 
activity and cellular excitability in the medial EC of the rat. This has been approached 
using a recently developed method, based on membrane voltage fluctuations (the 
“VmD Method”, Rudolph et al., 2004) that enables us to obtain, using simple 
intracellular recordings, an estimation of global background excitatory and inhibitory 
conductance in principal neurones, at the same time, in the same cell. As it is based on 
intracellular recordings, the VmD method also allows measurements of cellular 
excitability to be made in the recorded cells, thus enabling concurrent observation of 
how changes in the degree and proportion of background excitation and inhibition 
affect the ability of principal cells to fire action potentials. This in turn provides 
information on the relationship between the inhibitory and excitatory systems within 
the EC. 
 
The Entorhinal Cortex 
 
The EC is a structure forming part of the limbic system, located within the rhinal 
sulcus in the rostral ventromedial surface of each temporal lobe (Fig 1.1). The EC can 
be roughly divided in to two triangular sections, as outlined in Witter et al. (1989). 
These sections, the medial entorhinal cortex (mEC) and lateral entorhinal cortex (lEC), 
are distinct in their connections to and from the hippocampal cornu ammonis, dentate 
gyrus and neocortex. The intricate connections between the EC and the hippocampus 
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have been studied since Cajal first noted them. It has long been proposed that both the 
EC and hippocampus are associated with memory processes (Zola-Morgan and Squire, 
1993; Eichenbaum et al., 1994). The rat EC is often used to model human diseases, as 
it has functional and anatomical similarities, especially with primates (Insausti et al., 
1997). 
 
 
 
 
Figure 1.1: Location of the EC in the human (top) and rat brain (bottom left). Top left 
illustration is coronal section of human brain, taken through the front of the temporal 
lobes. the EC is visible in green next to the hippocampus. In the slice of rat brain 
(bottom right) the CA1 and CA3 areas of the hippocampus, the dentate gyrus (DG) 
and EC are all visible. Human illustration courtesy of McGill University. Rat 
illustration adapted from Cajal (1911). 
 
The EC has been implicated in a number of diseases, such as schizophrenia, 
Alzheimer’s disease and Parkinson’s disease (Kovari et al., 2003; Prasad et al., 2004; 
  
18 
Pennanen et al., 2004). However, the disease most commonly associated with 
dysfunction of the EC is temporal lobe epilepsy (TLE), which is thought to be the 
cause of seizures in around 40% of adult epilepsy (McNamara, 1992; Schwarcz et al., 
2000; Jones and Woodhall 2005). 
 
Despite considerable focus on the hippocampus as the cause of TLE (Bradford, 1995; 
McCormick and Contreras, 2001), there is increasing evidence from surgical studies 
that the EC is heavily involved in seizure generation and propagation. There have 
been many reports of seizure activity arising independently, or even preferentially, in 
the EC (Rutecki et al., 1989; Spencer and Spencer, 1994; Alarcon et al., 1997; Assaf 
and Ebersole, 1997; Asaf et al., 2003; Bartolomei et al., 2004, 2005). 
 
Studies performed during operations on patients undergoing temporal lobe resection 
to treat intractable TLE highlighted a similarity between spikes evoked in the 
hippocampus by EC stimulation, and spontaneous activity in the hippocampus 
observed between seizures (Rutecki et al., 1989). These studies also showed that 
spontaneous activity recorded within the EC clearly preceded many similar discharges 
recorded within the hippocampus. Wennberg et al. (2002) suggested that seizures 
arising within the hippocampus generally fail to propagate beyond their site of onset, 
and have little or no clinical manifestation. However, seizures with focal onset in the 
amygdala or the parahippocampal cortex (see Fig. 1.1) displayed clear clinical 
symptoms and showed definite signs of propagation. When parahippocampal cortex-
based seizures (including the EC) were considered alone, the correlation between 
these seizures and clinical manifestations/propagation was 100%. 
 
In human epilepsy, as many as 30% of patients are refractive to current drug therapy, 
but the reasons for this lack of response are currently unknown (Sander, 1993; Kwan 
and Brodie, 2000). Surgical intervention to control drug-resistant TLE involves a 
partial temporal lobectomy removing both the hippocampus and the EC. The success 
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rate of this surgery appears to correlate with the amount of parahippocampus and EC 
removed during temporal lobe resection (Siegel et al., 1990; Fried, 1993; Sperling et 
al., 1996). Goldring et al., (1992, 1993) have suggested that the removal of the EC is 
essential for surgical control of refractory TLE. One of the symptoms of TLE is 
hippocampal atrophy, as seen in MRI studies with epileptic patients. However, a large 
number of MRI studies have shown that the EC is significantly reduced in volume in 
TLE patients. Supporting the above intraoperative studies, atrophy of the EC has been 
observed in TLE without accompanying loss of hippocampal volume. In epilepsies 
arising outside of the temporal lobe, or in generalised epilepsies of unknown 
aetiologies, no entorhinal atrophy is evident (Bernasconi et al., 1999, 2001, 2003; 
Jutila et al., 2001; Bonilha et al., 2003). 
 
After acute seizure activity had been induced in vitro in rat brain slices, recorded 
seizure activity (and increased glucose consumption associated with a rise in neuronal 
activity) appears in the EC before spreading to other parts of the limbic system, again 
suggesting the EC as a source of seizure activity (Ben-Ari et al., 1981; Collins et al., 
1983; Stringer, 1994). Furthermore, in vivo studies in rats with chronically induced 
epilepsy have demonstrated events such as high frequency events and oscillations in 
the EC, with a high degree of similarity to events recorded in human TLE patients (e.g. 
Bragin et al., 2002, 2004). Additionally, electrophysiological studies have suggested 
that seizures in acutely-evoked TLE are generated by the EC, propagating from the 
deep to the superficial EC and on to the hippocampus (Jones and Lambert 1990a, b; 
Nagao et al., 1996). 
 
Anatomy and Physiology of the EC 
 
Much of the anatomical study of the EC has focussed on its connections to and from 
the hippocampus (Fig. 1.2), and the rich interconnection between layers within the EC 
itself. As stated above, the EC can be divided into medial and lateral sub-sections. The 
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lateral sections project to the caudal levels of the dentate gyrus (DG), whilst the mEC 
projects towards more caudal sections of the DG. There is a direct relationship 
between the position of cells and their projection, as more medial cells in the EC 
project further towards the caudal end of the DG (Witter et al., 1989). 
 
The EC itself can be further divided into six layers, from layer I (the most superficial) 
to layer VI (the innermost layer), although the exact divisions vary between 
investigators. There have been many efforts made to further divide the EC, with the 
number of proposed subfields ranging from as little as two, to as many as 23. This 
thesis will employ the divisions noted in Witter et al. (1989). Two of the layers (I and 
IV) are sometimes termed “plexiform layers”, and contain very few neuronal soma. 
Layer I contains mostly fibres, whilst layer IV, the lamina dessicans, has an extremely 
low density of neurones and is not found at the more rostral areas of the EC. There is 
some debate as to whether layer IV is a subdivision of layer V, or a structure in its 
own right. It has been postulated that the EC represents an evolutionary transition 
between the three-layered hippocampus and the clear six layers of the mammalian 
neocortex (Insausti et al., 1997). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2: Extrinsic connectivity of the mEC. The superficial layers receive much of 
the input from the neocortex, with layers II and III projecting towards the 
hippocampus, forming the “trisynaptic loop”. Layer V is densely innervated by the 
hippocampus, and projects to the neocortex and back to the superficial EC, leading to 
high levels of recurrent connections. 
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Laminar Structure and Internal Connectivity of the EC 
 
Even from early anatomical studies (for example, those of Cajal, 1911 or Lorente de 
No, 1933) it is clear that there is an extensive network of interconnections between 
cells in different layers of the EC, and a number of differences in the density and 
morphology of neurones between these layers. As staining and imaging techniques 
improve, more and more is being discovered about the relationship between neurones 
in different layers of the EC; this information can be further supported by complex 
electrophysiological studies investigating the functional relationship of the layers, and 
their susceptibility to diseases such as epilepsy. 
 
Layer I of the EC is only very sparsely populated with neurones, containing mostly 
fibres. There are small populations of both horizontal and multipolar cells, projecting 
and ramifying locally in a limited manner (Germroth et al., 1989). Layer II also 
contains some horizontal cells. However, the majority of neurones in layer II are spiny 
stellate cells, with a greater proportion in the mEC than the lEC (Alonso and Klink, 
1993; Jones, 1994; Klink and Alonso, 1997). These spiny stellate cells, with many 
diverse and far-reaching projections, form the main output from the EC. Layer II 
stellate cells form the major part of the perforant pathway to the hippocampus. A 
single layer II cell has been shown to project axonal branches towards the entire 
transverse dentate gyrus (suprapyramidal and infrapyramidal blades, and the DG 
crest), the CA2-3 fields of the hippocampus, and the subiculum (Tamamaki and 
Nojyo, 1993). Their dendritic trees branch extensively throughout the three outermost 
layers of the EC. Given the large amount of information passing from the neocortex to 
the hippocampus through these layers, it is evident that layer II stellate cells provide 
the pivotal link between these two structures. There is limited evidence to suggest that 
layer II stellate cells also project to layers V and VI of the EC (Ino et al., 2000; 
Buckmaster et al., 2004). 
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Activity in layer II is tightly regulated by a wealth of inhibitory connections. In vitro 
electrophysiological studies have shown that layer II neurones are kept mostly 
quiescent and prevented from firing action potentials due to the overwhelming level 
of inhibitory postsynaptic potentials (IPSPs) from GABAergic interneurones (Jones, 
1993, 1994; Heinemann et al., 2000). These interneurones form a complex web of 
connections comprising of feed-forward and feed-back inhibitory links to principal 
cells in both layer II and layer III. The most potent inhibitory interneurones in the 
cortex are considered to be basket cells and chandelier cells, and these are both most 
abundant within layers II and III (Hendry et al., 1989; DeFelipe, 1999). Horizontal 
inhibitory cells in layer II possess dendritic and axonal structures that are largely 
confined to the layer, in contrast with the principal neurones (Germroth et al., 1989; 
Jones and Buhl, 1993). 
 
The principal excitatory cells of layer III are pyramidal cells (Fig. 1.3). The primary 
function of excitatory cells in layer III is thought to differ from that of layer II 
principal cells. Instead of forwarding information from the cortex to the hippocampus 
(as layer II cells do largely through the perforant pathway), a proportion of pyramidal 
cells in layer III have been proposed to act as “controller cells” for pyramidal 
neurones in the CA1 hippocampal area. Layer III principal cells exist in two groups, 
those that project towards the hippocampus, and those that project within the EC. The 
former group forms a closed-loop system with the hippocampal CA1 cells, controlling 
the exit of information from the hippocampal trisynaptic pathway, whereas the latter, 
internally projecting cells extend their axons throughout layer III. Both groups of 
layer III pyramidal cells have rich dendritic trees within layers I and II (Gloveli et al., 
1997; Buckmaster et al., 2004). This extensive interconnection between principal cells, 
the proposed controller role for the externally-projecting pyramidal cells, and the 
large amount of inhibitory control exerted within layer III would all suggest that the 
pyramidal cells in this layer perform a crucial information-processing function, 
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presumably integrating and processing cortical signals via layers I and II of the EC, 
then controlling the passage of this information to the hippocampus. 
 
Layer IV, the lamina dessicans (LD), contains a sparse number of pyramidal cells in 
its deeper sections, and is rich in myelinated fibres. In the rostral sections of the EC, 
layer IV is not readily apparent. Cajal (1911) described the LD as a distinct layer, 
whereas Lorente de No (1933) described the majority of the layer as a subset of layer 
III, with his layer IV referring to the small group of pyramidal neurones contained 
within the deeper lamina dessicans.  Whatever terminology is applied, it is clear that 
the majority of layer IV consists of fibres from cells in other layers traversing the LD 
(Amaral et al., 1987). 
 
The majority of principal cells in layers V and VI are pyramidal cells, however there 
are also a number of bipolar and multipolar cells (Gloveli et al., 2001). The pyramidal 
cells in these layers possess prominent apical dendrites, extending towards the 
superficial layers of the EC. The axons of these cells extend into the white matter, and 
also towards the more superficial layers of the EC. The somata of these deep 
pyramidal cells are significantly smaller than those of the pyramidals in layers II and 
III (Buckmaster et al., 2004). 
 
Inhibition in the deeper layers of the EC is less pronounced than the tight control 
exerted by interneurones in the superficial layers. Excitatory postsynaptic potentials 
(EPSPs) dominate IPSP activity in the deep pyramidal neurones. Inhibitory responses 
in layer V are very weak, and in some cases they are not apparent at all (e.g. Jones and 
Heinemann, 1988). Woodhall et al. (2004) showed that there was a four-fold higher 
basal frequency of spontaneous IPSC activity, and a greater intensity and frequency of 
IPSC bursts, in layer II compared to layer V. The proportion of activity dependent 
inhibitory events was found to be much greater in layer V than in layer II, i.e. the 
inhibitory system in the superficial layers is more constitutively active than the 
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interneurones of the deep layers. The superficial layers of the EC are said to be more 
“epilepsy resistant” than the deeper layers, this is possibly explained by the increased 
inhibition in the superficial layers, reducing the chances of excitatory synchronisation 
and subsequent epileptogenesis (Jones and Lambert 1990a; Jones 1993; Woodhall et 
al., 2004). The direct link of inhibitory activity levels and susceptibility to 
epileptogenesis has, however, been challenged by studies linking GABAergic 
inhibition with the promotion of synchronous activity (Cobb et al., 1995). There is 
evidence to suggest that the difference in basal inhibitory activity between EC layers 
is due, at least in part, to lamina-specific differences in presynaptic GABAB 
autoreceptor activity. Bailey et al. (2004) found that feedback control (reduction) of 
GABA release by metabotropic autoreceptors occurs tonically in layer V, but not in 
layer II. This would go some way to explain the lamina-specific differences in 
inhibitory activity. 
 
Transmission and Activity in the EC 
 
Our laboratory has long been focussed on the properties of transmission in the mEC, 
largely due to its involvement in TLE. Several studies have been undertaken detailing 
the lamina-specific differences in spontaneous and evoked transmission in the mEC, 
providing valuable insight into the physiology and pathophysiology of this area. 
 
Lamina-specific Differences in Activity-dependent Transmission 
 
Early work highlighted the properties of neurones in the deeper layers. In layer V, it 
was shown that low-frequency stimulation of afferent pathways leads to a dominance 
of excitatory synaptic activity, particularly NMDA receptor-mediated responses. In 
contrast, inhibitory activity in layer V was weak (Jones, 1987; Jones and Heinemann, 
1988). The relative dominance of excitatory activity in deeper layers has also been 
replicated by Funahashi and Stewart (1998) in the pre- and parasubiculum. Excitatory  
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Figure 1.3: Laminar structure and intrinsic connectivity of the mEC. Top: Location of 
the mEC in the slice preparation used within the experiments in this thesis. Bottom: 
The principal cells (pyramidal in layers III and V, stellate in layer II) are well 
connected both to each other and to external structures such as the hippocampus and 
neocortex. There is a great deal of inhibitory control exerted upon the principal cells 
by the GABAergic interneurones, especially in the superficial layers. Diagram from 
van Haeften et al., 2003. 
 
activity in layer V is subject to powerful frequency-dependent facilitation, and has 
been shown to cause repetitive firing and, in extreme cases, the generation of 
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synchronised population discharges (Jones, 1993, 1994; Cunningham et al., 2000). 
This facilitation would appear to be dependent upon the activity of NMDAr. 
Intracellular recordings show that layer V cells undergo a slightly larger degree of 
AMPAr-mediated facilitation than layer II cells, but the difference is not significant. 
However, NMDAr-mediated facilitation is clearly and significantly greater in layer V 
than in layer II (Jones and Woodhall, 2005). 
 
Activity in layer II, contrastingly, is dominated by inhibition. Whereas low-frequency 
stimulation in layer V produced a greater proportion of excitatory activity, similar 
studies in layer II indicated that the majority of responses to this stimulation were 
GABAA mediated inhibitory events (Jones, 1994; Glovelli et al., 1997; Heinemann et 
al., 2000). However, this inhibitory dominance is highly dynamic. With increasing 
stimulation frequency, inhibitory interneurones in layer II become increasingly labile, 
to the point that activity in layer II shifts towards increased excitation at stimulation 
frequencies above 1 Hz (Jones, 1993, 1994, 1995; Glovelli et al., 1997). This 
frequency dependent depression of inhibitory activity is, however, even more 
pronounced in layer V, further emphasising the dominance of excitation in the deeper 
layers (Jones and Woodhall, 2005). 
 
Lamina-specific Differences in Spontaneous Transmission 
 
A presynaptic membrane does not have to be depolarised by an action potential in 
order to release neurotransmitter. Spontaneous release of single quanta is a feature 
thought to be common to all synapses, and enabled the formulation of the quantal 
theory of neurotransmission in the first place (Del Castillo and Katz, 1954; Sara et al., 
2005). During in vitro intracellular recording, principal neurones in the superficial 
layers of the mEC remain quiescent and do not fire action potentials constitutively, 
presumably due to the large amount of inhibitory innervation in layers II and III, as 
discussed above. However, this does not mean that there is no excitatory release on to 
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these cells, and patch clamp studies have shown a constant generation of EPSCs in 
these cells, due to the release of glutamate from surrounding neurones. It should be 
noted that this activity continues to some extent even in the presence of the voltage-
gated sodium channel blocker tetrodotoxin (TTX), the remaining activity being 
termed as miniature excitatory post-synaptic currents (mEPSC) (Cunningham et al., 
2000). 
 
These miniature and spontaneous events also exert a great deal of control over the 
target cell. A single excitatory quantum can cause the generation of an action potential 
in small postsynaptic neurones, whilst single inhibitory quanta may delay, or even 
suppress, postsynaptic firing (Lu and Trussell, 2000; Carter and Regehr, 2002). It has 
recently been shown that activity-independent miniature events are mediated by the 
release of neurotransmitter from a distinct population of presynaptic vesicles, i.e. a 
separate pool from vesicles releasing neurotransmitter in response to action potentials 
(Sara et al., 2005). 
 
Our laboratory has carried out a range of studies investigating this spontaneous 
activity in the EC, using whole-cell voltage clamp to monitor spontaneous EPSCs and 
IPSCs. Neurones throughout the EC are constantly bombarded with both glutamate 
and GABA, released spontaneously from surrounding pre-synaptic boutons (Berretta 
and Jones, 1996a; Bailey et al., 2004; Woodhall et al., 2004; Jones and Woodhall, 
2005).  
 
Excitation 
 
Spontaneous excitatory activity, mediated by glutamate release, has been shown in 
both layer II and layer V to be largely independent of action potential activity, as the 
addition of TTX caused only a 15-20% reduction in sEPSC frequency (Berretta and 
Jones, 1996a). Comparing the baseline levels of spontaneous activity between deep 
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and superficial layers, average frequency of sEPSC activity is slightly, but 
significantly, higher in layer V than in layer II. Additionally, the amplitude of sEPSCs 
in layer V is significantly greater (Berretta and Jones, 1996a; Jones and Woodhall, 
2005). The reasons for this difference could be that excitatory terminals in layer V are 
more proximally located than in layer II, with evidence to suggest that layer II EPSCs 
are subject to a greater degree of dendritic filtering. Furthermore, recurrent excitatory 
connections in layer V of the mEC are very common, whilst being practically non-
existent in superficial layers (Dhillon and Jones, 2000). 
 
As well as frequency and amplitude differences, there would appear to be significant 
differences between the receptors mediating sEPSC activity in deep and superficial 
EC layers. Studies in Mg
2+
-free artificial cerebro-spinal fluid (ACSF) indicate 
expression of functional NMDAr in both layer II and layer V of the mEC. However, 
R-AP5 sensitive events were considerably more frequent in layer V, and a significant 
R-AP5 sensitive component exists within layer V sEPSCs recorded in normal ACSF, 
something not seen in layer II. This could suggest a greater expression of NMDAr in 
layer V. Alternatively, the expressed NMDAr could be more available to 
spontaneously released glutamate in deeper layers, perhaps due to differences in the 
site of expression (Berretta and Jones, 1996a; Jones and Woodhall, 2005). 
 
Inhibition 
 
As mentioned above, spontaneous inhibition of neurones in the mEC arises from the 
constant release of GABA, activating GABAA receptors in the post-synapse. A 
secondary component, a standing inhibitory current mediated through tonic GABAAr 
activation, has been proposed and located in areas such as the cerebellum and 
somatosensory cortex (Brickley et al., 1996; Salin and Prince, 1996). However, our 
laboratory has not been able to demonstrate such a component in any part of the mEC 
(Woodhall et al., 2004; Jones and Woodhall, 2005) in rats aged 6-9 weeks, an age 
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where tonic GABA conductance would be expected to be prominent (Hall and 
Usowicz, 1997). 
 
sIPSCs in the mEC possess broadly the same pharmacological characteristics, 
regardless of layer. However, there are significant differences in spontaneous release 
of GABA when layers II and V are compared. sIPSCs have a baseline frequency of 
approximately 12 Hz in layer II, compared with 2.5 Hz in layer V. Additionally, layer 
II neurones exhibited frequent and sustained bursts of sIPSC activity. These bursts 
were also evident in layer V, but were less frequent and contained fewer events 
(Woodhall et al., 2004). 
 
In contrast to the largely activity-independent EPSCs found in both deep and 
superficial layers, there are stark differences between the proportion of activity-
dependent GABA release in layer V and layer II of the mEC. Addition of TTX caused 
a reduction of 1-2 Hz in both layers. However, the baseline frequency of IPSCs in 
layer II was approximately 10-fold greater than layer V. Therefore, layer II inhibitory 
activity is largely (≈ 90%) activity-independent, whereas the proportion of miniature 
and AP-dependent IPSCs in layer V is about 1:1 (Jones and Woodhall, 2005). 
 
Background Activity and Cellular Excitability 
 
As discussed in the previous section, there is a constant release of both excitatory and 
inhibitory neurotransmitter onto cells throughout the cortex. This constant, 
background release differs between layers, and can have effects on the properties of 
principal cells within these layers. Furthermore, there is significant evidence to 
suggest that this background activity, a form of synaptic “noise”, contributes to the 
enhancement of signal detection (Stacey and Durand, 2000, 2001) and integration 
(Destexhe and Pare, 1999; Ho and Destexhe, 2000), and modulates gain to affect the 
input-output characteristics of cells (Hausser and Clark, 1997; Stevens and Zador, 
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1998; Chance et al., 2002; Fellous et al., 2003; Wolfart et al., 2005), e.g. gain 
modulation (Shu et al., 2003a) their resting properties (Pare et al., 1998a, b), their 
firing (Harsch and Robinson, 2000) and oscillatory behaviour (Dorval and White, 
2005) through the phenomenon of stochastic resonance (Rudolph et al., 2004). 
 
By way of illustration (see Fig. 1.4), we can imagine a weak signal as a sine wave that 
peaks just below the detection threshold (e.g. the firing threshold of a neurone). With 
a “clean” signal, the peaks of the wave will never breach the detection threshold, and 
the signal will never be acknowledged by the target neurone. However, if we 
introduce noise to the signal, at certain points additive noise will coincide with the 
peak of the wave, pushing the signal above threshold and enabling its detection. 
 
 
Figure 1.4: Random noise aids detection of subthreshold signals. A: A clean 
subthreshold signal never breaches the detection threshold, resulting in no output 
from the receiving cell. B: Addition of random noise, for example the constant 
background release of neurotransmitter, will eventually result in a peak subthreshold 
signal coinciding with additive noise, leading to a breach of the detection threshold 
and output from the target cell. 
 
It is clear that the combination of action potential-dependent and -independent release, 
in vivo at least, provides a possible method to aid signal detection through stochastic 
resonance, where sub-threshold synaptic events are pushed above threshold due to the 
presence of background activity. Thus, the relative level of inhibitory and excitatory 
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background activity is a reflection of network activity and is instrumental in 
determining the excitability of any given neurone. 
 
Changes in the level of background release are thought to be the cause of a range of 
network phenomena. There has been a great deal of recent research into the 
phenomenon of stochastic resonance in the modulation of neuronal and network 
properties, ranging from in vitro and in vivo electrophysiological approaches to in 
silico simulations of large neuronal networks (Hausser and Clark, 1997; Pare et al., 
1998a, b; Stacey and Durand, 2000, 2001; Rudolph et al., 2004). This range of 
approaches has allowed the problem to be approached from both sides, the 
computational studies lead to modelling methods that can subsequently be used to 
extract more information from electrophysiological data, as will be discussed later. 
 
In an intact brain in vivo, the level of background activity is so intense that it causes 
cortical neurones to attain a “high-conductance” state, in which the observed neurone 
is subject to such high levels of bombardment from surrounding cells that the 
membrane potential shows high-amplitude fluctuations and can be almost constantly 
depolarised (Vm around -65mV) when compared to quiescent cells in the absence of 
synaptic noise (Destexhe et al., 2003; Rudolph and Destexhe, 2004). These high-
conductance states are thought by some to be the cause of spontaneous sub-threshold 
depolarisations, “up-states”, which are most prominently observed in vivo during 
slow-wave sleep and under certain types of anaesthesia. However, some contention 
exists as to how much background activity is necessary to cause these spontaneous 
depolarisations. 
 
During intracellular recordings of principal neurones in vivo, and under certain 
conditions in vitro, the membrane potential of the observed neurone can be seen to 
suddenly undergo a sustained depolarisation, lasting several seconds and having an 
amplitude of as much as 20mV. These “up-states” would appear to be driven by 
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synchronised volleys of synaptic activity (Cowan and Wilson, 1994; Peterson et al., 
2003), leading to two distinct periods, one where neurones are subject to “normal” 
background activity, and another whereby increases in activity cause up- or high-
conductance states. Steriade et al. (1993) first proposed the distinction of up-states as 
slow oscillations separate from other observed cortical rhythms found in sleep or 
under anaesthesia. These up-states were found exclusively in pyramidal cells with 
large dendritic arbours, in layers III-VI of several cortical areas (association, motor 
and visual). It has been proposed by Cossart et al. (2003) that such up-states represent 
“circuit attractors”, an emergent network phenomenon that enables simple processing 
units (e.g. neurones) to function as highly complex computational units (Hopfield, 
1982). This circuit attraction property may form the basis of memory retention or 
computational function in neuronal networks. 
 
Waters and Helmchen (2004) show that up-states can be tracked throughout different 
parts of cortical neurones through matching with electrocorticogram (ECoG) 
recordings. By carefully matching patch-clamp recordings from somata, dendritic 
tufts and apical trunks with the time-course of up-states recorded with ECoG, it was 
concluded that up-state activity promotes action-potential back-propagation 
throughout the dendritic structure, with up-states occurring simultaneously across the 
entire neurone (instead of starting at one point and propagating outwards). Thus, up-
state activity increases the back-propagation of action potentials and subsequently 
increases AP-mediated calcium influx in the distal apical dendritic tree; this increases 
the level of association between deep and superficial neurones in vivo, and serves as a 
feedback signal to enhance the accuracy of time-dependent signalling in active 
dendrites.  
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Background Release and the Generation of Up-States 
 
The mechanistic causes of up-states are subject to some debate. It is entirely possible 
that the fluctuations investigated by various groups actually represent different 
manifestations of similar phenomena, however this does not explain the direct 
contradiction of certain theories on this matter. Destexhe et al. (2003) propose that up-
states are high-conductance states triggered by intense cortical activity, and are 
representative of neuronal function in the awake state. This assertion was based on 
intracellular electrophysiology performed in awake behaving animals (e.g. Matsumura 
et al., 1988; Baranyi et al., 1993; Steriade et al., 2001), where the recorded neurones 
were observed to have low input resistance (5 to 40 MΩ) and a depolarised, 
fluctuating membrane potential (-60 mV, σV 2-6 mV). These in vivo studies found 
consistent results regardless of the cortical area recorded. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5: Up-state activity in the barrel cortex. The top trace is a whole-cell 
recording of up-states in the barrel cortex of an anaesthetised rat. The bottom trace is 
electrocorticogram activity, indicating a cortex-wide increase in activity during an 
up-state. Dashed line (top) indicates -80 mV, solid line (bottom) indicates 0 mV. 
Adapted from Waters and Helmchen, 2004 
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Waters and Helmchen (2006) contend this notion of large amounts of synaptic activity 
being necessary for the generation of up-states. Using a combination of patch-clamp 
and computational methods, they have proposed that background activity is less 
prominent than previously thought, and that relatively sparse amounts of excitatory 
activity are necessary to instigate an up-state. They also forward the notion that 
Destexhe’s “high-conductance states” are, in fact, very small changes in the level of 
conductance (between 2-10 nS), with input resistance being increased by anomalous 
rectification. They account for differences in resistance and conductance measured by 
other groups to be a function of the level of action potential firing ongoing within the 
recorded neurones. This method of input resistance comparison has previously been 
rejected, however, by Destexhe et al. (2003), citing inconsistencies in the recording 
method and electrode properties between laboratories (and individual experiments) as 
being too variable to provide a reliable method of comparison. Furthermore, any 
comparison of resistance between in vitro studies, anaesthetised in vivo studies and 
awake behaving studies is confounded by the differences in cortical state between 
each approach – in the awake behaving animals, for example, the resistance changes 
markedly depending on what type of behaviour is being exhibited. 
 
Differences seen between in vitro and in vivo cellular characteristics were elucidated 
by recordings in the presence of TTX (Pare et al., 1998b). Under local perfusion of 
TTX in vivo, the recorded neurones displayed attributes closely resembling those of 
neurones found in acute slices. From this it was concluded that differences in activity 
between in vitro and in vivo recordings is due to activity-dependent neurotransmitter 
release in vivo, as opposed to any sort of cellular damage caused by the recording 
process, or differences between electrodes used in vitro and in vivo. Up-states can be 
reproduced in vitro by increasing overall background activity through careful 
adjustment of the perfused ACSF. Reducing the concentration of magnesium and 
increasing the concentration of potassium compared to “normal” levels simulates 
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increased activity across the slice by increasing NMDAr activity and lengthening 
action potential duration. 
 
Using a reduced (1.25 vs 2.0 mM) Mg
2+
 concentration in the ACSF, Cunningham et 
al. (2006) were able to show that slow-wave oscillations or up-states in the EC are at 
least partly dependent upon the activity of GluR5-containing kainate receptors. 
Blockade of either NMDA or AMPA-type ionotropic glutamate receptors failed to 
abolish up-state generation (although the characteristics of the up-states were altered 
in the presence of the AMPA receptor antagonist SYM-2206). However, when the 
GluR5-specific antagonist, UBP-302, was added, up-state activity was abolished, both 
at the single-cell and network levels. Cunningham et al. (2006) proposed that slow-
wave oscillations were highly dependent upon Glu-R5 KAr, but also partly governed 
by metabolic activity, based on oscillations are a function of ATP-modulated 
potassium channels. KATP blockade with tolbutamide led to prolonged “up” phases, 
and increasing KATP activity with diazoxide led to longer “down” periods. Blockade 
of KATP channels by MgATP slowed the transition between up- and down-state. The 
increased activity seen during up-states may cause rapid depletion of intracellular 
ATP, leading to KATP opening and the termination of the up-state. 
 
Conductance Estimates from Membrane Fluctuations 
 
The challenge of measuring background synaptic activity during high-conductance 
states has led to a range of approaches, as discussed previously. The most promising 
avenue would appear to be the combination of computational simulations with more 
traditional electrophysiology. This thesis uses a method developed by Alain 
Destexhe’s group to quantify background levels of excitation and inhibition, at the 
same time, in the same cell, based on membrane voltage fluctuations recorded 
intracellularly from principal neurones. 
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The whole-cell voltage clamp approach used previously in our laboratory does not 
lend itself well to relating the level of background activity to cellular excitability. 
Generally, experimental recording conditions are established to record either 
excitatory or inhibitory currents in isolation. The somatic recording location means 
that more distally located currents may not be detectable. Most importantly, the 
inclusion of blockers of voltage-gated ion channels in the patch pipette solution, to 
improve space clamp etc., largely precludes meaningful estimates of cellular 
excitability. Sharp-electrode intracellular recording allows for the latter, but does not 
provide high enough electrical resolution for direct observation of small amplitude 
background synaptic events. 
 
In 2004 Destexhe’s group described a method of estimating global background 
synaptic conductances from measurement of fluctuations in membrane potential 
(termed VmD) derived from sharp electrode intracellular recordings (Rudolph et al., 
2004). The analytic expression of mean and standard deviation of membrane potential 
distribution permits simultaneous estimation of the global background excitation 
mediated by glutamate acting at AMPA receptors (EBg) and background inhibition 
(IBg, due to GABA acting via GABAA receptors). Importantly, the use of intracellular 
recording allows us to simultaneously obtain measurements of cellular excitability 
and, thus, to relate excitability to relative levels and changes in EBg and IBg. 
The Destexhe group’s approach to modelling background conductance from single-
neurone recordings is based on two fundamental starting points, both having roots in 
stochastic calculus and the description of the time evolution of random processes.  
 
The Fokker-Planck equation (see Eq. 6) is used to describe the time evolution of 
probability density functions for the velocity and position of a particle subjected to a 
Wiener process (Brownian motion). The equation can be used outside the confines of 
equations of motion in order to model processes with a relatively small number of 
important variables, with other factors varying in such a random and rapid manner 
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that they can be considered to be noise, very much like the membrane potential of a 
neurone in an active network. Consider that the spontaneous release of 
neurotransmitter onto a given cell can be described as a Poisson process (i.e. one that 
is random, orderly and without memory). Under intense periods of synaptic activity 
(high conductance states), the release of transmitter has an average frequency of 1 Hz 
for excitatory synapses and 5 Hz for inhibitory synapses (Destexhe and Pare, 1999). 
This barrage of synaptic activity causes the membrane potential to undergo a 
continuous random walk, and this potential distribution can be said to be a time-
homogeneous Markov process (i.e. its future state does not depend upon its past state) 
that obeys the Fokker-Planck equation as an Ornstein-Uhlenbeck process. 
 
The Ornstein-Uhlenbeck (OU) process (Uhlenbeck and Ornstein, 1930) is a stochastic 
process that can be used for describing low-pass filtered Gaussian white noise, which 
was originally forwarded in the 1930s as a model of Brownian motion: 
 (Eq. 1) 
 
In this form (Eq 1.) the equation serves as an approximation of the one-dimensional 
Brownian motion of a particle in a liquid, where W(t) is a Wiener process (essentially 
white noise), V(t) is the particle’s velocity, m its mass and βV(t) is representative of a 
friction proportional to the velocity. The OU process is easily adapted to express a 
range of other situations such as harmonic motion or membrane voltage under 
synaptic bombardment simply by changing the meaning of the constants. 
 
Rudolph and Destexhe (2003) use the OU process to describe the time-dependent 
probability density functions of several components of their neuronal models. By 
adapting the OU equation to predict the probable distribution of membrane voltage for 
a given set of conductances and cellular parameters, and then setting up a 
simultaneous equation using two levels of injected current to work the model 
backwards and predict conductances from membrane voltage distribution, they were 
( ) ( ) ( )dttVtmdVtdW β+=
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able to arrive at the VmD method, used in this thesis for all background conductance 
estimates. 
 
The initial step (Destexhe et al., 2001) was to describe the passive membrane 
properties of cortical neurones by the following equation (Eq 2): 
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Here V(t) is membrane potential, Cm represents specific membrane capacitance (e.g. 
Gentet et al., 2000), a is membrane area, gL is leak conductance and EL is leak 
reversal (this latter variable can be obtained through recordings of neurones in 
completely quiescent states). Isyn represents current mediated by receptors subject to 
synaptic bombardment. This passive membrane equation (Eq. 2) was incorporated (Eq. 
3) into a point conductance model (Destexhe et al., 2001; Rudolph et al., 2004) which 
introduces a constant stimulating external current, Iext.  
  
   (Eq. 3) 
 
We now have two sources of current onto our passive membrane – the external 
stimulation Iext and the synaptic noise, described by the total synaptic current Isyn(t), 
which is split further into two independent components; excitatory conductance (with 
reversal potential) and inhibitory current (again with its own reversal potential). This 
current breakdown can be described by the following equation: 
 
 (Eq. 4)  
 
Here ge and Ee are excitatory conductance and reversal, respectively, and gi and Ei are 
inhibitory conductance and reversal. We see clearly from this equation that Isyn(t) is 
merely the function of two distinct conductances over time, based on the present state 
of the membrane voltage (V(t)) and nothing else. The above-mentioned OU equation 
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can be used to describe the time-evolution of the excitatory and inhibitory 
conductances as a one-variable stochastic process: 
 
   (Eq. 5) 
 
In Equation 5, the concept of average conductances, describing the estimated mean 
level of excitatory (ge0) and inhibitory (gi0) activity mediated by AMPA and GABAA 
receptors, respectively, is introduced. Also taken into account are the time constants 
(τ{e,i}) of the receptors involved in mediating these currents. To make a workable 
model, these are taken to be AMPA and GABAA receptors, which are the main 
excitatory and inhibitory populations in cortical neurones. The random nature of 
synaptic activity is simulated by a white-noise process (χ{e,i}) described with zero 
mean and standard deviation σe and σi for excitatory and inhibitory noise respectively. 
 
The point-conductance model described in Equations 3-5 was tested analytically and 
numerically against two more complex models (a single-compartment model and a 
detailed biophysical model) by Rudolph et al. (2004), using a NEURON simulation 
environment (Hines and Carnevale, 1997). It was concluded that the point-
conductance model provided an estimation of synaptic conductance to a degree of 
accuracy comparable to the other, more detailed models, whilst being simpler (and 
faster) to simulate and more readily manipulated. Rudolph et al. found that the time 
course of the probability density function ρ(V,t) of the membrane voltage (Vm) 
attaining voltage V at time t could be described by solving the Fokker-Planck equation 
for the point conductance model detailed above (as described in detail in Rudolph et 
al., 2004). It was also observed that the voltage distribution for a neurone in an active 
network at physiological voltages (between around -70 and -50 mV) is only very 
weakly asymmetric, and could therefore be approximated to a Gaussian distribution. 
This allowed a simplified version of the Fokker-Planck equation for the point-
conductance model to be derived, hence: 
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    (Eq. 6) 
 
Here ρ(V) is the probability of voltage V, with V representing the average voltage and 
σV the standard deviation of the voltage distribution. This approximation can be 
further refined by replacing the exponential function in the Fokker-Plank with a 
Taylor expansion (a representative of a function calculated from single-point values of 
its derivatives) based on the maximum V  of the probability ρ(V). The Gaussian 
distribution of the voltage can then be based around the following equations: 
          (Eq. 7) 
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This expression of the average voltage yields the Gaussian distribution: 
    (Eq. 8) 
 
 
 
The variance is given by: 
 
 
          (Eq. 9) 
 
Here S0 and S1 are defined in the average voltage equation (Eq. 7). Using two levels of 
injected external current, two simultaneous equations are formed, which allows the 
model to be inverted, meaning that the values for synaptic conductance can be 
deduced from the voltage distribution over time. In practice, this involves taking the 
average and standard deviation of membrane voltage at two levels of injected current, 
and entering them into the following equation: 
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          (Eq. 10) 
 
This (Eq. 10) is the equation central to the VmD method. It gives estimates of average 
background synaptic conductance, split into excitatory (ge0, referred to in this thesis as 
EBg) and inhibitory (gi0, referred to as IBg) components, based on the reversal 
potentials of AMPA and GABAA receptors and the passive membrane parameters 
such as leak conductance and input resistance. The estimates are based on working 
out the conductances from the membrane probability density outlined by the Fokker-
Plank and Ornstein-Uhlenbeck functions used to construct the point conductance 
model, by finding the best-fitting parameters for a voltage distribution that is already 
there, rather than predicting the probable voltage generated by certain conductance 
parameters, the model is working backwards to glean information from real neurones. 
 
The second part of the VmD equation (Eq. 11) calculates the variance (and hence 
standard deviation, SD) of the background synaptic conductances. This may provide 
important information concerning the level of synchronous activity in inhibitory and 
excitatory neurone populations. It has been suggested that an increase in SD in EBg, 
for example, would reflect increased synchronisation among principal neurones. As a 
result of coordinated firing, there would be time-locked release of glutamate from 
multiple terminals resulting in larger “peaks” of voltage changes. EBg and IBg 
variances are described by the following equation: 
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          (Eq. 11) 
This estimation of variance requires special treatment of the time constants of the 
modelled receptors ( },{
~
ieτ ). These are referred to as “effective noise time constants”, 
and their purpose is to improve the accuracy of the variance estimation by correcting 
for synaptic noise filtering effects. The time constants are defined as: 
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=τ   (Eq. 12) 
 
Hence the time constants used in the variance estimation take into account the global 
background conductance estimates made in the first part of the VmD method. 
 
The validity of the VmD method was tested by Rudolph et al. (2004) using a variety 
of methods. Firstly, two different computational models were run concurrently with 
VmD approximations. The VmD voltage distributions strongly agreed with those 
obtained through both a point conductance model and a more detailed, multi-synaptic 
model where noise was simulated by stochastic release from around 4000 synapses. A 
more demanding computational test of the method was performed by comparison with 
a highly detailed biophysical model, in which randomly firing synapses were 
distributed randomly across the soma and dendrites of the modelled “recorded” 
neurone. Once again, VmD-derived estimates of voltage distribution were in 
agreement with those obtained using the detailed model, however there was some 
slight discrepancy at the extreme ends of the distributions. Encouragingly, it was 
shown using this model that dendritic filtration of synaptic input, and active dendrites 
driven by voltage-sensitive currents (e.g. INa, IKA, Ih) cause only minor deviations in 
the distributions of membrane potential and background conductance predicted by the 
VmD equations, that do not significantly affect the accuracy of the obtained estimates. 
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The final test of the reliability of the VmD method was performed using a dynamic 
clamp approach in vitro. Up-state firing cells were recorded and levels of IBg and EBg 
during up-state activity were estimated using the VmD method (Fig. 1.6). 
Stochastically fluctuating current, within the parameters estimated by the VmD 
equation, was then injected back into the same neurone. Upon current injection, an 
“artificial” up-state, closely resembling those fired spontaneously by the cell, was 
observed. Thus, VmD estimates are able to re-create the input to a principal neurone 
during an up-state, suggesting that the acquired estimates are an accurate portrayal of 
the synaptic activity around the observed neurone. 
 
 
 
Figure 1.6: Artificial up-state activity. Using the conductance parameters gained 
from the VmD method, Rudolph et al. (2004) were able to mimic up-state activity by 
injection of current during dynamic clamp recordings. 
 
In summary, it is clear that the EC is a vital brain structure, both in the normal 
function of the mammalian brain, and in its role in TLE. Equally clear is that 
background activity can exert a large amount of control over neurones throughout the 
cortex, leading to increased synchronisation and the appearance of high-conductance 
states, or up-states. Using the VmD method, I aim to link the levels of background 
conductance estimated with the above equations to levels of cellular excitability 
within the EC, and observe how one or both of these properties changes in the 
presence of a range of pharmacological tools. 
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Specific aims of this thesis: 
 
• To test and verify the VmD method in principal cells in layers II, III and V 
of the mEC 
• To characterise the changes in global conductance estimates mediated by a 
range of pharmacological tools, and link these changes to levels of cellular 
excitability 
• To investigate the differences, if any, between conductance levels in 
different layers of the EC, especially with regards to seizure generation 
• To observe the effects on background activity, and hence gain possible 
insight into the mode of action, of a range of poorly understood drugs, i.e. 
anticonvulsants 
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CHAPTER 2 
METHODS 
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Introduction 
 
All the experiments in this thesis were conducted in combined EC-hippocampal slices 
prepared from rat brain. The electrophysiological approach involved conventional, 
sharp-electrode intracellular recordings of membrane potential, made “blind” in slices 
maintained in an interface chamber. The majority of recordings were made from 
pyramidal neurones in layer III of the mEC. However, in one study (Chapter 5) 
comparison was made with stellate/pyramidal neurones of layer II and pyramidal cells 
in layer V. 
 
Slice Preparation 
 
Slices were prepared as originally outlined in Jones and Heinemann (1988). Three to 
four-week old male Wistar rats (50-70 g) were used in all experiments. Rats were 
either anaesthetised (ketamine 120 mg/kg and xylazine 80 mg/kg i.m.) and 
decapitated, or killed by cervical dislocation and decapitated. The entire brain was 
rapidly removed and placed in normal artificial cerebrospinal fluid (ACSF, see table 
2.1) at ≈ 4°C. The cerebellum was removed, and the cerebrum dissected into two 
hemispheres by cutting the corpus callosum along the central sulcus. Sections of each 
cerebral hemisphere were removed by making a transverse incision several 
millimetres from the dorsal surface of the cerebrum, parallel to the base of the brain. 
This incision allows for a flat surface for mounting the brain during slicing. 
 
The dissected cerebral hemispheres were attached by their cut dorsal surfaces to a 
Teflon slicing plinth using cyanoacrylate adhesive, and quickly rinsed using more ice-
cold ACSF. The plinth and mounted brain were then transferred to the chamber of a 
Vibroslice (Campden Instruments, Loughborough, UK) filled with cold ACSF, 
continually gassed with 95% O2 / 5% CO2. Also included in the slicing solution was 
uric acid (300 µM), N-acetyl-cysteine (250 mM), indomethacin (45 µM) and 
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ketamine (200 µM). Empirical evidence from our laboratory shows that the COX 
inhibitor indomethacin greatly improves the quality of the obtained brain slices, with 
more viable cells, whilst the neuroprotective effects of anti-oxidants such as uric acid 
and N-acetyl-cysteine are well documented (Sekhon et al., 2003; Jayalakshmi et al., 
2005). An improvement in slice viability is also gained through the use of ketamine, 
and this is likely to result from a reduction of excitotoxicity, mediated through a 
blockade of NMDA receptors (Church et al., 1988; Fujikawa, 1995). These 
manipulations have been used in this laboratory for a number of years, and produce 
slices of high quality, with no evidence for any irreversible abnormal effects. 
 
 Normal ACSF Recording ACSF Up-state ACSF 
NaCl 126 126 126 
KCl 3 3.75 3.75 
MgSO4 2 1.5 1.25 
NaHCO3 19 19 19 
NaH2PO4 1.4 1.4 1.4 
Glucose 10 10 10 
CaCl2 2 2 2 
Table 2.1: Composition of artificial cerebrospinal fluid (mM) 
 
Slices were cut with vibration set to 75% of the maximum speed of the vibroslice, 
moving from posterior to anterior at an ultra-slow pace (2-3 mm per minute). Once 
the hippocampal formation was clearly observed, along with the beginnings of the 
rhinal sulcus, slices were cut at 350-400 µM and transferred to a holding chamber 
(BSC-PC, Harvard Instruments, USA) for recovery. Slices containing the EC and 
hippocampus were dissected from the horizontal sections, with appearance shown in 
Fig. 1.3. Slices were cut and retained until the rhinal fissure was no longer apparent in 
the tissue block. This led to slices containing all hippocampal areas (e.g. CA1-3, 
dentate gyrus), subiculum, lateral and medial EC and part of the remainder of the 
parahippocampal cortex. mEC layers were identified based on their distance from the 
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A 
 
95% O2/5% CO2 
 
 
B 
 
 
Figure 2.1: Design of brain slice holding chambers. A: Original in-house chamber 
constructed from syringes. B: Harvard BSC-PC made from machined Perspex. After 
cutting, slices are immediately transferred to the holding chamber, where they sit on a 
nylon mesh, fully submerged in ACSF. Carbogen gas (95% O2 5% CO2) is bubbled 
through the chamber, causing the ACSF to circulate, and ensuring that the slices are 
well oxygenated. Slices in these chambers can stay viable for 6-8 hours after slicing. 
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pia and the position of the lamina dessicans, if apparent. In all experiments in this 
thesis, no attempt was made to distinguish results obtained from ventral slices as 
opposed to those from more dorsal levels. 
 
The slices were allowed to recover at room temperature for at least one hour before 
recording. The holding chamber for the slices was filled with normal ACSF, along 
with N-acetyl-cysteine (250 mM) and uric acid (300 µM). The chamber was gassed 
constantly with 95% O2 / 5% CO2 and was of a design that allowed gassed ACSF to 
freely circulate around the chamber, maintaining optimum conditions for slice 
preservation. Slices sat on a nylon net at the bottom of the main holding chamber, and 
were completely submerged. Two different holding chambers were used over the 
course of this project. Originally, I used a chamber constructed in-house from the 
barrels of plastic syringes and a 250 ml Pyrex beaker (Fig. 2.1A). More recently a 
commercially available holding chamber was substituted for this (Harvard BSC-PC; 
Fig. 2.1B), and subjective evidence suggests that this has provided a further increase 
in slice quality. 
 
Intracellular Recording 
 
After the recovery period, individual slices were transferred to the recording chamber 
for experimentation. The custom made chamber was of a standard interface design, 
with a heated water compartment below the recording area that maintained a constant 
temperature of 32°C in the recording chamber. The water in the heated compartment 
was maintained at around 35°C by means of a thermistor controlled power supply, in 
order to achieve a temperature of 32°C in the recording compartment. Carbogen gas 
(95% O2 / 5% CO2) was constantly bubbled through the distilled water in the bottom 
of the chamber to maintain a high degree of humidity above the slices and prevent 
desiccation. Vents in the side of the recording chamber allowed the humidified gas 
access to the slices. 
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Recording ACSF (or up-state ACSF) gassed with carbogen was perfused through the 
recording chamber using a peristaltic pump (Gilson Minipuls 3) at a rate of 1.0 to 1.5 
ml/min. The ACSF was preheated to 28-30°C to prevent gas bubbles forming in the 
perfusion line and recording chamber. It was gassed with carbogen and had a pH of 
7.3 at the recording temperature. The perfusion lines entered the heated water 
chamber before being directed in to the recording chamber. Slices were placed on a 
nylon mesh with the pial surface of the EC facing away from the ACSF flow. Levels 
of ACSF in the recording chamber were altered using a nylon wick positioned 
downstream of the slice. The wick directed the ACSF to a drain hole at the bottom of 
the chamber, where fluid was removed by gravity to a waste bucket. Drug solutions 
were introduced by switching the perfused ACSF to a drug-containing ACSF using a 
three-way tap. Slices were allowed to equilibrate in the chamber for 15-20 minutes 
before recordings were attempted, to allow for anti-oxidant washout and recovery. 
 
Borosilicate glass pipettes (Clark/Warner Omega Dot, 1.2 mm outer diameter, 0.69 
mm internal diameter with internal filament) were pulled using a Flaming-Brown 
horizontal puller (Sutter Instruments P-87). Pipettes were filled with 3 M potassium 
acetate at least one hour before recording, and allowed to rest before use. Pipettes 
ideally had a resistance of 75-120 MΩ. This pre-fill method allows more stable 
recordings to be made as minute air bubbles are eliminated from the tip of the 
electrode during the resting period. 
 
Intracellular membrane potential recordings were obtained using an Axoprobe 1A 
(Axon Instruments, USA) in bridge mode with a 0.1X headstage. Recordings were 
made using a blind approach. The tip of the pipette was placed on the surface of the 
slice under visual control, using a binocular microscope (Leica Wild-M8). At this 
stage stray pipette and junction potentials were offset to zero using the voltage offset 
control of the amplifier. Hyperpolarising current pulses (50 ms) were injected at 1 Hz 
via the recording electrode using the step-command input of the amplifier and driven 
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by a Master-8 pulse generator (AMPI, Israel). The voltage deflection induced by the 
pulse was then adjusted to zero using the bridge balance control of the amplifier. At 
the same time any capacitance transients associated with the onset and offset of the 
pulses were minimised using the capacitance compensation control. 
 
The pipette was advanced slowly through the target area of the slice at a low speed 
using a Leitz manual micromanipulator, and the brief negative current pulses were 
continued. When an increase in resistance at the pipette tip occurred, signified by an 
increase in the voltage deflection during the current pulses, the Buzz control of the 
Axoprobe was briefly activated to attempt penetration of the potential cell at the 
pipette tip. During the buzz an oscillating voltage is applied to the pipette via the head 
stage capacitor, and the duration, frequency and amplitude of the voltage are set by 
amplifier controls. The mechanism by which this oscillation aids electrode penetration 
remains unknown, but it is highly effective. 
 
If a successful penetration was made, then constant hyperpolarising current was also 
injected in to the cell (0.1 – 1.0 nA) via a manual DC current command before starting 
recordings. This current injection stabilises the neurone at a negative potential and 
helps recovery from penetration. It is gradually removed as the membrane potential of 
the neurone stabilises towards a normal resting state. Any neurone that fired action 
potentials spontaneously when all manual current was removed was discarded from 
analysis. Neurones accepted for experimentation had stable resting potentials of > -65 
mV and action potentials that overshot zero by at least 10 mV. Data were stored on a 
Microsoft Windows based PC and acquired using a Digidata 1200B analogue to 
digital converter and Axoscope software (both Axon Instruments, USA). Recordings 
were digitised at 5 kHz and filtered at 2 kHz. 
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Patch Clamp Recording 
 
To further support the data obtained from the intracellular recordings, voltage clamp 
recordings of both inhibitory and excitatory spontaneous post-synaptic currents 
(sIPSC/sEPSC) were made from pyramidal neurones in layer III of the mEC. These 
spontaneous events are caused by the constant background release of both glutamate 
and GABA from synapses onto the recorded cell. Patch-clamp recordings of 
spontaneous events offer a more direct measurement of background excitation and 
inhibition, although these cannot be recorded at the same time, in the same cell. 
 
Individual slices were transferred (after recovery period) to a submersion chamber 
(Warner Instruments, Platform P1 with an RC-22C bath) perfused with normal gassed 
ACSF maintained at 31°C ± 1°C by an inline heater (Warner Instruments, SH-27B 
with TC-324 controller), and allowed to re-equilibrate for 20 minutes. Slices were 
visualised using a Zeiss Axioskop upright microscope and a differential phase-
contrast infra-red CCD system (Sony XC-77CE) with a CE-4 contrast enhancer 
(BRSL, Newbury, UK) to further improve visualisation of the slices. 
 
Borosilicate patch pipettes (Harvard PG120T-10, 1.2 mm OD, 0.93 mm ID) were 
pulled to a resistance of 1-4 MΩ using a Flaming-Brown type horizontal puller (Sutter 
Instruments P-87) and filled with either IPSC or EPSC patch solution, as described in 
Table 2.2. Before recording, the osmolality of the solution was measured using an 
Advanced Instruments M3300 Micro-osmometer. Solutions were diluted until the 
measured osmolality was 285 mOsmol/kg. pH was adjusted to 7.3 using CsOH. The 
patch solutions both contained the sodium channel blocker QX-314 to improve space 
clamp, and each solution was tailored to eliminate any unwanted activity i.e. the 
EPSC solution minimised IPSC activity and vice versa. These are the two primary 
reasons why our patch clamp method is not suitable for the simultaneous 
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measurement of inhibition and excitation, coupled with cellular excitability 
measurements, which the VmD method allows in intracellular recording. 
 
Pyramidal cells were visually selected from layer III of the mEC. No attempt was 
made to unequivocally identify the cells as pyramidal by dye injection, however all 
recorded cells possessed a clear pyramidal morphology. The micropipette was 
introduced to the cell membrane and a gigaseal was obtained through mouth suction. 
An Axon Instruments Axopatch 200B was used in voltage clamp mode (all cells were 
clamped at -60 mV) to record excitatory or inhibitory post-synaptic current events, 
dependant on the patch solution used. Access resistance was monitored at regular 
intervals, and if this changed by more than 10% during the course of the recording, 
the cell was rejected. Reversal potentials for both solutions were 0 mV. 
 
 EPSC Solution IPSC Solution 
CsCl 0 100 
HEPES 40 40 
QX-314 1 1 
EGTA 0.6 0.6 
MgCl2 0 5 
NaCl 2 0 
TEA-Cl 5 10 
Phosphocreatinine 10 10 
D-Gluconate 100 0 
Mg-Gluconate 5 0 
ATP-Na 4 4 
GTP-Na 0.3 0.3 
Table 2.2: Composition of patch solutions (mM) 
 
Recordings were stored using an Axon Instruments Digidata 1200B analogue to 
digital converter and saved directly to the hard disc of a Windows PC using Axoscope 
software (Molecular Devices, USA). Recordings were digitised at 20 kHz, and filtered 
at 2 kHz. Analysis of spontaneous EPSCs and IPSCs was performed off-line using 
MiniAnalysis software (Synaptosoft, USA). Spontaneous events were detected using 
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a threshold-crossing algorithm, and their inter-event interval (IEI), amplitude and 50% 
decay time were determined. Event detection threshold was adjusted for each neurone, 
to obtain the smallest events discernable from the baseline noise of the recording, and 
maintained at the same level throughout the analysis of that neurone. 200 consecutive 
events were analysed from both control and drug conditions of each neurone. 
 
These patch recordings were also used to obtain decay-time data for use with the SD 
estimation equation used in the VmD method. 95% decay times of both IPSCs and 
EPSCs were analysed using Mini-Analysis software (Synaptosoft, USA) and used to 
calculate the effective time-constants applied to the VmD method, as outlined in 
Chapter 1. These were chosen after consultation with Alain Destexhe. 
 
Reversal Potential Measurements 
 
In order to use the previously discussed VmD method (see Chapter 1), several 
parameters characterising the recorded cells were needed. Reversal potentials for 
AMPA and GABAA receptors, as well as leak conductance reversal, were required for 
each population of cells to be studied. Ideally, all these parameters should be 
determined for each neurone individually, but this is clearly impractical. Thus, a series 
of experiments was performed to obtain average reversal potentials for each layer of 
the mEC, which were then used in all later VmD estimations. 
 
Reversal potentials for AMPAr and GABAAr were obtained using evoked synaptic 
responses in the presence of a number of antagonists, at a range of membrane voltages. 
AMPAr mediated EPSP reversals were obtained in the presence of the GABAA 
antagonist bicuculline (10 µM), the GABAB antagonist CGP-55845A (5 µM), the 
NMDA antagonist 2-AP5 (30 µM) and the GluR5-specific kainate antagonist UBP-
302 (20 µM). A bipolar stimulating electrode was placed on the surface of the slice in 
layer V of the lateral EC. Synaptic responses were evoked using monopolar, square-
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wave pulses (0.1 ms duration, 5-30 V) delivered via the stimulating electrode at 0.05 
Hz using an isolated stimulator (AMPI Iso-flex, Israel) driven by pulses from the 
Master-8. The amplitude of the evoked AMPAr mediated EPSPs was set at about 85% 
of maximal, and they were recorder over a range of membrane voltages set by manual 
DC injection through the recording electrode. The first responses were measured at 
around -100 mV, and membrane voltage was then decreased in 5 mV steps until the 
recording became unstable (usually at around -40 mV), due to the failure of the 
pipette to pass current. Bridge balance was monitored throughout and adjusted as 
necessary. Five EPSPs were evoked at each voltage level, and these were averaged, 
graphed and extrapolated to determine the reversal potential. 
 
For GABAAr reversal potentials, the same procedure was carried out. The blocking 
cocktail consisted of CGP-55845A (5 µM), 2-AP5 (30 µM), UBP-302 (20 µM) and 
the AMPAr receptor antagonist NBQX (10 µM). 
 
Leak reversal potential is essentially the resting membrane potential of the cell when 
all synaptic activity is abolished. Ions flowing around the site of impalement, through 
voltage-dependent channels and by active transport all contribute to the resting 
potential of the cell, even without EPSPs and IPSPs mediated by synaptic activity. 
Using TTX in this instance is not appropriate, due to the constant background release 
of neurotransmitter from synapses surrounding the cell. Even when action potential 
activity is abolished, miniature EPSC/IPSC activity is still observed due to release of 
neurotransmitter from a distinct pool of vesicles at the pre-synaptic membrane (Sara 
et al., 2005). Instead, the AMPAr and GABAAr reversal potential blocker cocktails 
were combined, to ensure that all major receptors were blocked. 10 minute recordings 
of membrane potential were then made after a resting period of 20 minutes from first 
impalement. 
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The VmD Method 
 
Using the mean data collected for AMPAr, GABAAr and leak reversal potentials, and 
employing the intracellular recording method detailed above, the VmD method 
(Rudolph et al., 2004) was used to gain estimates of background excitatory (EBg) and 
inhibitory (IBg) conductance levels in principal cells of the mEC. When a stable 
intracellular impalement was obtained, resting membrane potential was recorded for a 
period of 10-15 minutes. At intervals thereafter, neurones were depolarised (for 10-15 
seconds) to two sub-threshold levels by injection of known positive currents (Iext1 and 
Iext2) via the recording electrode (Fig. 2.2B). The values of the currents differed from 
neurone to neurone, but were maintained the same throughout any individual 
experiment. Iext2 was chosen to elicit a depolarisation to within 1-2 mV of action 
potential threshold and Iext1 was adjusted to depolarise the neurone to about halfway 
between Iext2 and resting membrane potential. 
 
Membrane potential fluctuations at these two levels were fitted to Gaussian 
distributions and the mean and standard deviation of the membrane potential 
determined (Fig. 2.2C). Leak conductance in each neurone was calculated from the 
ohmic response produced by a small (0.1-0.3 nA, 100 ms) hyperpolarising current, 
injected at resting membrane potential. This leak value was not found to differ 
significantly at the depolarising currents, as long as the amplifier bridge was properly 
balanced. 
 
These parameters, together with the mean reversal potentials derived from preliminary 
experiments, allowed us to apply the VmD equation (Fig. 2.2D; Eq. 10 and 11 in 
Chapter 1) to quantify background inhibitory and excitatory conductances resulting 
from global network input onto individual neurones. 
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Figure 2.2: The VmD Method. A: Intracellular recordings were made from pyramidal 
neurones in slices of rat EC. B: At intervals, the membrane potential was depolarised 
by injection of two known external currents Iext1 and Iext2. C: Membrane potential 
fluctuations at each current level were fitted to Gaussian distributions and the mean 
and standard deviation determined. D: These values, together with previously 
determined reversal potentials for AMPAr (Ee) and GABAA (EI) and the leak 
conductance (gLa) obtained during each recording, were used to calculate IBg and EBg 
using the VmD method outlined by Rudolph et al. (2004). 
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Example Calculation 
 
What follows is a step-by-step calculation of the conductance and standard deviation 
values for one VmD run from a single neurone. This was a layer III pyramidal cell 
recorded under control conditions (i.e. normal ACSF and no added drug). Resting 
membrane potential was -75.6 mV. 
 
External Current 1 (IExt1) 0.15 nA 
External Current 2 (IExt2) 0.33 nA 
Excitatory Reversal (EE) 6.6 mV 
Inhibitory Reversal (EI) -66.7 mV 
Average Voltage 1 (V1) -68.7 mV 
Average Voltage 2 (V2) -60.3 mV 
Standard Deviation 1 (σ1) 0.6 mV 
Standard Deviation 2 (σ2) 1.22 mV 
Membrane Area (a) 34636 µm
2
 
Specific Membrane Capacitance (Cm) 1 µF/cm
2
 
Excitatory Decay Time (τe) 13.65 ms 
Inhibitory Decay Time (τi) 29.05 ms 
Cellular Leak Conductance (agL) 20 nS 
 
The equation must be calculated in a specific order. First, the conductances must be 
determined (Eq. 10, Chapter 1), as they need to be inserted in to the equation that 
determines the standard deviation. 
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Excitatory and inhibitory conductances are calculated separately from each other. To 
achieve the value for excitatory conductance, we substitute the correct parameters into 
the VmD equation, thus: 
 
This simplifies to: 
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Which gives an excitatory conductance value (geo, referred to in this thesis as EBg) of 
0.724 nS. Recalculating this equation for gio (referred to in this thesis as IBg) gives an 
inhibitory conductance value of 3.45 nS, with and I:E ratio of 4.8. 
 
The next stage is to calculate the standard deviation of the conductance components 
(Eq. 11, Chapter 1), which may provide some insight into the level of synchronisation 
within the network (Rudolph et al., 2004). 
 
Additionally, the effective noise time constant must be calculated, using the following: 
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Substituting the necessary values into these equations, we get: 
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Taking the square root of this gives us a standard deviation of 84 pS for geo, with a 
value of 0.12 nS for gio. 
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Excitability Measurements 
 
Since the intracellular recordings were performed blind, it was imperative to properly 
characterise their electrophysiological properties in order to identify which cells were 
being recorded and ensure that pyramidal cells only were studied. Identification of 
interneurones, pyramidal and spiny stellate cells could all be achieved through a 
comparison of their resting potential, action potential characteristics and response to 
injected current (e.g. Heinemann et al., 2000). In the majority of recordings (layer III), 
pyramidal cells were selected that exhibited no constitutive firing and maintained a 
resting membrane potential of between -65 and -80 mV.  
 
 
 
 
 
 
 
 
 
 
Figure 2.3: Response of layer III pyramidal cell to depolarising current. Left – a 
single action potential evoked by a 50ms depolarising current pulse. Right – a train of 
spikes generated by a supra-threshold 250 ms depolarising pulse. 
 
The current pulses used to characterise the recorded cell-type were also used to gauge 
cellular excitability. Between periods of VmD measurements, the step-command input 
of the amplifier, driven by pulses from the Master-8, was used to inject depolarising 
pulses (0.1-1.0 nA) via the recording electrode. These pulses were of two types: short 
(50 ms) pulses with amplitude incrementally increased so that one action potential 
was evoked at the peak of the depolarisation, and longer (250 ms) suprathreshold 
50 ms 
10 mV 
-75 mV 
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pulses, eliciting a train of action potentials. The short pulses allowed firing threshold 
(from rest) to be determined, and the longer pulses provided a measure of firing 
frequency. These parameters allowed cellular excitability to be quantified. These 
measurements were carried out throughout the recording, in order to constantly 
monitor cellular excitability and ensure that the recorded cell was healthy and viable. 
 
 
 
 
 
 
 
 
 
 
Figure 2.4: Measurement of cellular excitability from single evoked action potential. 
Higher spike threshold would indicate a lower probability of action potential 
formation, suggesting that the recorded cell is less excitable. Spike amplitude is 
measured to investigate the actions of the observed drugs on voltage-gated sodium 
channel activity, and ensure that cells remain viable throughout recording. 
 
Results and Statistics 
 
All values are expressed as mean ± standard error. Unless otherwise noted, all 
statistics are paired Student’s t-tests with a threshold of P=0.05. Where one-way 
ANOVA have been used to compare multiple groups, Bonferroni post-hoc tests were 
performed on all groups where P<0.05. Statistical analysis and membrane frequency 
distributions were calculated using GraphPad Prism 4 software. VmD method 
calculations were performed using Microsoft Excel 2003. 
 
 
spike threshold 
resting potential 
(V ) 
spike jitter and latency 
spike amplitude 
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List of Drugs Used 
 
Unless otherwise stated, all drugs were dissolved in de-ionised water. 
 
R-AP5 ([R]-2-amino-5-phosphonopentanoic acid; NMDA receptor antagonist; Tocris) 
 
4-AP (4-aminopyridine; potassium channel blocker; Tocris, dissolved in 50% 
dimethylsulphoxide) 
 
Bicuculline methiodide ([R-(R*,S*)]-5-(6,8-dihydro-8-oxofuro[3,4-e]-1,3-
benzodioxol-6-yl)-5,6,7,8-tetra-hydro-6,6-dimethyl-1,3-dioxolo[4,5-g]isoquinolinium 
iodide; GABAA antagonist; Tocris) 
 
Carbenoxolone (3β-hydroxy-11-oxoolean-12-en-30-oic acid 3-hemisuccinate; gap 
junction blocker; Sigma-Aldrich, UK) 
 
CGP-55845A ((2S)-3-[[(1S)-1-(3,4-dichlorophenyl)ethyl]amino-2-hydroxypropyl] 
(phenylmethyl)-phosphinic acid; GABAB antagonist; Tocris) 
 
Ethosuximide (2-Ethyl-2-methylsuccinamide; anticonvulsant; Sigma-Aldrich, 
dissolved in 20% ethanol) 
 
Felbamate (2-Phenyl-1,3-propanediol dicarbamate; anticonvulsant; Sigma-Aldrich) 
 
Gabapentin (1-(aminomethyl)cyclohexaneacetic acid; anticonvulsant; Tocris) 
 
GYKI-53655 (1-(4-aminophenyl)-3-methylcarbamoyl-4-methyl-3,4-dihydro-7,8-
methylenedioxy-5H-2,3-benzodiazepine; AMPA receptor antagonist, gift from Dr 
Dick Evans, Bristol University) 
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Lamotrigine (6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine; anticonvulsant; 
Tocris) 
 
NBQX (6-nitro-7-sulfamoylbenzo[f]quinoxlone-2,3-dione disodium; AMPA/Kainate 
receptor antagonist; Tocris, UK) 
 
PDC (L-trans-pyrrolidine-2,4-dicarboxylic acid; excitatory amino acid transporter 
blocker; Tocris) 
 
Phenytoin (5,5-diphenylhydantoin; anticonvulsant; Sigma-Aldrich) 
 
QX-314 bromide (N-(2,6-dimethylphenylcarbamoylmethyl)triethylammonium 
bromide; Na-channel blocker; Tocris) 
 
Sodium Valproate (Anticonvulsant; Sigma-Aldrich) 
 
Tiagabine ((3S)-1-[4,4-bis(3-methylthiophen-2-yl)but-3-enyl] piperidine-3-carboxylic 
acid; GABA uptake blocker/anticonvulsant; gift from Dr John Lambert, Aarhus 
University, Denmark) 
 
TMA (Trimethylamine; Gap junction opener; Sigma-Aldrich) 
 
TTX (Tetrodotoxin; Na-channel blocker; Alomone Labs, Israel) 
 
UBP-302 ((S)-1-(2-amino-2-carboxyethyl)-3-(2-carboxybenzyl)pyrimidine-2,4-dione; 
selective GluR5 antagonist; gift from Dr David Jane, Bristol University) 
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CHAPTER 3 
EVALUATION OF THE VmD METHOD IN THE EC 
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Introduction 
 
In order to be confident in the abilities of the VmD method, its limitations and its 
ability to measure predictable effects of known pharmacological tools on global 
background conductance needed to be investigated. In this Chapter, I will outline the 
methods used to construct and limit the VmD method, and observe the effect of 
common drugs on background conductance (and hence network activity) in layer III 
of the mEC. 
 
The global background conductances estimated by the VmD method represent the 
activity of the network in which the observed neurone is embedded. Drugs that 
change the activity of the network as a whole will therefore have a marked effect on 
the estimated conductances. The relative changes between IBg and EBg therefore 
provide insight in to the relationship between the two major neurone populations of 
the network, the principal, excitatory glutamatergic cells and inhibitory GABAergic 
interneurones. 
 
Spontaneous transmitter release at central synapses has two components, that driven 
by sodium-dependent action potentials (APs) invading the presynaptic terminal, and 
an AP-independent component which reflects quantal release. AP-dependent release 
is often multi-quantal, and depends on calcium entry through voltage-gated calcium 
channels. In contrast, AP-independent (“miniature”) neurotransmitter release reflects 
stochastic release of transmitter quanta from individual vesicles, and can occur at 
basal calcium levels when APs are blocked. As noted in Chapter 1, the majority of 
spontaneous GABA and glutamate release in both layer V and layer II neurones of the 
EC consists of miniature events (Berretta and Jones, 1996a; Woodhall et al., 2004; 
Jones and Woodhall, 2005). Unpublished whole-cell voltage clamp recordings in our 
laboratory show that sIPSC frequency in layer III neurones is reduced by around 50-
60% by addition of the voltage-gated sodium channel blocker TTX, whereas the toxin 
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only elicits a fall of around 20% in sEPSCs (Chamberlain and Jones, unpublished 
observations). 
 
Activity-independent release can be isolated by blocking action potentials with TTX. I 
used this approach in the current experiments to determine what proportion of IBg and 
EBg were attributable to activity-dependent/independent release. 
 
In the second series of experiments in this Chapter I attempted to induce a generalised 
increase in network activity by increasing the extracellular concentration of K
+
 (to 7.5 
mM from 3.75 mM control). This shifts the reversal potential of voltage-gated (and 
other) potassium channels to a less negative value (e.g. Charpak et al., 1990), causing 
a general depolarisation and slowing the repolarisation of neurones during action 
potentials. It is likely that this would result in increased spontaneous firing of 
neurones coupled with increased GABA and glutamate release. Thus, this approach 
should, to some extent, mimic a more in vivo-like situation, where spontaneous 
activity is considerably higher (Jones and Woodhall, 2005). 
 
The voltage-gated potassium channel blocker 4-aminopyridine (4-AP) has been 
shown to increase the amplitude and frequency of spontaneous postsynaptic potentials, 
with convulsant properties at higher concentrations (Galvan et al., 1982). 4-AP blocks 
A-type channels (Gustafsson et al., 1982), which have been shown to have no bearing 
on VmD estimates by Rudolph et al., (2004). However, blockade of these channels 
would be expected to prolong depolarisation at inhibitory and excitatory terminals, 
increasing release of both glutamate and GABA. In this Chapter I have used 4-AP at 
two different concentrations. The overall level of conductance for both inhibitory and 
excitatory components would be expected to rise with each concentration. 
Furthermore, the GABAAr blocker bicuculline and the AMPAr blocker NBQX were 
applied in the presence of 4-AP to investigate the changes in conductance that would 
be precipitated by these drugs in a high-conductance state. 
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Methods 
 
All recordings were made in layer III pyramidal neurones of the rat EC, obtained from 
juvenile male Wistar rats (50-70g). Typically, these neurones had a resting membrane 
potential of -72.2 ± 0.5 mV, input resistance of 79 ± 6 MΩ and action potential 
amplitude (from threshold) and half-widths of 72.1 ± 1.6 mV and 0.32 ± 0.01 ms, 
respectively. Reversal potentials for GABAA receptors were obtained by stimulation 
of white or grey matter near the recording site, in the presence of the NMDAr blocker 
R-AP5 (30 µM), the AMPA/kainate receptor antagonist NBQX (10 µM) and the 
GABAB receptor antagonist CGP-55845A (5 µM). Responses to electrical stimulation 
were measured at a range of membrane potentials (-100 to -50 mV) and extrapolated 
to obtain the reversal potential at Vm=0. Similarly, AMPAr reversal potentials were 
calculated in the presence of R-AP5, CGP-55845A and the GABAAr antagonist 
bicuculline (10 µM). Leak reversal potentials were measured by recording the resting 
membrane potential in the presence of all four of the above antagonists. All cells were 
allowed to rest for 5-10 minutes after impalement before recording was attempted. 
 
The majority of cells in this Chapter were recorded with K-Ac filled pipettes. In 6 
neurones, intracellular recordings using the VmD method were obtained using 
electrodes filled with QX-314 (5 mM) and caesium chloride (125 mM) to investigate 
the effects of internal voltage-gated sodium and potassium channel blockade. In these 
cells, VmD measurements were performed within 1-2 minutes of impalement, before 
the internal channel blockers dialysed into the cell. Positive current (0.2-0.5 nA) was 
then used at the recording electrode to aid dialysis of the channel blockers into the 
recorded neurone, before another VmD measurement was made at 10-15 minutes after 
impalement. 
 
Whole-cell voltage clamp recordings (held at -80 mV) were made in a small series of 
experiments to determine decay time constants for sEPSCs and sIPSCs. 
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Results 
 
Methodological Considerations 
 
The conductance estimates provided by the VmD method are based on the Gaussian 
approximation of the recorded membrane voltage at the two levels of polarisation, so 
the range of voltages at which this approximation holds has to be considered. For this 
purpose, I followed Rudolph et al. (2004) in restricting measurements to voltage 
ranges between -75 mV and -50 mV. The method requires the removal of any action 
potential activity from recordings as the spike, and any voltage-gated ion channel 
activity before and after it, will substantially effect the distribution and standard 
deviation of the recorded membrane voltage (Rudolph et al., 2004). Thus, 
depolarising the cell to a point where firing is constant and rapid drastically reduces 
the quiescent period necessary to construct the conductance model. 
 
Thus, the depolarising current used in the present studies was adjusted so that the 
higher current level held the neurone slightly below its firing threshold. This allows 
the membrane to be at its most excitable whilst reducing the amount of action 
potentials that must be removed. 
 
The estimates of EBg and IBg require knowledge of the reversal potentials for AMPA 
and GABAA receptors, and the leak conductance and reversal. The leak conductance 
can be measured simply by injecting a hyperpolarising current pulse through the 
recording electrode, and using Ohm’s law to calculate resistance, so specific 
measurement of this property is not needed. It was obtained before each run of the 
current injection protocol used in the VmD method. However, it is impractical to 
measure reversal potentials on a cell-by-cell basis. The necessary use of antagonists to 
obtain measurements of reversal potentials necessarily blocks receptors that mediate 
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EBg and IBg. Thus, the reversal potentials were characterised separately and 
individually in neurones other than those used for VmD measurements. 
 
Decay times, necessary to construct the “effective time constant” of the VmD method, 
were obtained from whole-cell patch clamp recordings made from layer III mEC 
pyramidal cells. Voltage clamp recordings were made as described in Chapter 2. 
EPSCs and IPSCs were recorded from quiescent neurones and the 95% decay time 
was used instead of the time constant (as recommended by Alain Destexhe, personal 
communication) to obtain the values necessary for the VmD equation (see Chapter 1, 
Eq. 11 and 12). Care was taken to ensure that both slow and fast conductances were 
included in the decay time. 
 
Determination of Reversal Potentials 
 
Reversal potentials for AMPAr-mediated EPSPs were obtained from 6 pyramidal 
neurones in layer III. Membrane voltage was manually clamped in 5 mV increments 
from -95 to -65 mV, and three EPSPs evoked at each voltage level for each cell. It 
was found that, at potentials less negative than -65 mV, problems were encountered 
with ability to pass current and membrane potential became too unstable to obtain 
reliable evoked measurements. Voltage offset after recording was carefully noted to 
ensure that the observed membrane potentials were as accurate as possible. Fig. 3.1A 
shows the averaged IV plots for the 6 neurones. Extrapolation of the plot gave an 
average reversal potential for AMPA receptors in layer III of 6.8 mV. 
 
Reversal potentials for GABAA receptor-mediated IPSPs were obtained in a similar 
fashion. 6 cells were recorded at membrane voltage steps of 5mV, from -95 to -70mV. 
The average relationship for the peak amplitude of IPSPs plotted against VM is shown 
in Fig. 3.1B. The reversal potential for these receptors was found by linear regression 
to be -66.7 mV. 
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Figure 3.1: Reversal potentials for (A) AMPA and (B) GABAA receptor mediated 
synaptic responses in layer III. Evoked responses at a range of membrane were 
averaged and plotted, using linear regression, from 6 pyramidal neurones in layer III 
of the mEC to find the reversal potentials of AMPA and GABAA receptors. AMPAr 
reversal was 6.8 mV, whilst GABAAr reversal was -66.7 mV. 
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 Layer III Decay Times 
 
Whole-cell patch clamp recordings were made from a total of 12 pyramidal cells in 
layer III of the mEC. The average 95% decay time for sEPSCs in 6 neurones was 13.7 
± 1.0 ms. The average 95% decay time of sIPSCs in 6 neurones was 29.1 ± 2.7 ms. 
 
Baseline Values for EBg and IBg in Layer III 
 
Currently, the VmD method is applicable to GABAA and AMPA receptor-mediated 
conductances (Rudolph et al., 2004), and does not take into account GABAB or 
NMDA receptor mediated activity. However, it is unlikely that spontaneous activation 
of GABAB receptors occurs in EC neurones (Woodhall et al., 2004), and although 
spontaneous currents mediated by postsynaptic NMDAr do occur in slices, such 
events are very infrequent (Berretta and Jones, 1996a). Thus, the vast majority of the 
background synaptic noise in EC neurones is mediated via AMPA and GABAA 
receptors. 
 
Baseline values for EBg and IBg have been averaged in a population of 61 layer III 
neurones (Fig. 3.2). Mean EBg in these neurones was 2.5 ± 0.3 nS and IBg was 10.2 ± 
1.6 nS, giving a ratio of approximately 4:1 in favour of inhibition. There was 
considerable variability in the two conductances from neurone to neurone. There are a 
number of practical reasons why this may be so, including the day to day variation in 
quality of slices, whether slices were selected from more dorsal or ventral regions, 
variations in preservation of intrinsic connectivity etc. It seems unlikely that the 
variations are due to sampling of different neuronal types. We studied regular spiking 
neurones in layer III, and these have an homogenous pyramidal cell morphology and 
electrophysiological characteristics (e.g. Dickson et al., 1997; Tahvildari and Alonso, 
2005). Typically (n=6), these neurones had a resting potential of -72.2 ± 0.5 mV, 
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input resistance of 79 ± 6 MΩ and action potential amplitude (from threshold of 21.2 
± 2.3) and half-widths of 72.1 ± 1.6 mV and 0.32 ± 0.01 ms, respectively. 
 
0 5 10 15 20 25
Inhibition
Excitation
Conductance (nS)
 
Figure 3.2: Distribution of conductance values for layer III pyramidal cells. Scatter 
plot shows values for EBg (top) and IBg (bottom) taken from 61 neurones in layer III of 
the mEC. 
 
Despite the neurone to neurone variation IBg was consistently greater than EBg. The 
ratio of inhibitory to excitatory conductances (I:E) was clearly in favour of inhibition 
(4.08:1), and this is similar to the situation estimated from naturally occurring up-
states of activity recorded in ferret occipital cortex in vitro (Rudolph et al., 2004), and 
cat neocortex in vivo (Rudolph et al., 2007). In other experiments in this laboratory 
we have been studying sEPSCs and sIPSCs using whole-cell patch clamp recording in 
layer III neurones. Whilst it is difficult to directly relate global conductances to 
spontaneous currents, it is pertinent that in a sample of 7 neurones sIPSCs had a mean 
frequency and amplitude of 12.4 ± 2.9 Hz and 37.4 ± 3.2 pA, whilst in a further 7 
neurones the corresponding values for sEPSCs were 6.6 ± 1.2 Hz and 11.5 ± 0.9 pA. 
Together with the considerably longer decay times for sIPSCs noted above, it is clear 
that total charge transfer associated with spontaneous inhibitory events would be 
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considerably greater than that of spontaneous excitation (Chamberlain and Jones, 
unpublished observations). 
 
High Potassium ACSF 
 
Increasing extracellular potassium depolarised the resting membrane potential by 2.9 
± 0.7 mV. When extracellular potassium was elevated from 3.75 mM to 7.5 mM 
(n=7), both EBg and IBg were increased (Fig. 3.3). EBg increased from a control level of 
2.4 ± 0.5 nS to 4.4 ± 1.3 nS. This increase was significant to P=0.04. IBg, however, 
increased substantially more, from 7.1 ± 1.6 nS to 34.0 ± 12.7 nS (significant at 
P=0.03). These changes caused a shift in the I:E ratio in favour of inhibition, from 3.1 
± 0.2 to 8.6 ± 2.6. 
 
When the standard deviation (SD) of the conductances was calculated, raising the 
extracellular potassium had practically no effect on EBg SD: the control value was 5.0 
± 1.9 pS and in high-K
+
 it was 5.1 ± 1.6 pS (P>0.05). IBg SD, similarly, showed no 
change (0.12 ± 0.04 nS to 0.13 ± 0.05 nS, P>0.05). 
 
The change in I:E ratio was accompanied by changes in cellular excitability. Spike 
firing threshold showed a marked reduction (20.0 ± 0.6 mV to 13.0 ± 0.3 mV, 
P<0.001). However, surprisingly, the number of spikes generated during a 250ms 
depolarising pulse was unchanged (4.3 ± 0.3 vs 4.3 ± 0.9, P>0.05). The overall 
amplitude of action potentials evoked during a 50 ms depolarising pulse was reduced 
from 93.1 ± 0.7 mV to 85.0 ± 1.6 mV. This change was found to be significant at 
P<0.001. 
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Figure 3.3: Effect of increasing [K
+
]o on background activity and neuronal 
excitability. A: Examples of membrane potential recordings made in two layer III 
neurones at two levels of injected current in control and high-K
+
 ACSF. B: The bars 
show the mean (± sem) values for background conductances, measured using the 
VmD approach, pooled from 7 neurones. Note the difference in scales for IBg (left) 
and EBg (right). This applies to all subsequent similar figures. The right hand panel 
shows the I:E ratio. C: Mean SD of IBg and EBg in the same neurones as in (A).  
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(Fig. 3.3 Cont) Note scale for EBg SD is in pS, not nS in this and subsequent figures. D: 
Mean action potential width measured at half height in the same neurones. E: 
Threshold for spike firing measured as mV from rest. F: Spike amplitude as measured 
from threshold G: Number of spikes generated by a 250 ms supermaximal 
depolarising pulse. Asterisks indicate P>0.05 by paired t-test in this and all 
subsequent figures. 
 
 
4-Aminopyridine 
 
4-aminopyridine was applied to 6 neurones at two concentrations (20 µM and 40 µM). 
Subsequently the AMPA/kainate receptor antagonist NBQX (10 µM) was added, 
followed by the GABAA receptor antagonist bicuculline (20 µM). 
 
Addition of 20 µM 4-AP caused an upward trend in both IBg and EBg, with IBg going 
from 6.3 ± 1.1 nS to 24.6 ± 9.6 nS (Fig. 3.4). EBg increased from 1.7 ± 0.3 nS to 4.2 ± 
0.8 nS. Neither change was significant by ANOVA. However, increasing the 
concentration of 4-AP to 40 µM caused EBg to become significantly different from 
control values (P=0.01) at 4.6 ± 0.7 nS. 40µM 4-AP caused a slight decrease in mean 
IBg (19.1 ± 4.4 nS) compared to 20 µM, however the smaller error values led to a 
significant difference from control (P=0.03). The I:E ratio was essentially unchanged 
throughout, at 3.9 ± 0.5 for control conditions, 5.2 ± 1.2 in the presence of 20 µM 4-
AP, and 4.2 ± 0.9 when 4-AP was increased to 40 µM (Fig. 3.4A). 
 
The SD of IBg and EBg was steadily decreased by the rising 4-AP concentration (Fig. 
3.4B). Control values for the SD of IBg and EBg were 0.35 ± 0.20 nS and 6.5 ± 3.3 pS 
respectively. In the presence of 20 µM 4-AP, these decreased to 0.13 ± 0.09 nS for IBg 
SD and 3.2 ± 1.8 nS for EBg SD. When the 4-AP concentration was increased to 40 
µM, IBg SD decreased further to 0.022 ± 0.008 nS, whilst EBg SD decreased to 1.8 ± 
0.2 pS. None of these changes were found to be significant by ANOVA. 
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Figure 3.4: Effect of 4-AP on background activity and cellular excitability. Details as 
for Fig. 3.3 A: 4-AP significantly increases both IBg and EBg at a concentration of 40 
µM, but does not change the I:E ratio or significantly affect the SDs (B), despite 
causing a noticeable downward trend in IBg SD. The increased conductance would 
appear to be mediated by enhanced transmitter release due to prolonged action 
potentials (C) which would prolong depolarisation at presynaptic terminals. However, 
due to the lack of change in I:E ratio, cellular excitability is not affected (D-F). 
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In the presence of 4-AP there appeared to be slight reduction in cellular excitability, 
most likely because of the increase in inhibition. From a control level of 21.7 ± 2.0 
mV, spike firing threshold was essentially unchanged at 22.7 ± 1.9 mV in the 
presence of 20 µM 4-AP, and only slightly higher at 24.2 ± 0.8 mV with 40 µM 4-AP 
(P>0.05). The mean number of spikes generated by a 250 ms depolarising pulse was 
5.5 ± 0.2 in control conditions, 5.2 ± 0.2 with 20 µM 4-AP and 4.3 ± 0.2 with 40 µM 
4-AP. The latter change was found to be significant with ANOVA (P<0.001). The 
overall amplitude of evoked action potentials was unaffected (see Figs 3.4 C-E). 
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Figure 3.5: Effects of NBQX and bicuculline on background activity on 4-AP treated 
neurones. Details as for Fig. 3.3. A: NBQX in the presence of 4-AP causes a 
significant drop in EBg, but has no effect on IBg. Subsequent addition of bicuculline 
caused a reduction in IBg, increased EBg back to previous levels, and (B) significantly 
increased the SD of IBg. The I:E ratio is shifted in favour of inhibition by NBQX and 
excitation by bicuculline. Asterisk indicates P<0.05 by one-way ANOVA. 
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Further experiments used specific antagonists to determine whether the increase in IBg 
and EBg with 4-AP were mediated by increased activation of GABAA and AMPA 
receptors. Addition of the AMPAr antagonist NBQX (10 µM) during 4-AP caused a 
marked decrease in EBg and an increase in inhibitory conductance (Fig. 3.5A). The I:E 
ratio increased to 23.9 ± 8.2 compared with 4.2 ± 0.9 in 40 µM 4-AP. The SD of IBg 
was decreased to 0.017 ± 0.013 nS, and EBg SD was increased to 4.0 ± 1.7 pS 
compared to 4-AP alone (see above and Fig. 3.5B). 
 
The subsequent and sequential addition of the GABAA antagonist bicuculline (20 µM) 
to these neurones caused a pronounced reduction in IBg (to 8.5 ± 5.2 nS). However, 
surprisingly, EBg was actually increased compared to the value obtained under NBQX 
(to 4.5 ± 1.5 nS). Thus, with bicuculline plus NBQX, EBg was almost the same as with 
4-AP alone. I:E ratio was reduced to 2.1 ± 0.6, and SD values were 0.14 ± 0.012 nS 
for IBg and 5.0 ± 2.0 pS for EBg. The change in EBg elicited by NBQX was found to be 
significant (P=0.04), and the change in IBg mediated by bicuculline was significant at 
P=0.03. Of the SD measurements, only the change in IBg SD caused by bicuculline 
was significant (P<0.001). No ratio changes were significant by ANOVA. 
 
Tetrodotoxin 
 
TTX (1 µM) was added to 6 neurones, with the further addition of NBQX (10 µM) 
and bicuculline (10 µM) in 3 each of these neurones. A separate group (n=5) was 
recorded in high potassium (7.5 mM) ACSF in the presence of TTX. No measures of 
cellular excitability could be made as abolition of action potentials by TTX precludes 
estimates of spike threshold etc. 
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Figure 3.6: Effect of TTX (1 µM) on conductance estimates and conductance SDs in 
layer III pyramidal neurones. Details are as for Fig. 3.3. A: Blockade of VGSC with 
TTX precipitates a far larger change in IBg than in EBg, suggesting that inhibitory 
transmission in layer III is more dependant upon action-potential activity than 
excitatory transmission is. Thus, the I:E ratio shifts towards excitation when VGSC 
are blocked. B: The SD of IBg and EBg is unaffected by TTX. This is surprising as the 
SDs are thought to be a measure of synchrony, which would logically be mediated 
largely by action potentials. 
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Figure 3.7: Effect of increased extracellular K
+
 in neurones pre-treated with TTX. A: 
High-K
+
 with TTX did not have a significant effect on conductance estimates. B: 
Similarly, the SDs of both IBg and EBg were not significantly changed, although the SD 
of IBg shos a trend towards reduction. 
 
The addition of TTX caused a reduction in both EBg and IBg. However, the reduction 
in IBg (18.3 ± 3.8 nS to 6.7 ± 1.5 nS) was much larger than the reduction in EBg (4.4 ± 
1.0 nS to 3.6 ± 1.1 nS). Both changes were found to be significant using paired t-test 
(P<0.01 for both, Fig. 3.6A). TTX did not cause a significant change in either IBg or 
EBg SD (Fig. 3.6B). 
 
The effect of potassium-induced depolarisation during VGSC blockade was 
investigated by increasing extracellular potassium to 7.5 mM in the presence of TTX. 
Transition to high potassium ACSF only slightly increased IBg from 6.7 ± 1.5 nS to 
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8.3 ± 2.2 nS. EBg, however, was essentially unaffected by high potassium (3.6 ± 1.1 
nS vs 3.4 ± 0.5 nS). The I:E ratio was also unaffected (2.2 ± 0.5 vs 2.4 ± 0.5). None of 
these changes were found to be statistically significant (Fig. 3.7A). The SD of IBg and 
EBg was unaffected by high K
+
 with TTX (Fig. 3.7B). 
 
Internal Voltage-gated Channel Blockade 
 
In their description of the VmD method, Rudolph et al. (2004) tested the effects of 
including active conductances, including voltage-dependent Na
+
 and K
+
 currents for 
spike generation, IM for spike-frequency adaptation, a transient A-type K
+
 current 
(IKA), a low-threshold Ca
2+
 current (ICaT) and a hyperpolarisation-activated current (Ih) 
in soma and dendrites. Although greater variability and small deviation of estimated 
background conductances was seen in this model, overall the inclusion of these 
conductances had little effect. I have attempted to partially replicate this situation in 
my experiments by effectively deleting voltage-gated Na
+
 and K
+
 conductances by 
inclusion of Cs
+
 and QX-314 in the recording electrode in 5 neurones. 
 
In two of these neurones, despite no obvious differences in voltage traces, the VmD 
method was unable to calculate conductance values, with the neurones producing 
membrane voltage distributions that led to impossible conductance estimates (i.e. 
negative numbers). The remaining three neurones showed very little difference in 
background synaptic activity estimated immediately after penetration and after 15 
minutes internal dialysis with Cs
+
 and QX-314. IBg was 10.1 ± 2.0 nS in control 
conditions and 12.2 ± 2.7 nS after 15 minutes recording. Likewise, EBg was 3.2 ± 0.5 
nS before and 3.6 ± 0.3 nS after VGC block (Fig. 3.8A). This meant that the I:E ratio 
was largely unchanged. None of the changes was statistically significant. In addition, 
the SD of both IBg and EBg although slightly reduced by VGC blockade, was not 
significantly altered (Fig. 3.8B). 
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Figure 3.8: Effect of blockade of transient Na
+
 and K
+
 currents on background 
conductance estimates. A: Cs
+
 and QX-314 have little or no effect on VmD 
measurements of background conductance in these cells. B: The SDs of IBg and EBg 
are also not significantly affected. This agrees with the findings of the Destexhe group 
(Rudolph et al., 2004). 
 
Discussion 
 
Sub-threshold background synaptic activity or “synaptic noise” is increasingly seen as 
a functional way of controlling excitability and gain in cortical neurones, and hence of 
the processing capabilities of cortical networks. Conversely, the characteristics of the 
background activity in individual elements provide information concerning the 
dynamic state of the network. Recording excitability of network elements and 
simultaneously quantifying the level of background activity presents considerable 
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technical problems, and most studies have employed a dynamic clamp approach to 
model in vivo-like synaptic noise and determine its effects on gain and excitability. 
The VmD method devised by Rudolph et al. (2004) potentially allows us to quantify 
excitatory and inhibitory synaptic noise at the same time as monitoring excitability. In 
the experiments in this Chapter I have provided initial evidence that this method is a 
valid and useful approach for the investigation of network activity even under the 
quiescent conditions present in acute brain slices. The results show that it is clearly 
possible to realistically obtain a simultaneous quantification of the naturally arising, 
global, background synaptic inhibition and excitation in entorhinal neurones in resting 
conditions. 
 
Baseline estimations of IBg and EBg in layer III neurones clearly indicate a 
substantially higher level of background inhibition compared to excitation. Destexhe’s 
group have reported a dominance of inhibition compared to excitation during 
spontaneous up-states recorded from ferret visual cortex slices in vitro (Rudolph et al., 
2004), and in cat parietal neurones under ketamine/xylazine anaesthesia in vivo, using 
the VmD method (Rudolph et al., 2005). A similar ratio in favour of inhibition was 
recorded in the same animals during EEG-activated states following electrical 
stimulation in the porcine reticular formation. More recently, the same group have 
demonstrated dominant inhibition during natural sleep/waking states in non-
anaesthetised cats (Rudolph et al., 2007). Other studies using different approaches 
have previously suggested dominant inhibitory conductances in cat visual cortical 
neurones under anaesthesia in vivo (Borg-Graham et al., 1998). However, others have 
provided evidence to suggest that excitatory and inhibitory conductances are 
approximately equal during spontaneous up-states in ferret cortex in vitro or in vivo 
(Shu et al., 2003b; Haider et al., 2006). In contrast, the VmD method applied to 
neurones in the anaesthetised (urethane) rat somatosensory cortex suggests that 
spontaneous up-states are associated with a rise in excitatory conductance with a 
concurrent fall in inhibition (Zou et al., 2005). My data add to these observations by 
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showing that under quiescent resting conditions in layer III of the EC in vitro, 
background synaptic noise mediated by GABA strongly dominates over excitation. 
This agrees with whole-cell patch clamp experiments done in this laboratory, which 
have shown that under the same conditions, sIPSCs are larger, longer and more 
frequent than sEPSCs. 
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Figure 3.9: Schematic diagram of network connectivity in the mEC. The principal, 
pyramidal cells (P1 and P2) are connected both to each other and to a rich network of 
inhibitory interneurones (e.g. I1 and I2). An increase in excitatory activity will bring 
about a rise in inhibitory firing, due to the action of glutamate at the inhibitory cells. 
Thus, any change in one system’s activity would be expected to affect the other, due to 
the level of feedback present between the two systems. Both 4-AP and high K
+
 
increases activity of all connections, TTX abolishes all action potential activity 
between cells. Under 4-AP, NBQX will reduce the activity of AMPA receptors at the 
post-synapse of both principal cells and, to a lesser extent, interneurones. Bicuculline 
will antagonise GABAA receptors at the pre- and postsynapse of both types of cells. 
 
 
It is important to remember that EBg and IBg are not static background conductances, 
but are each the sum of dynamically varying inputs, the activity of which result from 
stochastic release of transmitters, and events driven by network interactions. Fig. 3.9 
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shows a highly simplified schematic representation how inhibitory and excitatory 
neurones may interact in the mEC. The principal cells (in green) modify, and are 
modified by, the inhibitory interneurones (in red). Thus, when the global background 
conductances are recorded in the central pyramidal neurone it is clear that changes in 
excitation will have inevitably consequent effects on inhibitory transmission, and vice 
versa. The activity of the interneurones is driven by the excitatory drive provided by 
the principal pyramidal cells, so increases or decreases in this drive would be 
expected to strongly affect the inhibitory component. Likewise the change in 
inhibition will in turn affect the level of activity in the principal neurones. So how 
does this network arrangement contribute to the changes in EBg and IBg observed in 
my experiments? 
 
In the first series of experiments, I attempted to more closely mimic the in vivo 
situation by provoking a generalised elevation of synaptic activity across the whole 
network by increasing extracellular K
+
. This resulted in an approximate doubling of 
EBg, but a much more dramatic five-fold rise in IBg. However, when these experiments 
were repeated in TTX, high K
+
 had little effect on either background conductance. 
This suggests that the predominant effect of high K
+
 alone was to promote action 
potential driven release, rather than activity-independent miniature release. Increased 
activity-dependent release most likely arises because cells will be depolarized closer 
to threshold and will fire more action potentials when K
+
 is raised.  The increase in 
EBg can be explained by increased glutamate release from excitatory afferents from 
other principal neurones in the slice, possibly compounded by recurrent excitatory 
connections between them. The increase in IBg will be dependent on increased GABA 
release from multiple interneurones onto the recorded principal neurone.  
 
The greater effect on IBg compared to EBg may reflect the fact that interneurones are 
generally polarised less negatively than principal neurones (see Jones and Buhl, 1993; 
Jones, 1994) and will already be closer to firing threshold. Indeed, as noted above, 
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TTX alone reduces IBg to a greater extent than EBg, showing that the interneurones are 
likely to display a greater level of spontaneous firing than the principal neurones 
under baseline conditions. 
 
Considering the network circuit (Fig. 3.9), there are a number of other points to note. 
Increased firing in principal neurones should also increase the excitatory drive onto 
the interneurones, thereby enhancing the elevation of GABA release occurring as a 
result of increased interneurone firing. However, as IBg rises this should actually 
temper the rise in EBg to some extent. Conversely, as the interneurones themselves are 
subject to inhibition from other interneurones, the elevation of IBg in the principal cell 
should be partly mitigated by increased inhibition in the interneurones. 
 
Despite the increases in IBg and EBg, there was no change in the SD of either. This 
suggests that there is little added synchronisation between interneurones or pyramidal 
neurones when network excitability is generally increased. What is clear is that the I:E 
ratio is further increased in favour of inhibition when overall activity across the 
network is elevated. Thus, during relative quiescence in the slice, the network is 
inhibition-dominated. When activity is raised towards more in vivo-like levels, this 
dominance becomes even more marked. This mirrors the situation in the cortex of 
awake cats in vivo (Rudolph et al, 2007), experiments from which suggested that in 
the inhibition-dominant network action potentials were evoked in response to a drop 
in inhibition rather than an increase in excitation.  
 
What implications does this have for excitability of the principal neurones in our 
experiments? Spike threshold was significantly reduced, which can be explained 
partly by the depolarizing effects of the high K
+
 medium.  The increase in EBg could 
also contribute to this although it might be expected that this would be ameliorated by 
the concurrent increase in IBg. Surprisingly, there was no change in the number of 
spikes evoked by a supra-threshold depolarizing pulse. It is possible that the increased 
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K
+
 enabled easier generation of action potentials, but that this was counteracted by the 
relative increase in IBg, which then acted to reduce sustained firing. However, since 
changing extracellular K
+
 itself clearly alters intrinsic membrane excitability, it is 
difficult in this instance to draw any firm conclusions about the relationship between 
IBg, EBg and cellular excitability. 
 
In later experiments I studied the relative contributions of action potential driven 
glutamate and GABA release and that occurring by stochastic, activity-independent 
processes (i.e. miniature events) to global background synaptic activity. The former 
was eliminated by blockade of VGSC with TTX. Under these conditions both IBg and 
EBg decreased significantly. If we examine the schematic network in Fig. 3.9 the 
effects of TTX are easily explained. Action potentials in all connections will be 
blocked and therefore, glutamate and GABA release onto the recorded neurone will 
both fall. The reduction in GABA release will be the result of direct loss of 
spontaneous activity in the interneurones as well as the loss of excitatory drive onto 
them, which would normally help to promote spontaneous activity.  
  
EBg was slightly decreased (by around 20%) but IBg was reduced sharply, to around 
35% of control. This clearly indicates that activity-dependent GABA release driven 
by spontaneous firing in interneurones contributes much more to global inhibition, 
compared to the respective contribution of activity-dependent glutamate release to 
overall excitation. This is in line with whole-cell voltage clamp recordings in our 
laboratory, which show that sIPSC frequency in layer III neurones is reduced by 
around 50-60% by TTX whereas the toxin only elicits a fall of around 20% in sEPSCs 
(Chamberlain and Jones, unpublished observations).  
 
There was little change in the SD of either IBg or EBg in the presence of TTX. If one 
accepts that the SD is a reflection of the degree of synchrony in the network (see 
Introduction) then this suggests that synchrony may be minimal under baseline 
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conditions, so there is no real change when spontaneous firing in both principal and 
interneurones is abolished.  
 
What is abundantly clear is that any manipulation that alters even one element of the 
network will have consequent dynamic effects on virtually all elements of the network. 
This stresses the importance of being able to monitor the global effects of inhibition 
and excitation in the principal neurones. Changes in these global conductances can tell 
us not only how a substance influences excitability of the output neurones, but 
provides information on how it may alter interactions within the network. This 
provides an enormous advantage when it comes to examining and predicting how 
therapeutic substances may change CNS activity. Any substance administered 
systemically and which penetrates the blood brain barrier will have access to all 
elements of the network. Therefore, knowing how the substance alters IBg and EBg will 
provide us with information about where in the network it may act and how it then 
globally alters network activity. In a later chapter of this thesis I have studied the 
actions of one group of CNS active drugs, anticonvulsants, in this way. 
 
As discussed in the introduction, 4-AP blocks A-type K-channels (IKA). Rudolph et al. 
(2004) have shown that several voltage-dependent currents (INa, IKd, IH, ICaT, and IKA) 
do not significantly distort conductance estimates obtained with the VmD method. 
Thus, blockade of IKA with 4-AP will not directly change IBg or EBg estimations, in the 
sense that the VmD equation alone is not changed by the actions of these channels. 
However, EBg and IBg values can be affected by activity changes elsewhere in the 
network. It has been shown that blockade of A-type channels leads to an increase in 
presynaptic Ca
2+
 influx without changing postsynaptic Ca
2+
 influx. The presynaptic 
fibre volley was also increased with 4-AP (Jones and Heinemann, 1987). This 
suggests that there will be greater release of neurotransmitter from presynaptic 
terminals, leading to increases in both EBg and IBg, as was observed in this Chapter. 
Using whole-cell studies, Tan and Llano (1999) showed that 4-AP increases the 
  
89 
frequency of spontaneous IPSCs in cerebellar basket cells, and work from our own 
laboratory has shown that spontaneous glutamate release is mediated through 
dendrotoxin insensitive channels that are likely to be type-A (Cunningham and Jones, 
2001). 
 
Adding 10 µM NBQX to neurones already exposed to 4-AP produced an expected 
reduction in EBg, without having much effect on IBg. However, when bicuculline was 
subsequently added, EBg was restored to previous levels. This suggests that the 
activity of the inhibitory interneurones is having a marked effect on the level of 
excitatory transmission, i.e. when the inhibition is reduced, the excitation increases 
(see Fig 3.9). 
 
Blockade of voltage gated Na
+
 and K
+
 channels by internal perfusion with Cs
+
 and 
QX-314 had little effect on estimations of either IBg or EBg in a small population of 
neurones. The lack of change in EBg or IBg in these neurones supports the assertion 
(Rudolph et al., 2004) that active dendritic channels should have little effect on 
overall background synaptic conductances. There was a tendency for the SD of both 
conductances to decrease, which would be in line with the observation that the SD of 
both conductances was increased in the model when active channels were introduced 
(Rudolph et al., 2004). I cannot rule out the possibility that dendritic Ca
2+
 channels 
may strongly influence IBg or EBg, as I have not tested this possibility. However, it is 
interesting that one of the anticonvulsants I have tested, ethosuximide (see Chapter 7), 
is a blocker of transient Ca
2+
 channels (the Ca
2+
 conductance included by Rudolph et 
al., 2004) had little overall effect on EBg or IBg.  
 
In conclusion, the VmD method offers insight in to the relationship between 
glutamatergic and GABAergic transmission in these slices, which can be carefully 
investigated with the application of various drugs. It would seem that the SD 
estimates, at least in this Chapter, do not offer a great deal of information with regards 
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to the synchrony of the neuronal populations. This may be a function of the vastly 
reduced preparation used here, compared to an intact brain. However, the conductance 
estimates offer a robust and predictable method for the study of network activity. In 
the next Chapter, I will continue to investigate the function of the mEC by using the 
VmD method with a range of well characterised pharmacological tools. 
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CHAPTER 4 
PHARMACOLOGICAL CHARACTERISATION OF BACKGROUND 
SYNAPTIC CONDUCTANCES 
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Introduction 
 
In the previous chapter I described experiments designed to validate the VmD 
approach in EC slices, and to determine the effects of raising or lowering network 
activity. In this chapter I will focus on the effects of modifying synaptic activity, by 
blockade of receptors pre- and postsynaptically and on the effects of blockade of 
neurotransmitter uptake (both glutamate and GABA). 
 
Currently, the VmD method estimates conductances arising as a result of activation of 
two receptor populations, the glutamate and GABA ionotropic receptors, AMPAr and 
GABAAr, respectively, and does not take into account GABAB or NMDA receptor 
mediated activity. However, it is unlikely that spontaneous activation of GABAB 
receptors occurs in EC neurones (Woodhall et al., 2004), and although spontaneous 
currents mediated by postsynaptic NMDA receptors do occur in slices, such events 
are very infrequent (Beretta and Jones, 1996a). Thus, the vast majority of background 
synaptic noise in EC neurones is mediated via AMPA and GABAA receptors. Hence, 
the first set of experiments determined how blockade of either population of receptors 
would alter IBg and EBg. It is clear that the excitatory and inhibitory neurone 
populations do not exist in isolation, as shown by the experiments with TTX and high 
K
+
 in the previous chapter. For example, blockade of glutamatergic activity would be 
expected to alter the activity of GABAergic interneurones, since the inhibitory 
neurones rely on excitatory input to drive their firing. Likewise, inhibitory neurones 
control the activity of principal cells, so reducing inhibition may well alter EBg as well 
as IBg.  
 
Despite the fact that VmD does not take into account and conductance mediated by 
NMDA receptors in the principal cells, it is interesting to consider how alteration of 
NMDAr activity may affect EEg and IBg for a number of reasons. Interneurones in 
many regions are driven by a strong NMDAr mediated excitation (Monyer et al., 
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1994; Glitsch and Marty, 1999; Maccaferri and Dingledine, 2002), and this is also the 
case in the EC (Jones and Buhl, 1993). In addition, glutamate release in the EC is 
facilitated by presynaptic NMDA autoreceptors (Berretta and Jones, 1996b; Woodhall 
et al., 2001; Yang et al., 2006). Presynaptic NMDAr have also been shown to 
increase GABA release in layer II of the EC (Woodhall et al., 2001). Thus, although 
they may not contribute directly to EBg, NMDAr are potentially important in 
controlling the background excitation and inhibition driven by network activity. 
 
Much less is known about the role of kainate receptors (KAr) in cortical synaptic 
transmission. KAr consist of a tetrameric combination of subunits from two related 
families (GluR5-R7 and KA-1 and 2). It is thought that KA-2 requires combination 
with GluR5-R7 subunits to achieve surface expression, however GluR5, 6 and 7 
receptors can form homomeric receptors by themselves (Gallyas et al., 2003; Alt et al., 
2004). KAr have been implicated in fast synaptic transmission and presynaptic 
modulation of transmitter release in hippocampus and cortex (Collingridge et al., 
1983; Clarke et al., 1997; Vignes et al., 1998). Recent work from our own laboratory 
has implicated KAr in glutamatergic and GABAergic transmission in layer III of the 
mEC. In summary, this work has shown that glutamate release can be facilitated by 
presynaptic GluR5 receptors, whereas another subtype may mediate weak 
postsynaptic excitation of principal neurones. GluR5 receptors make a substantial 
contribution to glutamate drive onto interneurones and may also directly facilitate 
GABA release onto principal cells (Chamberlain and Jones, unpublished 
observations). Thus, it is of interest to determine how alteration of KAr may alter 
network driven IBg and EBg. Pharmacologically, there are very few subunit specific 
kainate antagonists available for study. However, a GluR5-selective antagonist (UBP-
302) is available, and has been used in the experiments in this chapter. 
 
Reuptake is the major means of inactivation for glutamate and GABA at central 
synapses. Glutamate re-uptake is mediated by a family of excitatory amino acid 
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transporters (EAAT1-5), which facilitate the inward transportation of glutamate 
molecules, coupled to the inward movement of multiple sodium ions and a proton, 
along with the outward movement of a potassium ion (Seal and Amara, 1999). The 
actions of the EAAT family can be antagonised by the non-specific EAAT antagonist 
L-trans-pyrrolidine-2,4,-dicarboxylate (PDC). Similarly, GABA is removed from the 
synapse into neurones or glia by a sodium-dependent transporter (GAT-1) that can be 
blocked by the actions of tiagabine (Suzdak and Jansen, 1995). 
 
Methods 
 
Pyramidal cells were recorded in layer III of the mEC, in EC-hippocampal slices 
prepared from juvenile male Wistar rats (40-70g), as outlined in Chapter 2. VmD 
recordings using sharp electrodes comprise the majority of the data in this chapter. 
Whole cell patch clamp studies were also performed in layer III pyramidal cells to 
determine the effects of the glutamate transport blocker PDC, and the GABA 
transport blocker tiagabine on sEPSCs and sIPSCs.  
 
Results 
 
Effects of Blocking AMPAr 
 
NBQX (10 µM) was tested in a total of 11 neurones. In the presence of NBQX, EBg 
fell, as predicted, from a control level of 2.9 ± 0.7 nS to 1.2 ± 0.5 nS (P=0.02). This 
was accompanied by a non-significant decrease in IBg (Fig. 4.1A, P>0.05). Overall, 
this resulted in a shift in the I:E ratio further in favour of inhibition, from 6.2 ± 1.0 to 
13.1 ± 1.8 (P=0.02). 
 
The SD of the background conductances before and after NBQX exhibited a clear 
downward trend. NBQX caused a reduction in the SD values of both EBg and IBg, as 
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outlined in Fig. 4.1B. IBg SD was subject to around a 3-fold drop, whilst EBg SD was 
reduced almost four-fold, however, surprisingly, neither was significant. 
 
NBQX also caused a decrease in cellular excitability. The number of spikes generated 
by a 250 ms train showed a downward trend from 6.2 ± 0.9 to 4.2 ± 1.1 (Fig. 4.1E). 
Spike amplitude was unchanged (Fig. 4.1D). However, spike threshold was 
significantly increased (P=0.01, Fig. 4.1C) to around 5 mV more positive to rest 
compared to control. 
 
NBQX is not specific for AMPA receptors. At higher concentrations it can also block 
KAr. So, in three further neurones, a specific AMPAr antagonist, GYKI-53655, was 
tested at a concentration of 25 µM. Control values for EBg and IBg in this sample were 
much lower than those seen in experiments with NBQX. However, the effect of 
GYKI-53655 was very similar. 
 
In the presence of GYKI-53655, IBg was reduced from 5.4 ± 0.5 nS to 2.0 ± 0.7 nS. 
EBg was also reduced, from 1.4 ± 0.1 nS to 0.4 ± 0.1 nS. Both these changes were 
found to be significant (PI=0.02 and PE=0.01, Fig. 4.2A). The I:E ratio was not 
 significantly altered, in contrast to the effects of NBQX where it increased 
substantially in favour of inhibition. Given the low number of experiments using 
GYKI-53655 and the marked difference in control values for IBg compared to NBQX, 
it would be premature to place any great significance on this result. It is also true that 
GYKI-53655 had less of an effect on the SD of IBg and EBg than NBQX, although 
again the control values, especially for inhibitory SD, were lower in this group. IBg SD 
was largely unchanged, although EBg SD was reduced by around 40% (Fig. 4.2B) 
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Figure 4.1: Effect of AMPAr blockade on background activity and cellular excitability 
estimates. NBQX (10 µM, n=11) was applied during intracellular recording from 
layer III principal cells. A: A small decrease in IBg, likely due to decreased drive onto 
interneurones, was accompanied by a significant drop in EBg. The I:E ratio shifted in 
favour of inhibition. B: SD estimates showed a downward trend but were not 
significantly altered. C: Only spike threshold was significantly changed, with no 
change in amplitude (D) and a small decrease in spikes/train (E). 
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Figure 4.2: Effects of specific AMPAr blockade on conductance estimates and 
cellular excitability. A: Similar to NBQX, both IBg and EBg are reduced by GYKI-
53655, with a small shift in I:E ratio in favour of inhibition. B: SDs are not affected, 
suggesting that any change seen with NBQX is mediated by KAr. C: Spike threshold is 
significantly increased, with no change in amplitude (D) and a significant reduction 
in the number of spikes generated by a 250 ms pulse (E). This suggests reduced 
cellular excitability with GYKI-53655. 
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As with NBQX, cellular excitability was reduced by GYKI-53655. Spike threshold 
increased from a control value of 21.6 ± 0.6 mV to 25.7 ± 0.5 mV (P=0.002, Fig. 
4.2C). At the same time, spikes evoked during the depolarising pulse fell by around 
50% (P=0.006, Fig. 4.2E), without accompanying change in action potential 
amplitude (Fig. 4.2D). Thus, it is clear that blocking AMPA receptors drastically 
reduces EBg, but that IBg is also concurrently reduced meaning that overall, 
background inhibition comes to predominate further. This change is reflected by 
indications of decreased cellular excitability. 
 
Blockade of NMDA Receptors 
 
As noted previously, the VmD method does not account for NMDA receptors in 
estimation of EBg, so it might be expected that NMDA receptor blockade would have 
little effect. The competitive NMDAr antagonist R-AP5 was used at a concentration 
of 30 µM on a total of 7 neurones. Overall, NMDAr blockade had relatively weak 
effects on the global background inhibitory and excitatory conductances (Fig. 4.3A). 
IBg was not significantly affected, from 15.0 ± 5.6 nS to 10.1 ± 3.0 nS in the presence 
of R-AP5 (P>0.05). At the same time, EBg was little altered, from a control level of 
3.2 ± 0.9 nS to 2.8 ± 0.5 nS (P>0.05). The end result was little change in the I:E ratio 
(Fig 4.3A, P>0.05). 
 
It was possible to split the neurones in this group into two subgroups, based on the 
control levels of background conductances. In four neurones (Fig. 4.4), values of EBg 
and IBg were very similar to those recorded in the general population as a whole. R-
AP5 had little or no effect on conductance values in these neurones. However, the 
other three cells showed much higher levels of baseline inhibition and excitation. In 
these cells addition of 30 µM R-AP5 caused a reduction in IBg, from 32.1 ± 11.9 nS to 
9.8 ± 3.7 nS. Concurrently, EBg was reduced from 5.4 ± 1.8 to 1.7 ± 0.6 nS. 
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Figure 4.3: NMDAr blockade has little effect on conductance estimates. A: Slight 
downward trends are seen in both IBg and EBg in the presence of R-AP5 (30 µM) 
though these are not significant. I:E ratio is unchanged. B: The SD of IBg is slightly 
reduced, but neither SD is significantly altered by NMDAr blockade. C: Spike 
threshold is slightly, but significantly, increased by R-AP5. D: Neither spike 
amplitude or (E) spikes per 250 ms pulse are significantly altered during NMDAr 
block. 
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Figure 4.4: Effect of NMDAr blockade on high-activity networks. In a subgroup of the 
R-AP5 treated cells, those showing higher levels of baseline activity were significantly 
affected by addition of 30 µM R-AP5. A: Both inhibitory and excitatory conductance 
was reduced. B: There was no change in I:E ratio. C: Only the SD of IBg was 
significantly altered. C-E: No change in cellular excitability was observed. 
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The I:E ratio was unchanged (control = 5.4 ± 0.3, drug = 5.6 ± 1.1). Thus, these 
results may suggest that NMDA receptors may help to maintain a high level of 
baseline network activity in some slices. The reasons why this may be so are 
discussed below. 
 
In the total population of 7 neurones, NMDAr blockade decreased the SD of IBg 
without affecting that of EBg (Fig. 4.3B). If the SDs are accepted as a measure of 
population synchrony, this may indicate that inhibitory interneurones rely on NMDA 
receptor mediated drive for synchronisation, whereas principal neurones may not. 
 
The weak overall effects of R-AP5 on IBg, EBg and I:E ratio were reflected by cellular 
excitability changes that were marginal. Spike firing threshold rose from 20.4 ± 1.2 
mV to 23.4 ± 1.6 mV (P=0.01). However, the number of spikes generated by a 250 
ms train was not significantly affected. Spike amplitude was also unaffected (Fig. 4.3 
C-E). 
 
Blockade of GluR5 Kainate Receptors 
 
A contribution of KAr to background excitability is not directly accounted for in 
VmD measurements, as mentioned earlier. However, in studies in layer III neurones, a 
role for the GluR5 subtype in controlling both glutamate and GABA release has been 
demonstrated in this lab (Chamberlain and Jones, unpublished observations), so it was 
of interest to study effects on EBg and IBg. 
 
The GluR5-specific antagonist UBP-302 was tested at a concentration of 20 µM in 6 
pyramidal neurones. Control values were 10.8 ± 3.4 nS for IBg, 2.7 ± 1.0 for EBg, with 
a mean I:E ratio of 4.6 ± 0.4. 
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Figure 4.5: Blockade of Glu-R5-containing KAr with UBP-302 (20 µM). Whilst there 
is little effect on IBg, EBg or I:E ratio (A), and no appreciable change in cellular 
excitability (C-E), the obvious reduction in conductance SD may indicate that these 
receptors have a role to play in synchrony either within or between neurone 
populations. This notion is supported by studies observing slow-wave activity in the 
cortex (e.g. Cunningham et al., 2006). 
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The antagonist had little effect on any of these conductance values. IBg and IBg were 
both unchanged leading to no change in the I:E ratio. This is illustrated by Fig. 4.5A. 
 
However, the addition of UBP-302 did have noticeable effects on the SD of both IBg 
and EBg. IBg SD was reduced from 0.78 ± 0.30 nS to 0.11 ± 0.04 nS (P=0.04). EBg SD 
was not significantly reduced, although there was a clear trend towards this (see Fig. 
4.5B). The reduction in SDs may suggest that kainate receptors play a role in 
synchronisation of principal and interneurone populations in layer III. 
 
Cellular excitability was largely unaffected in the presence of UBP-302. However, 
spike firing threshold was slightly increased, and the number of spikes evoked in a 
train fell by around 10% (Fig. 4.5 C and E). Action potential amplitude was not 
affected (Fig. 4.5D). These results would suggest that, whilst it has little effect on 
overall synaptic activity or cellular excitability, blockade of GluR5-containing kainate 
receptors may alter network synchronisation. 
 
Blockade of Glutamate Uptake 
 
Having determined the effects of blockade of pre- and postsynaptic ionotropic 
glutamate receptors on background synaptic activity, it was interesting to see what the 
effect of increasing activation of these receptors would have. To that end, I attempted 
to increase the ambient levels of glutamate by blocking its re-uptake. The restricted 
glutamate analogue PDC was used to study the effect of EAAT blockade using both 
VmD and whole cell patch clamp methods. 
 
VmD 
 
The VmD method was applied to 6 pyramidal neurones. Again, it should be noted that 
the control values for both background conductances were rather lower than usual, in  
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Figure 4.6: Effect of glutamate uptake blockade with PDC (50 µM). IBg and EBg are 
increased by uniform amounts, although neither is changed significantly, leading to 
little change in I:E ratio (A). Similarly, IBg and EBg SD are both slightly increased (B). 
The lack of change in I:E ratio leads to no change in cellular excitability (C-E) in the 
presence of PDC. 
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this sample of neurones. Perfusion with PDC (50 µM) caused little overall change in 
the I:E ratio, as a result of a uniform rise in both IBg and EBg.  
 
IBg was increased from 3.9 ± 1.0 nS to 8.5 ± 3.4 nS (P>0.05). Similarly, EBg increased 
by nearly two-fold, from 1.0 ± 0.2 nS to 1.9 ± 0.5 nS (P>0.05). At the same time, the 
SD of IBg and EBg did not change significantly, although both were increased (Fig. 
4.6B). SD of IBg increased by 69%, whilst SD of EBg increased by 23%. 
 
Despite the rise in EBg, PDC had little effect on cellular excitability measurements. 
Spike firing threshold, spikes generated during a 250 ms depolarising pulse and action 
potential amplitude were not significantly changed (Fig. 4.6 C-E). 
 
Whole Cell Patch Clamp 
 
Since the EBg and IBg depend on global integration of spontaneous transmitter release 
(see Introduction) it was decided to compare the effects of PDC on VmD 
measurements to effects on spontaneous synaptic currents in layer III neurones, as 
these had not been investigated previously. sIPSCs and sEPSCs were recorded in a 
total of 12 layer III pyramidal neurones (6 per group). In pooled data analysis, 200 
consecutive events were analysed in each neurone, in the presence and absence of the 
drug. 
 
The results of the patch clamp studies of sEPSCs are summarised in Fig. 4.7. It is 
possible to see an increase in the frequency of sEPSCs in the raw voltage clamp traces 
from one neurone shown in Fig. 4.7A, and by the pooled data from Fig. 4.7B. 
Addition of PDC (50 µM) caused a leftward shift in the cumulative probability curve  
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Figure 4.7: Effect of EAAT blockade on sEPSC activity in layer III pyramidal cells. A: 
Example traces from whole-cell recording of one layer III mEC pyramidal neurone 
show that between control (top) and PDC (50 µM) there is a discernable increase in 
frequency during PDC application. B: The inter-event interval curve shifts to the left 
with PDC, indicating increased sEPSC frequency during EAAT blockade. C: Mean 
amplitude of sEPSCs is unchanged by PDC. D: sEPSC decay time is similarly 
unaffected. 
 
for IEI (Fig. 4.7B). This indicates a reduction in IEI, the corollary of which is an 
increase in the frequency of EPSCs. Apart from the increased frequency of sEPSCs, 
there was little alteration in other properties. PDC had little effect on the kinetics of 
the observed excitatory events. 50% decay times were measured as the increased 
frequency made it difficult to observe the slower component of the events. Average 
sEPSC amplitude was also largely unaffected by the addition of PDC (Fig. 4.7D). 
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Fig. 4.8 illustrates the effects of PDC on sIPSCs in layer III neurones. The voltage 
clamp records in 4.8A show a high frequency of events in the control situation, with 
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      50 µM PDC 
 
 
 
 
 
 
          C          D 
 
 
 
 
 
 
 
 
 
 
Figure 4.8: Effect of PDC on sIPSC activity in layer III. Details as for Fig. 4.7. A: 
Looking at the example trace shown, there is no readily noticeable difference between 
activity during control and PDC states. B: The IEI curve shifts slightly to the left with 
PDC, indicating slightly increased frequency. C: sIPSC amplitude is significantly 
increased, probably accounting for the majority of the increase seen with the VmD 
method. D: Decay time is unaffected. 
 
no obviously discernable change in PDC. However, in pooled data the mean IEI was 
decreased from 110.4 ± 2.9 ms to 89.6 ± 1.9 ms by PDC. Again, this is shown by the 
leftward shift in the IEI curve, indicating an increase in sIPSC frequency (Fig. 4.8B). 
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PDC also caused a small but significant increase in the average amplitude of IPSCs in 
these cells (23.3 ± 0.6 pA control, 27.7 ± 0.5 pA PDC, P<0.001). However, neither 
the 50% decay time of sIPSCs nor the 10-90% rise time (1.9 ± 0.2 ms to 2.1 ± 0.3 ms) 
were altered (Fig. 4.8C-D). 
 
Blockade of GABA Re-uptake 
 
Thus, it is clear that blockade of GABAA receptors powerfully reduces IBg as would 
be expected, but with concurrent effects on EBg. In the next series of experiments, I 
investigated the effects of enhancing GABA transmission using the GABA uptake 
blocker, tiagabine. 
 
In a similar study to the PDC data above, tiagabine was investigated using both VmD 
and whole cell voltage clamp approaches. In the VmD studies, a concentration of 4 
µM tiagabine was used, as it was found that higher concentrations caused 
unpredictable and spontaneous depolarisations of the membrane potential. In 
subsequent voltage clamp studies, tiagabine was tested at both 4 and 12 µM. 
 
VmD 
 
VmD conductance and SD estimates were obtained from a total of 6 pyramidal 
neurones. Addition of tiagabine (4 µM) caused a large, six-fold rise in IBg from a 
control level of 8.1 ± 2.1 nS to 48.8 ± 16.8 nS (P=0.0017), although there was little 
change in SD. Surprisingly, perhaps, EBg also increased but to a much lesser degree, 
from 1.8 ± 0.4 nS to 3.9 ± 1.0 nS (P>0.05). Although EBg was more than doubled, the 
overall change shifted the I:E ratio very heavily in favour of inhibition, from 4.5 ± 0.2 
to 12.5 ± 4.4 (P=0.026, Fig. 4.9A). 
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Figure 4.9: Effects of GABA uptake blockade on conductance estimates and cellular 
excitability. A: In all neurones, ttiagabine (4 µM) causes a persistent upward trend in 
EBg and a significant increase in IBg. The I:E ratio is shifted two-fold in favour of 
inhibition. B: SD of IBg or EBg is not significantly changed by GAT-1 blockade. C: 
Spike threshold is made 5 mV less negative from rest during tiagabine application. D: 
Spike amplitude is not changed. E: The number of spikes during a 250 ms pulse is 
reduced 3-fold by tiagabine. 
  
110 
0
5
10
15
Control 4 µM Tiag 12 µM Tiag
*
E
P
S
C
 A
m
p
lit
u
d
e
 (
p
A
)
0.0
0.2
0.4
0.6
0.8
1.0
1.2
E
P
S
C
 5
0
%
 D
e
c
a
y
 (
m
s
)
Tiagabine EPSCs
0 1000 2000 3000 4000 5000 6000
0.0
0.2
0.4
0.6
0.8
1.0
Control
4µM Tiagabine
12µM Tiagabine
Inter-event Interval (ms)
C
u
m
u
la
ti
v
e
 P
ro
b
a
b
ili
ty
This large shift in I:E ratio was accompanied by an appreciable effect on neuronal 
excitability. Tiagabine raised the action potential firing threshold from 18.8 ± 0.5 mV 
to 24.9 ± 0.5 mV positive to rest (P<0.001). The number of spikes generated during a 
250 ms depolarisation fell substantially from 3.5 ± 0.4 to 1.3 ± 0.21 (P=0.001), but 
action potential amplitude was unaffected (Fig. 4.9C-E). 
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Figure 4.10: Effect of increasing tiagabine concentration on sEPSCs. A: The example 
traces, somewhat surprisingly, clearly show an increase in EPSC frequency with 12 
µM tiagabine. B: This is supported by the IEI data, showing a concentration-
dependent shift to the left with tiagabine. This is in agreement with the VmD data for 
this drug (Fig. 4.9). C: At 4 µM, sEPSC amplitude was significantly increased, with 
the subsequent reduction in 12 µM possibly due to depletion of glutamate from 
presynaptic stores. D: Decay time is not significantly affected, but shows a downward 
trend with increasing tiagabine. 
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Whole Cell Patch Clamp 
 
As with PDC, whole-cell patch clamp recordings of the effects of tiagabine on 
spontaneous transmitter release had not previously been conducted in these neurones. 
To correlate effects on spontaneous release with estimate of IBg and EBg I studied the 
effects of tiagabine on sEPSCs and sIPSCs in a total of 12 neurones (6 for each group). 
As in the PDC experiments, 200 consecutive events were analysed for each of the 
control and drug periods in each neurone. The results are summarised in figures 4.10 
and 4.11. Tiagabine had a contrasting effect on EPSCs and IPSCs, however the results 
were perhaps not what would be expected, especially when the VmD data above are 
considered.  
 
The effect of increasing tiagabine concentration on sEPSCs is illustrated in Fig. 4.10. 
An increase in EPSC frequency with tiagabine can be seen in the trace from a single 
neurone in Fig. 4.10A, and is supported by the increasing leftward shift in the IEI 
curve seen in Fig. 4.10B. Additionally, EPSC amplitude was slightly, but significantly, 
increased from control (11.2 ± 0.2 pA) by 4 µM (12.3 ± 0.3 pA) and 12 µM tiagabine 
(11.3 ± 0.2 pA, P<0.01, ANOVA). EPSC decay time showed a downward trend in 
increasing concentrations of tiagabine, from 0.99 ± 0.04 ms to 0.89 ± 0.04 ms in 12 
µM tiagabine (P>0.05). 
 
The results obtained for IPSCs in tiagabine were surprising, especially with reference 
to the VmD data. As seen in Fig. 4.11A and B, increasing concentrations of tiagabine 
actually cause a reduction in sIPSC frequency, illustrated by a rightward shift in the 
IEI curve (Fig. 4.11B). However, the kinetics of the observed events may provide 
some explanation for the VmD results. IPSC amplitude and decay time increased 
steadily with tiagabine concentration (Fig. 4.11C-D). Amplitude increased from 17.8 
± 0.5 pA to 21.8 ± 1.1 pA in the presence of 12 µM tiagabine (P=0.004). Similarly, 
50% decay times were increased from 3.65 ± 0.06 ms to 4.51 ± 0.15 ms (P<0.001). 
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These results indicate that, although frequency of IPSC activity is reduced, the longer 
duration and larger amplitude of the GABAergic events may account for the observed 
increases in background inhibitory conductance. 
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Figure 4.11: Tiagabine reduces sIPSC frequency in a concentration-dependent 
manner. A: In contrast to the EPSC data (Fig. 4.10), example traces show a reduction 
in sIPSC frequency with tiagabine. However, an increase in amplitude is clearly 
evident. B: The IEI curve shifts right with increasing tiagabine, supporting the trend 
seen in (A). C: However, any decrease in IPSC frequency may be cancelled out by the 
observed significant concentration-dependent increases in amplitude. D: Similarly, 
decay time is significantly increased with tiagabine, suggesting that, in agreement 
with the VmD data (Fig, 4.9), IBg may actually be increased, despite reductions in 
sIPSC frequency. 
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Blockade of GABAAr or AMPAr During VGSC Blockade 
 
I have previously demonstrated the effects of the VGSC blocker TTX on conductance 
estimates layer III pyramidal cells (Chapter 3). Subsequent to TTX application, 
GABAAr or AMPAr were blocked using bicuculline (10 µM, n=3) and NBQX (10 
µM, n=3) respectively. In the presence of TTX (1 µM), IBg = 6.7 ± 1.5 nS, EBg = 3.6 ± 
1.1 nS and I:E ratio = 2.2 ± 0.5. 
 
A 
 
 
 
 
 
 
 
 
 
B 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.12: Addition of bicuculline and NBQX to TTX treated cells. Graphs show 
VmD estimates in cells treated with 1 µM TTX. Conductance values in TTX were IBg = 
6.7 ± 1.5 nS, EBg = 3.6 ± 1.1 nS, I:E ratio = 2.2 ± 0.5. A: Addition of bicuculline (10 
µM) causes a significant decrease in IBg, leaving EBg unchanged and significantly 
shifting the I:E ratio in favour of excitation(to 0.6 ± 0.1). Conversely, treatment with 
NBQX (10 µM) caused no change in IBg, but a significant decrease in EBg. The I:E 
ratio displayed a trend towards increased inhibition (to 4.1± 1.6) but this was not 
significant. B: None of the SD estimates were affected by bicuculline or NBQX. This 
was to be expected, as action-potential mediated network connections would be 
abolished by TTX. 
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Addition of bicuculline (10 µM) in the presence of TTX caused a significant 
reduction in IBg (to 2.3 ± 1.0 nS, P=0.02), but EBg was unaffected (at 3.5 ± 1.2 nS, Fig. 
4.12A). The SDs of IBg and EBg were not affected. 
 
NBQX (10 µM), in the presence of 1 µM TTX, had essentially the opposite effect to 
bicuculline. Compared to TTX alone, EBg was decreased at 1.4 ± 0.5 nS (P=0.02), 
whereas IBg was unaffected at 5.9 ± 2.8 nS. Similarly to bicuculline, neither SD was 
affected by NBQX addition (Fig. 4.12B) 
 
Discussion 
 
The experiments in this chapter were designed to investigate the control exerted on 
background activity, and hence cellular excitability, by a range of receptor 
populations. However, the VmD method is designed only to incorporate conductance 
mediated by postsynaptic AMPA and GABAA receptors in the recorded cell, giving 
values for EBg and IBg, respectively. As stated in Chapter 3, spontaneous activation of 
GABAB receptors is highly unlikely in EC neurones under normal circumstances 
(Woodhall et al., 2004), and spontaneous NMDAr-mediated events are very 
infrequent (Berretta and Jones, 1996a). Background synaptic noise in EC neurones is, 
therefore, overwhelmingly reliant on the activation of AMPA and GABAA receptors. 
We are confident, therefore, that a reliable and repeatable measure of background 
activity can be obtained through the current version of the VmD method. 
 
The Destexhe group has considered, and is working on, the incorporation of multiple 
excitatory components to a revised version of the VmD method. However, the 
mathematical equations necessary to support multiple excitatory (or inhibitory) inputs 
in this way become exponentially more complex with increasing numbers of 
components. Thus, given the already highly complex nature of the VmD method and 
the equations used to construct and test it, it may not be practicable to include more 
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than AMPA and GABAA receptors at this time (Alain Destexhe, personal 
communication). 
 
The VmD results obtained in the presence of both NBQX and GYKI-53665 indicate 
that AMPA receptors are indeed mediating the majority of excitatory transmission in 
these cells. EBg in both cases was significantly reduced to around 33% of control 
levels. This reduction could logically be attributed to the reduction in postsynaptic 
AMPAr activity, something that is directly measured in the VmD equation. 
Theoretically, it is possible that recurrent excitatory drive, as seen between cells P2 
and P1 in Fig. 4.13, could account for some of the background activity abolished by 
AMPAr antagonists (Dhillon and Jones, 2000). However, in our VmD studies with 
TTX and NBQX, it is clear that recurrent, action potential dependent excitatory 
activity has very little bearing on EBg measured in these experiments. 
 
Both NBQX and GYKI-53655 cause a clear reduction in IBg. With reference to the 
above-mentioned TTX experiments, the majority of inhibitory transmission in layer 
III of the mEC would appear to be activity-dependent. Thus, the most likely 
explanation for the reduction in IBg mediated by the AMPAr antagonists is a reduction 
in excitatory drive onto inhibitory interneurones. A further reduction in inhibitory 
transmission could be mediated through reduction of GABA release due to blockade 
of presynaptic AMPAr (and, in the case of NBQX, KAr) at inhibitory terminals 
(Bureau and Mulle, 1998; Rusakov et al., 2005), however the co-application of TTX 
and NBQX in Chapter 3 showed only a slight, insignificant reduction in IBg. 
 
NBQX causes a far larger reduction in levels of IBg and EBg SD than GYKI-53655. If 
we are to continue to accept that these SD measurements provide an idea of the 
synchronisation of neuronal populations, it must be concluded that the greater effects 
seen with NBQX are due to its action at KAr, the role of which will be discussed later. 
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Figure 4.13: Schematic diagram of network connectivity in the mEC. Antagonism of 
one population of receptors, for example AMPAr, could have secondary effects across 
the network, not just at the postsynaptic membrane. Blockade of AMPAr could reduce 
recurrent excitation (P2 -> P1 -> P2) or excitatory drive onto interneurones (I1 and I2) 
leading to changes in the observed conductances not mediated directly at the 
postsynapse. During application of uptake blockers (i.e. PDC and tiagabine) the 
affected neurotransmitter (glutamate and GABA, respectively) would be more 
available at all synapses across the network, leading to changes in the activity of both 
principal cells and interneurones. Coupled with the high levels of recurrent 
connection, uptake blockade has complex effects across the whole network. 
 
 
Cellular excitability is significantly reduced by both NBQX and GYKI-53655. 
Considering the lack of significant change in IBg in the presence of these drugs, this 
suggests either that excitability is predominantly controlled by levels of EBg, or that it 
is dependent on the I:E ratio. The latter theory is more likely to be correct, as we will 
see from studies with anticonvulsants in Chapter 7. 
 
Blockade of NMDA receptors with R-AP5 had only moderate effects on IBg and EBg. 
As mentioned previously, postsynaptic NMDAr at the recorded cell do not form part 
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of the VmD estimates. Therefore, any changes seen in conductance or SD must be 
mediated through network transmission changes or modulation of transmitter release 
by presynaptic NMDAr. Blockade of presynaptic NMDAr would directly reduce 
glutamate release, thus reducing EBg. These presynaptic NMDAr have been shown to 
be tonically active (Berretta and Jones, 1996b; Woodhall et al., 2001; Yang et al., 
2006) so their blockade is likely to be the chief mediator of any reduction in EBg. 
Alternatively, some reduction in EBg could be due to reduced NMDAr activity in 
recurrent excitatory connections (Dhillon and Jones, 2000), but as discussed for 
AMPAr blockade this would appear to contribute little to EBg observed in these 
studies. 
 
Reduction of IBg by R-AP5 could be due to a reduction in GABA release mediated by 
antagonism of presynaptic NMDA receptors on inhibitory terminals. However, it is 
not clear whether layer III inhibitory terminals contain presynaptic NMDAr. Previous 
studies from our laboratory have indicated the presence of NMDAr at inhibitory 
terminals in layer II of the mEC, but not in layer V (Woodhall et al., 2001). What is 
more likely is a reduction of the NMDAr-mediated excitatory drive onto inhibitory 
interneurones, which mediates much of their AP-dependent activity (Jones and Buhl, 
1993; Monyer et al., 1994; Glitsch and Marty, 1999; Maccaferri and Dingledine, 
2002). This reduction in drive may be supported by the observed reduction in IBg SD 
with R-AP5, which would indicate reduced synchrony of interneurone activation. 
 
Spike firing threshold is slightly, but significantly, reduced in the presence of R-AP5. 
This is difficult to explain in terms of direct activity of NMDAr at the postsynaptic 
membrane, but may be related to the reduction in EBg. However, the I:E ratio does not 
change significantly. It may be that a reduction in EBg alone is enough to significantly 
reduce firing threshold in certain cases. 
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The effects of R-AP5 on the subgroup of neurones exhibiting markedly higher control 
levels of EBg and IBg provide some insight into the mechanism of conductance 
modulation by NMDAr antagonism. These cells may have higher levels of baseline 
conductance due to the presence of a more intact network within the slices. This 
would cause a circular increase in glutamate release; the higher baseline release of 
glutamate from excitatory synapses would trigger more facilitation of release by 
presynaptic NMDAr, further increasing EBg. This higher level of excitation may lead 
to an increase in levels of recurrent excitation between principal cells (see Fig. 4.13) 
leading to even greater amounts of glutamate being released from excitatory synapses. 
Furthermore, the network-wide elevation in glutamate release (and hence EBg) would 
be expected to increase drive onto inhibitory interneurones, leading to increased IBg. 
Thus, given the crucial role that presynaptic NMDAr play in this sequence of events, 
it is unsurprising that addition of R-AP5 precipitates a large reduction in both EBg and 
IBg. That the I:E ratio is unchanged by R-AP5 supports the notion of network driven 
increases in conductance, since the reduction in EBg appears to remove the excitatory 
drive from inhibitory cells, leading to a commensurate reduction in IBg. 
 
The use of UBP-302 to block GluR5-containing KAr has no significant effect on 
background conductance or cellular excitability. Whole-cell patch clamp studies from 
our laboratory have indicated that KAr present on the postsynaptic membrane do not 
contain GluR5. Furthermore, the GluR5-containing KAr that have been shown to 
mediate facilitation of glutamate and GABA release are not tonically active, so in 
these quiescent slices the addition of a KAr antagonist would have little effect 
(Chamberlain and Jones, unpublished observations). 
 
In contrast to conductance and excitability measurements, blockade of GluR5-
containing KAr does have an appreciable effect on SD estimates for both IBg and EBg. 
This suggests that, whilst having little bearing on levels of background conductance, 
these KAr are responsible for maintaining some degree of neuronal synchrony. 
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Evidence to support this notion comes from studies involving up-state behaviour in 
cortical networks (Cunningham et al., 2006), where the use of UBP-302 abolishes 
sub-threshold oscillations which would appear to be reliant on a high degree of 
network synchrony. This oscillatory behaviour will be discussed in more detail in 
Chapter 6. An interesting avenue for research could possibly be the use of a specific 
GluR5 antagonist as an anticonvulsant. Given the minimal effects on both overall 
conductance and cellular excitability, coupled with the reduction in synchrony, a drug 
such as UBP-302 could be used to reduce the likelihood of seizure generation without 
disrupting normal network function, as epileptiform activity is essentially the 
synchronised firing of many neurones across a network. 
 
The blockade of glutamate uptake with PDC causes an increase in both IBg and EBg. 
The increase in EBg could be further enhanced by activation of presynaptic NMDA 
receptors, and increased input from recurrent excitatory connections. However, the 
lack of change in EBg SD, and hence no change in the synchronicity of the excitatory 
neurone population, would suggest that these recurrent connections to not play a large 
role in the observed EBg increase. The observed increase in IBg is likely to be down to 
increased excitatory drive onto interneurones. Again, there may be further 
enhancement of interneurone activity by NMDAr-mediated facilitation of glutamate 
release onto inhibitory cells. Considering both conductance components together, it 
may be that the overall value of EBg has been underestimated in this instance, as the 
increase in IBg may be acting to dampen some of the excitatory activity throughout the 
network. 
 
PDC does not cause a large change in the SD of EBg or IBg, and has no effect on the 
I:E ratio, as both conductance components rise by proportionally equal amounts. The 
lack of change in cellular excitability suggests that the I:E ratio does have some 
bearing on the degree of cellular excitability. 
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The use of whole-cell patch clamp studies in conjunction with the VmD method 
allows for further investigation of changes in synaptic activity in the presence of this 
drug. The increase in sEPSC frequency, without a change in decay time, was 
somewhat surprising. Blockade of glutamate uptake would be expected to increase the 
persistence of glutamate at the binding sites of postsynaptic receptors, leading to 
increased activation time. However, no such increase in event duration was observed. 
The increase in frequency may be due to activation of presynaptic NMDA receptors, 
leading to a more depolarised presynaptic membrane and a higher probability of 
glutamate release. Furthermore, there was no increase in EPSC amplitude. This may 
suggest that the AMPA receptor population in the recorded cells is close to saturation. 
The increase in frequency would result in a greater overall conductance, which fits in 
with the observations made using the VmD method. 
 
Considering IPSC activity under PDC, the observed increase in frequency is most 
likely due to increased excitatory drive onto inhibitory interneurones, caused by the 
increased persistence of glutamate at the synapse. The increase in excitatory drive 
would necessarily increase the amount of multi-quantal, activity-dependent GABA 
release from inhibitory terminals, leading to the significant increase in decay time 
seen in this study. The increase in GABAA-mediated conductance, along with the 
increase in excitatory drive onto interneurones, accounts for the rise in IBg and the 
slight rise in IBg SD seen in the VmD study. 
 
The use of tiagabine to block the uptake of GABA yields some surprising results, in 
both the VmD method and patch clamp studies. As would be expected, levels of IBg 
estimated by VmD are significantly increased in the presence of tiagabine. This can 
simply be explained by the increased amount of GABA present in the synapse. 
However, tiagabine also causes a noticeable rise in EBg. There is mounting evidence to 
challenge the traditional view of GABA as a hyperpolarising, inhibitory transmitter. 
Presynaptic GABAAr are thought to be depolarising due to a high concentration of 
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chloride ions in glutamatergic terminals causing outward movement of Cl
-
 (Jang et al., 
2001). It has been shown that these receptors can facilitate glutamate release in the 
hippocampus (Jang et al., 2006; Alle and Geiger, 2007) and locus coeruleus (Koga et 
al., 2005). Presynaptic GABAA receptors have also been shown to facilitate GABA 
release (Xiao et al., 2007). The fact that EBg was not reduced by a GABAA antagonist 
such as bicuculline (see Chapter 5) suggests that these receptors are not tonically 
active, and only affect glutamate release in the presence of large amounts of GABA. 
 
Furthermore, blockade of GABA uptake by tiagabine or NO-771 has been shown to 
induce spontaneous depolarisations of neurones in seizure prone mice (Hu and Davies, 
1997; Davies and Shakesby, 1999). Initial trials with high concentrations of tiagabine 
in our own laboratory led to spontaneous slow depolarisations in slices obtained from 
healthy juvenile rats. The most likely mediator for these depolarising events is the 
presynaptic GABAAr mentioned above. 
 
Of further interest is the effect of tiagabine on both IPSCs and EPSCs in the patch 
clamp studies. Tiagabine shows a concentration-dependent increase in sEPSC 
frequency, most probably due to the actions of the presynaptic GABAA receptors 
discussed above. What is more surprising is the reduction in sIPSC frequency 
precipitated by increasing concentrations of tiagabine. Increased amounts of GABA in 
the synapse may lead to the activation of presynaptic GABAB receptors. These 
metabotropic receptors have been shown to inhibit the release of GABA from 
presynaptic terminals, however their activity has been shown to be tonic in deeper 
layers and phasic in more superficial layers of the mEC (Bailey et al., 2004). The 
reduction in IPSC frequency is, however, accompanied by concentration-dependent 
increases in both amplitude and duration of inhibitory events. Thus the total charge 
transfer mediated by postsynaptic GABAA receptors may be increased from control 
levels, in agreement with the large rise in IBg seen in the VmD experiments. 
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CHAPTER 5 
LAMINA-SPECIFIC DIFFERENCES IN BACKGROUND SYNAPTIC 
ACTIVITY 
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Introduction 
 
As previously stated in Chapter 1, the EC is divided in to six anatomical layers, 
although some controversy exists as to the exact classification, e.g. the lamina 
dessicans. All the experiments to validate the viability of the VmD approach 
described in previous chapters have been conducted in layer III. This is largely 
because previous work in our laboratory (Cunningham et al., 2006) has shown that 
this area has a propensity to develop synchronised slow-wave oscillations (SWO), and 
later experiments (Chapter 6) have used the VmD method to characterise I:E changes 
leading to SWO generation. In the current Chapter I have compared IBg and EBg in two 
further populations of neurones, those in layer V and layer II of the mEC. 
 
As discussed in Chapter 1, there are a number of differences in the structure and 
nature of inhibitory connections between layers in the mEC, which may affect the 
susceptibility of these layers to epileptic activity. Briefly, there would appear to be a 
greater degree of inhibitory control exerted over neurones in superficial layers than in 
deep layers. Layer II principal cells, consisting mostly of spiny stellate cells, form the 
major part of the output from EC to hippocampus, with projections towards the 
dentate gyrus, CA2-3 hippocampus and subiculum (Alonso and Klink, 1993; 
(Tamamaki and Nojyo, 1993; Jones, 1994; Klink and Alonso, 1997). Inhibition in 
layer II is mediated by basket and chandelier cells, providing tight control of principal 
cell activity with dendritic trees that are confined mostly within the layer (Germroth et 
al., 1989; Jones and Buhl, 1993). Layer III principal neurones are mostly pyramidal 
cells, many of which act as “controller cells” for neurones in CA1 (see Chapter 1). 
Inhibition in layer III is again mediated by basket and chandelier cells (Hendry et al., 
1989; DeFelipe, 1999). Excitation in layer V is also mediated by pyramidal cells, 
however these cells mostly project back towards the superficial layers of the EC, see 
Figs. 1.2 and 1.3. 
 
  
124 
There is a significant difference in the inhibitory properties of layer V and layers II 
and III. Previous studies, mainly from our own laboratory, have indicated clear 
electrophysiological differences between the levels of inhibitory transmission in 
layers II and V. Principal cells in layer II are kept mostly quiescent, and prevented 
from firing action potentials, by the high level of inhibitory activity in this layer 
(Jones, 1993 and 1994; Heinemann et al., 2000). In contrast, activity in layer V is 
dominated by excitation, with inhibitory responses sometimes not being apparent at 
all (Jones and Heinemann, 1988). Furthermore, inhibitory activity in superficial layers 
is more constitutively active, with a greater proportion of IPSCs being action potential 
independent than in layer V (Woodhall et al., 2004). These results suggest that 
neurones in different parts of the EC are subject to differing balances of network 
control.  
 
Considering the lamina-specific differences in inhibitory control of principal cells, the 
superficial layers of the EC have been labelled as “epilepsy resistant”, with the deeper 
layers being “epilepsy prone” (Jones and Lambert 1990a; Jones 1993; Woodhall et al., 
2004). However, in human patients and in animal models of chronic epilepsy, there is 
evidence for a preferential loss of neurones in layer III of the EC (Du and Schwarz, 
1992; Du et al., 1993, 1995). Additionally, changes in recurrent inhibition in layer II 
result in excessive output towards the dentate gyrus in the pilocarpine model of 
epilepsy in rats (Kobayashi et al., 2003; Kumar et al., 2007). Bear et al. (1996) found 
that electrically induced chronic epilepsy in rats led to a prolongation of evoked 
responses in superficial layers, that could be shortened by application of 2-AP5. The 
same group found that, again in electrically induced chronic epilepsy, deep-layer 
neurones in the EC of epileptic rats were hyperexcitable, partly due to an increase in 
NMDA-mediated excitation (Fountain et al., 1998). Scharfman et al. (1998) found 
that, in a rat model of chronic epilepsy induced by injection of amino-oxyacetic acid, 
similar prolongations of excitatory discharges to those found by Bear et al. above 
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were seen in superficial neurones in the EC. In deeper layers, ictal discharges 
occurred after a short delay in some neurones. 
 
Several in vitro studies of acutely generated seizures have shown that, within the EC 
itself, seizure events are initiated in the deeper layers (V-VI) and propagate ictal 
discharges to both deeper and more superficial areas of the EC and beyond. This role 
of the deep layers in the generation of seizures lends weight to the notion that they are 
“seizure sensitive”, compared to the more “seizure resistant” areas in the superficial 
layers (Jones and Lambert, 1990a, b; Jones, 1993; Avioli et al., 1996; Lopantsev and 
Avioli, 1996; D’Arcangelo et al., 2001). This picture of the lamina-specific 
differences in the EC has been mirrored in studies of seizure initiation in the 
neocortex (Hoffman and Prince, 1995; Barkai et al., 1995; Badea et al., 2001; Yang 
and Benardo, 2002). Furthermore, in agreement with the results of similar studies 
investigating acutely invoked seizures in vivo (e.g. Ben-Ari et al., 1981; Collins et al., 
1983; Stringer, 1994), this acute seizure activity would appear to originate in the EC 
and spread to adjacent areas of the limbic system (Jones and Lambert, 1990a; Iijima et 
al., 1996; Avioli et al., 1996; Bucheim et al., 2002; Weissinger et al., 2000; 
D’Arcangelo et al., 2001). These studies serve to support the notion of the EC as a 
crucial structure in TLE, and highlight the importance of understanding the lamina-
specific differences in excitability and epilepsy sensitivity that may underlie the 
generation of seizures in animal models and, ultimately, human patients. 
 
To investigate the differences in background activity between layers in the mEC, and 
any differences in susceptibility to acutely-evoked epileptiform activity, this chapter 
will focus on using the VmD method to obtain estimates of IBg and EBg in layers II, III 
and V of the mEC, and how these change over time in response to the application of 
the GABAA antagonist bicuculline, used in several studies to mimic epilepsy in vitro 
(e.g. Jones, 1988; Jones and Lambert, 1990a, b). The time-course of onset of epileptic 
activity, and changes in background conductance, in each layer should give some 
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indication of the susceptibility of each layer to acute seizures, with faster onset 
indicating increased propensity towards seizures. In order to properly characterise IBg 
and EBg in layers II and III, values for AMPAr and GABAAr reversal must also be 
obtained. 
 
Methods 
 
All experiments were carried out on EC-hippocampal slices taken from juvenile male 
Wistar rats, as described in Chapter 2. In order to apply the VmD method to principal 
cells in layers II and V it was necessary to first determine reversal potentials for 
AMPAr-mediated EPSPs and GABAAr-mediated IPSPs in these two populations. 
Reversal potentials of AMPA and GABAA receptors, leak reversal potentials, and 
sEPSC and sIPSC decay times, for layer II and V pyramidal cells were obtained in the 
same manner as those for layer III cells, as described in Chapter 3. 
 
The VmD method was used to obtain the time-course of action of the GABAAr 
receptor antagonist, bicuculline (10 µM). Cells were allowed to equilibrate for 5-10 
minutes after impalement, after which time recording was started and control values 
were measured using the two-current protocol described previously. Bicuculline was 
then perfused over the slice for a period of up to 15 minutes, with estimates of IBg and 
EBg being made every two minutes. Epileptic seizure activity (as seen in Fig. 5.7) was 
observed in the majority of cells. A final estimate of conductances was made after 
seizure activity began. Accurate measurement of conductances was not possible after 
the establishment of regular seizure activity. With continued perfusion of bicuculline, 
regular and frequent seizures were observed in most slices. This makes it difficult to 
obtain stable periods of membrane potential necessary for accurate VmD estimations, 
due to both the seizure itself and the refractory period after each discharge. As such, 
the obtained time-courses display the run-up to the initial seizure, and the final values 
obtained after this event. 
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Results 
 
Layer II and V Reversal Potentials 
 
Reversal potential recordings were made from a total of 12 pyramidal neurones, 3 in 
each group for GABAAr and AMPAr reversal potentials for both layer II and layer V. 
The results obtained do not differ greatly from the values measured in layer III 
pyramidal cells, as outlined in Chapter 3. The reversal potentials for AMPAr, 
GABAAr and leak conductance can be compared in table 5.1. Graphs of AMPAr-
mediated EPSPs and GABAAr-mediated IPSPs at a range of membrane voltages in 
layers II and V can be seen in figures 5.1 and 5.2 respectively. 
 Reversal Potentials (mV) Decay Times (ms) 
Layer AMPAr GABAAr Leak EPSC IPSC 
II 3.9 -66.1 -77.6   
III 6.8 -66.7 -78.1 13.7 29.1 
V 6.1 -65.2 -78.8   
 
Table 5.1: Reversal potentials for layers II, III and V of the mEC. Average reversal 
values, especially for leak and GABAAr reversal, are very similar across the layers. 
 
 
Comparison of Laminar Baseline Values 
 
The baseline values of IBg, EBg and their respective SDs give some idea of the 
differences in transmission and synchrony between layers in the mEC. In layer II 
(n=6), IBg = 12.3 ± 2.0 nS, EBg = 3.3 ± 0.4 nS and I:E ratio = 3.6 ± 0.3. Baseline SD in 
layer II was higher than for other populations, suggesting greater synchrony in control 
conditions. IBg SD was 2.1 ± 1.1 nS, and EBg SD was 46.0 ± 9.1 pS. The average 
number of spikes generated by a 250 ms depolarisation was 4.0 ± 0.4, and the mean 
baseline spike threshold was 18.8 ± 0.4 mV. 
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Figure 5.1: Reversal potential graphs for AMPA and GABAA receptors in layer II of 
the mEC. Evoked responses at a range of membrane potentials in the presence of 
antagonists for other ionotropic receptors were averaged and graphed, using linear 
regression, to find the reversal potentials of 3.91 mV for AMPA and -66.05 mV for 
GABAA receptors. Each graph represents pooled data from 3 neurones. 
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Figure 5.2: Reversal potential graphs for AMPA and GABAA receptors in layer V of 
the mEC. Evoked responses at a range of membrane potentials in the presence of 
antagonists for other ionotropic receptors were averaged and graphed, using linear 
regression, to find the reversal potentials of 6.10 mV for AMPA and -65.20 mV for 
GABAA receptors. Each graph represents pooled data from 3 neurones. 
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The majority of neurones recorded in this thesis were from layer III, allowing a larger 
group to be used for control values. In 61 cells, as previously stated (Chapter 3), 
baseline IBg = 10.2 ± 1.6 nS, EBg = 2.5 ± 0.3 nS and I:E = 4.1 ± 0.3. IBg SD was 0.3 ± 
0.1 nS and EBg SD = 7.8 ± 1.3 pS. Cellular excitability values were 20.5 ± 0.7 mV for 
firing threshold, and 4.4 ± 0.3 spikes per train. 
 
Layer V values were as follows (n=5): IBg = 6.8 ± 1.6 nS, EBg = 2.8 ± 0.6 nS and I:E 
ratio = 2.5 ± 0.4. SD was 0.30 ± 0.2 nS for IBg and 4.7 ± 1.6 pS for EBg. Spike firing 
threshold was 24.2 ± 0.5 mV and average spikes per 250 ms pulse was 2.7 ± 0.2. 
From these results it is clear that there is a much higher level of synchrony present in 
both inhibitory and excitatory populations within layer II. Layer V has the lowest 
baseline levels of inhibition and an I:E ratio that is more in favour of excitation than 
the superficial layers. This reflects previous studies by our laboratory and others, 
suggesting that activity in layer V is less biased towards inhibition compared to layers 
II and III. 
 
Effects of Bicuculline in Layer II 
 
Having calculated the baseline levels of IBg and EBg in the three layers, I now 
determined time-course of changes during application of the convulsant GABAA 
blocker, bicuculline. 
 
Three neurones exhibited consistent seizure activity upon application of bicuculline 
(10 µM). The cells that did not display any discernable epileptiform activity were 
recorded for up to 25 minutes, but no events were observed. Lack of epileptiform 
activity did not appear to be dependant upon the level of network preservation in the 
slices used, as cells exhibiting and lacking epileptic activity were recorded from slices 
taken from the same animals, on the same day. 
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Figure 5.3: Time-course of bicuculline in layer II non-epileptic cells. A: Apart from a 
drop in IBg 2 minutes after bicuculline (10 µM) addition, conductance values are 
largely unchanged in these cells. B: The lack of significant change in EBg or IBg leads 
to no overall change in the I:E ratio throughout. C: SD estimates for EBg and IBg 
fluctuate throughout, but do not show a significant change. None of these cells 
exhibited any epileptiform events (n=3) 
  
132 
Conductance measurements were carried out over a 12 minute period in 6 pyramidal 
cells from mEC layer II. In three neurones where no epileptiform events were 
observed, there was an initial reduction in IBg from 10.7 ± 3.6 nS to 6.6 ± 2.2 nS after 
2 minutes exposure to bicuculline (P > 0.05), after which no change was evident. EBg 
was generally unchanged throughout the experiment. The I:E ratio was unchanged 
apart from a sharp rise at the end of the experiment (Fig. 5.3A-B). In the unresponsive 
neurones, SD estimates for both IBg and EBg fluctuated rapidly throughout the 
experiment. However, there was no significant change in either component at any 
time point (Fig. 5.3C). 
 
The remaining three layer II neurones exhibited epileptiform events at an average of 
447.0 ± 17.6 seconds (7.5 minutes) after the start of bicuculline perfusion. EBg was 
unchanged throughout, staying close to its initial value of 3.7 ± 0.4 nS. In contrast, IBg 
exhibited a clear reduction between 2 and 4 minutes after bicuculline addition, to 46% 
of its initial value (Fig. 5.4A). After this initial reduction, IBg remained steady until the 
end of the experiment. 
 
The change in IBg was reflected in the I:E ratio for these cells (Fig. 5.4B). From an 
initial value of 3.6 ± 0.3, I:E was reduced to 1.8 ± 0.2 at 4 minutes, attaining a final 
value of 1.5 ± 0.1 after 12 minutes in the presence of 10 µM bicuculline. Despite 
these clear trends, changes in conductance and I:E ratio were not significant at any 
time point. 
 
The SD estimates of IBg and EBg arguably provide the most interesting data in this 
layer (Fig. 5.4C). Immediately after exposure to bicuculline, the SD of both 
conductance components is noticeably reduced. However, in the run up to the first 
seizures at approximately 7.5 minutes, both IBg and EBg SD are steadily increased. 
This suggests an increase in the level of synchronisation in both excitatory and 
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Figure 5.4: Time-course of bicuculline in layer II epileptic cells. Dotted line shows 
average time of first seizure. A: EBg levels are unchanged throughout. IBg, however, 
shows a sharp reduction after 2 minutes, from 13.8 ± 2.0 to 6.6 ± 1.8 nS. B: This 
rapid change in IBg is reflected in the I:E ratio. C: The SD of both IBg and EBg is 
reduced rapidly after bicuculline addition. However, in the period leading up to the 
first seizure event, both SDs show a steady increase. This suggests increased 
synchrony in both populations preceding an epileptiform event. 
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inhibitory populations before epileptiform activity. Again, however, despite a clear 
trend in both excitatory and inhibitory components, the changes in SD were not 
significant throughout. The value of a in these cells was 32426 µm. 
 
Cellular excitability measurements were taken after each VmD measurement. 
Changes were not significant in either responsive or unresponsive neurones. In pooled 
data from all six layer II cells, neither spike threshold (18.8 ± 0.4 mV vs 17.0 ± 0.7 
mV) nor spikes per train (4.0 ± 0.4 vs 5.7 ± 0.5) showed any change after 12 minutes 
of bicuculline perfusion. 
 
Effects of Bicuculline in Layer III 
 
In a similar manner to the study in layer II, the time-course of the effect of bicuculline 
was observed in 6 neurones in layer III of the mEC. All of these cells eventually 
exhibited epileptiform activity, in contrast with the findings in layer II. 
 
The development of epileptiform activity in layer III was faster than that seen in layer 
II. Cells displayed epileptiform activity after 4-7 minutes, with a mean value of 313.5 
± 42.7 seconds (5.2 minutes). This value contrasts with the 7.5 minute mean for 
activity to develop in layer II cells. Control conductance levels in bicuculline-treated 
layer III neurones were slightly lower than the mean values generally found in this 
layer, with initial measurements of IBg = 7.1 ± 0.9 nS, EBg = 1.2 ± 0.3 nS, and an I:E 
ratio of 4.8 ± 0.4. 
 
Layer III cells, upon exposure to bicuculline (10 µM), exhibited a steady and rapid 
reduction in IBg, up to and beyond the point of seizure initiation. EBg was largely 
unaffected, causing a shift in the I:E ratio firmly in favour of excitatory activity. This 
is illustrated in Fig. 5.5. IBg was decreased from 7.1 ± 0.9 nS to 1.5 ± 0.5 nS after 8 
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Figure 5.5: Time-course of bicuculline in layer III principal cells. As in Fig. 5.4, the 
dotted lines indicate the mean time of initial epileptiform activity. A: IBg shows a 
marked decline throughout the experiment, up to and beyond the first seizure. EBg is 
unchanged. B: The change in IBg is reflected in the steady movement of I:E ratio in 
favour of excitation. C: IBg SD initially drops to a low of 0.17 ± 0.07 nS at 4 minutes, 
before increasing again to 0.40 ± 0.09 nS as seizure activity begins. The SD of EBg is 
slightly decreased throughout. 
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minutes of bicuculline perfusion. EBg tended to increase slightly throughout the 
experiment, but was not significantly changed from the initial value (Fig. 5.5A). The 
I:E ratio fell to 1.1 ± 0.1 after 8 minutes, indicating almost equal amounts of IBg and 
EBg (Fig 5.5B). 
 
During bicuculline perfusion, the SD of IBg was rapidly reduced from 1.3 ± 0.3 nS to a 
final level of 0.12 ± 0.07 nS after 8 minutes (Fig. 5.5C, a = 34636). EBg SD also 
decreased from 21.0 ± 18.0 pS to 8.1 ± 4.2 pS. The difference between the SD of IBg 
in control recording and after 8 minutes perfusion with bicuculline was significant 
(P=0.028), whereas the change in the SD of EBg was not (P>0.05, t-test). Similar to 
the findings in layer II, cellular excitability was not significantly altered by 
bicuculline. Firing threshold was 20.6 ± 1.1 mV in control recordings and 18.2 ± 0.9 
mV after 8 minutes (P>0.05). The number of spikes generated by a 250 ms 
depolarising pulse was also not significantly affected (4.3 ± 0.3 to 5.5 ± 1.0 after 8 
minutes). 
 
Effects of Bicuculline in Layer V 
 
The time-course of the effects of bicuculline (10 µM) was studied in 5 pyramidal 
neurones in layer V of the mEC. All of these recorded cells displayed rapid 
epileptiform activity within 5-8 minutes of bicuculline addition. 
 
During application of bicuculline, IBg displayed a rapid and sustained drop from 6.8 ± 
1.6 nS, being more than halved after 2 minutes and reaching 1.9 ± 0.6 nS by only 4 
minutes. After this it remained largely the same, reaching 1.4 ± 0.4 nS after 8 minutes. 
EBg displayed little change throughout after an initial fall from 2.8 ± 0.6 nS to 1.9 ± 
0.5 nS. Thereafter it tended to increase again slightly, but was still reduced, compared 
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Figure 5.6: Time-course of bicuculline in layer V. Dotted line shows mean seizure 
point. A: IBg is quickly reduced to 1.9 ± 0.6 nS after 4 minutes, after which time the 
reduction is far slower. EBg undergoes a small initial reduction and then remains 
largely unchanged. B: I:E ratio decreases throughout, mirroring the trend seen with 
IBg. With an endpoint of 0.8 ± 0.1, I:E ratio in the presence of bicuculline shows 
dominance of EBg over IBg. C: The SD of IBg is reduced steadily throughout. EBg SD 
shows an initial dip at 2 minutes, and then recovers to near-control levels. 
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to control, at 1.8 ± 0.3 nS after 8 minutes (Fig. 5.6A). The I:E ratio was reduced from 
2.5 ± 0.4 to 1.0 ± 0.3 after 4 minutes, and fell slightly further to 0.8 ± 0.1 after 8 
minutes (Fig. 5.6B). This indicates that, after 8 minutes of bicuculline perfusion, EBg 
actually dominates IBg in these neurones. The changes in IBg and I:E ratio were both 
found to be significant by ANOVA (PI=0.005 and PR=0.002), whereas EBg was not 
found to have changed significantly.  
 
The SDs of the IBg and EBg were very low in layer V, compared to values obtained for 
neurones in superficial layers. From a control value of 0.30 ± 0.20 nS, IBg SD fell 
steadily throughout, reaching 0.043 ± 0.006 nS after 8 minutes. EBg SD was very low, 
starting on 4.7 ± 1.6 pS. Although there was no significant change at 8 minutes (4.2 ± 
1.8 ps) compared to control, it is interesting that after an initial fall (2.7 ± 0.7 pS after 
2 minutes), the SD of EBg then increased again back to control levels (Fig. 5.6C). 
Neither change in SD was found to be statistically significant. 
 
Bicuculline had a slight but significant effect on cellular excitability in layer V. Spike 
amplitude remained largely unchanged, however spike threshold was reduced steadily 
throughout, from 24.2 ± 0.5 mV in control recordings to 20.7 ± 0.8 mV after 8 
minutes (P=0.004). The number of spikes generated by a 250 ms pulse was not 
significantly affected. 
 
Laminar Comparison of Epileptiform Activity 
 
In addition to observed differences in the time-course of seizure initiation, and 
changes in IBg, EBg, and their respective SDs, there was a clear difference between 
epileptiform events in different layers. Typical events are illustrated in Fig. 5.7. 
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Figure 5.7: Comparison of epileptiform events in layers II, III and V of the mEC. A: 
Layer II events are shorter, have smaller amplitude and have shorter refractory 
periods than in either of the other two layers. B: Layer III events are more emphatic 
than layer II, with greater and more frequent spikes, longer duration and greater 
amplitude. C: Layer V events are the most violent of all, with very high frequency 
spike activity and high amplitude, taking several seconds to recover to baseline 
membrane potential. These differences in event length and amplitude reflect the 
laminar means for I:E ratio (LII = 1.5 ± 0.1, LIII = 1.1 ± 0.1, LV = 0.8 ± 0.1). D: 
Epileptiform activity takes significantly longer to develop in layers III and V 
compared to layer II. Some cells exhibited varying patterns of epileptiform activity, 
but these traces represent the vast majority of events in each layer. 
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The duration, amplitude and firing frequency of epileptiform events would appear to 
correlate with the I:E ratio in the presence of bicuculline in each layer. Typically, 
layer II neurones (I:E = 1.5 ± 0.1) display small, short epileptiform bursts. Layer III 
bursts are longer and larger (I:E = 1.1 ± 0.1), with layer V events the most prolonged 
and depolarised (I:E = 0.8 ± 0.1). Furthermore, layer II cells take significantly longer 
to develop signs of epileptic activity (447.0 ± 17.6 seconds) compared to layers III 
and V (313.5 ± 42.7 and 350.0 ± 48.0 seconds). These results would appear to support 
the theory that deeper layers are progressively more susceptible to epilepsy compared 
with layer II. 
 
Discussion 
 
The VmD data from different layers of the mEC provides further insight into 
differences in transmission and excitability between these layers. From baseline data 
in each layer, it is possible to obtain an idea of the normal resting conditions, i.e. the 
balance of inhibition and excitation, in deep and superficial layers. Ideally, 
simultaneous intracellular recordings, using the VmD method, from layers II, III and 
V in the same slice would give the most accurate picture of lamina-specific 
differences in I:E ratio and excitability, however this was not possible with our 
current experimental setup. 
 
 Conductance (nS) SD (pS) 
Layer IBg EBg I:E IBg EBg 
II 12.3 3.3 3.6 2120 46.0 
III 10.2 2.5 4.1 302 7.8 
V 6.8 2.8 2.5 296 4.7 
Table 5.2: Comparison of baseline values for layers II, III and V of the mEC 
 
Table 5.2 provides a simple means of comparing baseline conductance and SD values 
across layers. The two most noticeable differences are the low IBg in layer V, and the 
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high degree of SD (of both IBg and EBg) in layer II. EBg in layer V is not significantly 
less than mean EBg levels in the superficial layers, leading to an I:E ratio more in 
favour of inhibition in layer V. 
 
The results obtained using the VmD method in this chapter are in agreement with a 
number of patch clamp and intracellular studies, which suggest that inhibitory control 
of layer II principal neurones is far greater than in deeper layers (Finch et al., 1986; 
Jones, 1987; Finch et al., 1988; Jones and Heinemann, 1988; Jones and Buhl, 1993; 
Jones, 1993; 1994; Heinemann et al., 2000). Overall IBg levels in control conditions 
were greatest in layer II, followed by layer III. Baseline conditions in layer V indicate 
that IBg levels are almost 50% less in layer V compared to layer II (6.8 nS vs 12.3 nS). 
EBg levels are comparable across all three layers, the corollary of which is an I:E ratio 
in layer V that is more in favour of excitation compared to the other two layers. 
 
The VmD method is based on the actions of AMPAr and GABAAr, and as such 
provides a reliable estimate of background conductance levels, as we have seen 
throughout this thesis. However, the reliance on only two populations of receptors 
leads to a risk of underestimation in certain circumstances. Whereas spontaneous 
excitation is almost exclusively mediated by AMPAr in superficial layers of the mEC 
(with presynaptic NMDAr facilitating glutamate release), there is evidence to suggest 
that a significant component of spontaneous excitatory transmission in layer V is 
mediated by postsynaptic NMDAr, again with facilitation of glutamate release by 
presynaptic NMDAr (Berretta and Jones, 1996a, b; Jones and Woodhall, 2005). In 
whole-cell patch clamp studies, sEPSC frequency and amplitude has been found to be 
greater in layer V than in layer II (Berretta and Jones, 1996a). This is not reflected in 
the VmD values for EBg in this Chapter (3.3 nS in layer II, 2.8 nS in layer V). It is 
likely that the VmD method is underestimating the actual amount of excitatory 
activity in layer V, further shifting the “real” I:E ratio in favour of excitation 
compared to other layers. 
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There is little risk of this underestimation occurring when IBg is considered. Whole-
cell patch clamp studies from our own laboratory have indicated that spontaneous 
inhibition in both layer II and layer V is mediated postsynaptically by GABAAr, with 
GABAB autoreceptors regulating GABA release from inhibitory terminals (Bailey et 
al., 2004; Woodhall et al., 2004). The levels of spontaneous inhibition seen in deep 
and superficial layers in these patch clamp studies are in agreement with the VmD 
data in this Chapter. Woodhall et al. (2004) showed that sIPSCs in layer II occurred at 
an average of around 12.5 Hz, whereas the mean frequency in layer V was 2.5 Hz. 
The amplitude of sIPSCs in layer II was also slightly higher. 
 
Levels of IBg and EBg SD may give some indication of the degree of synchronicity 
within inhibitory and excitatory populations, respectively. If so, the baseline data 
indicate that inhibitory activity in layer II is highly co-ordinated. In the study by 
Woodhall et al. (2004) mentioned above, it was found that high-frequency bursts of 
sIPSCs occurred on a regular and frequent basis. This is indicative of a high level of 
synchrony in layer II. Additionally, EBg SD in layer II suggests an unusually high 
level of excitatory synchrony compared to other layers. Whether this synchronisation 
is a function of the high level of IBg, i.e. transmission-mediated, or through a high 
level of recurrent connections, i.e. anatomically-mediated, is unclear. It is likely to be 
due to a combination of both factors. 
 
Contrary to the conductance levels, cellular excitability measurements would indicate 
that layer II neurones are most excitable, with layer V neurones having the highest 
firing threshold and lowest firing frequency in control conditions. This is in 
contradiction to the expected values, as an I:E ratio in favour of inhibition, with high 
levels of IBg, would be expected to lead to low cellular excitability. However, the 
neurones recorded in different layers may be of differing cell types (e.g. pyramidal 
cells in layers III and V, stellate cells in layer II), each with their own cellular 
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morphology and passive channel properties, which may in this instance have more 
bearing on firing threshold/rate than overall and relative conductance levels. No 
attempt was made to unequivocally identify cellular morphology in these experiments. 
This discrepancy between I:E ratio and cellular excitability was overturned in the 
presence of bicuculline. Addition of bicuculline caused a slight reduction in firing 
threshold compared to resting potential in all three layers. However, the change in 
threshold was greater in layer III than in layer II, and in layer V bicuculline causes the 
largest reduction of all (14.5% over 8 minutes), a significant difference compared to 
control values (P = 0.004). Layer V may start with the highest firing threshold, but 
this appears to be more sensitive to GABAAr blockade than in superficial layers. This 
may be a function of the fact that the I:E ratio with bicuculline is biased in favour of 
EBg in layer V (0.8 ± 0.1), something that is not seen in other layers. 
 
The lamina-specific differences in baseline IBg and EBg are reflected in the relative 
speed of onset of epileptiform activity, the characteristics of the epileptiform events, 
and the response of each layer to the addition of bicuculline. In layer II, only half of 
the 6 neurones exposed to bicuculline exhibited epileptiform activity. The non-
epileptic cells showed a slight reduction in IBg, but this was not significant. This is 
somewhat surprising, as VmD estimates of background inhibition are based directly 
on the actions of GABAAr, of which bicuculline is a competitive antagonist. It may be 
that the high level of inhibitory activity in layer II causes a displacement of 
bicuculline from GABAAr, however this theory is undermined by the fact that the 
layer II neurones that eventually exhibited seizure activity had higher baseline levels 
of IBg than those that did not. Since epileptiform activity is population driven, and 
takes place throughout the EC in a co-ordinated fashion, apparently driven by layer V 
(Jones and Lambert, 1990a, b), differences in epileptic susceptibility seen from slice 
to slice could be due to the effects of bicuculline elsewhere in the mEC. 
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In all layers, initiation of seizure behaviour is preceded by clear declines in IBg, with 
I:E ratio shifting in favour of inhibition. Interestingly, in layer II, the first sign of 
epileptic activity is preceded by clear upward trends in the SD of both IBg and EBg, 
suggesting increased synchronisation in both inhibitory and excitatory populations. 
No clear SD trend is evident in the layer II cells that do not display epileptiform 
events. It may be that this apparent change in levels of synchronisation underlies the 
generation of seizures in layer II. 
 
The degree of severity of epileptiform activity, and the classic picture of lamina-
specific differences in epileptic sensitivity, is reflected in the values of I:E ratio for 
each layer in the presence of bicuculline. EBg is increasingly favoured by the I:E ratio 
in progressively deeper layers, and this is evident in the prolonged and larger-
amplitude epileptiform events in layer V compared to layer III, which in turn has 
larger and longer events than layer II. Paired recordings in slices have shown that 
epileptiform activity in layer V precedes activity in layers II, III and VI by several 
milliseconds (Jones and Lambert 1990a, b). This implicates layer V in the initiation 
and propagation of epileptic activity not just in the EC, but possibly throughout the 
entire mesial temporal lobe. 
 
The results in this Chapter highlight the lamina-specific differences in IBg and EBg that 
appear to underlie the susceptibility of each layer to acutely-evoked seizures. 
Certainly, the relatively low level of IBg in layer V would support studies implicating 
it in seizure generation and propagation, with the high IBg level in layer II leading to 
greater “seizure resistance” in superficial layers (Jones and Lambert, 1990a, b; Avoli 
et al., 1996; Lopantsev and Avoli, 1996; D'Arcangelo et al., 2001). However, some 
studies using resected human tissue and animal models of chronic epilepsy have 
implicated layer II in seizure generation, possibly due to higher levels of 
synchronisation (Silva-Barrat et al., 1988; Louvel et al., 1992; Scharfman et al., 1998; 
Kohling et al., 1998, 1999). Certainly, the SD of IBg and EBg in layer II suggests a 
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significantly higher level of network synchronisation in this area of the mEC. This 
purported seizure susceptibility, however, is not supported in acutely evoked 
epileptiform activity, with paired recordings indicating generation in layer V (Jones 
and Lambert 1990a, b) and the VmD data in this Chapter indicating larger, longer and 
more easily evoked seizures in deeper layers. 
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CHAPTER 6 
BRIEF MEMBRANE OSCILLATIONS IN THE EC 
 
 
  
147 
Introduction 
 
We have seen, in previous data chapters, that interference with individual receptor 
populations, or small changes in environment, can have wide-ranging effects on the 
activity of the entire network throughout the EC. Furthermore, the effect of a single 
drug can vary between layers within the mEC. Within a physiological context, small 
changes in the activity of neurone populations can have dramatic effects on the 
membrane voltage of an individual cell, manifested in brief membrane oscillations 
(BMO), or up-states, events that are easily recordable using intracellular 
electrophysiology. In this Chapter, I will investigate the phenomenon of membrane 
oscillations within layer III of the mEC, and use the VmD method in an attempt to 
quantify some of the network activity underlying these events. 
 
As discussed previously, cortical neurones, whether in the intact brain or an acutely 
prepared slice, are subject to constant background synaptic bombardment. It is this 
“synaptic noise” that forms the basis of the membrane voltage equation used as the 
core of the VmD method. The constant neurotransmitter release, and subsequent 
postsynaptic activity, is believed to aid the detection of at- or below-threshold signals 
due to the additive effect of random noise on a “weak” signal, i.e. stochastic 
resonance. This stochastic noise is increasingly thought to be an important factor in a 
variety of cellular and network processes throughout the mammalian brain; regulating 
signal integration from a number of neurones, modulating signal gain and determining 
the excitability of single neurones, or populations (Ho and Destexhe 2000; Chance et 
al., 2002; Dorval and White, 2005; Wolfart et al., 2005). Increases in the intensity of 
background conductance have been implicated in the generation of BMO and up-
states, as mentioned above. However, there is much debate as to the exact nature of 
the conductance changes necessary to mediate such events. 
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The advantage of using the VmD method to investigate background noise, and any 
subsequent consequences of changes in its level, is that it is complementary to a range 
of studies carried out using other means, from more traditional electrophysiology 
studies to the computer-based simulations that gave rise to the VmD method in the 
first place. Indeed, the VmD method was originally devised to study periods of 
increased background activity, leading to BMO (termed “high-conductance states” by 
the Destxhe group) and, under certain circumstances, the subthreshold oscillations in 
membrane potential known as “up-states” (Hausser and Clark, 1997; Pare et al., 
1998a, b; Stacey and Durand, 2000, 2001; Destexhe et al., 2003; Rudolph et al., 2004; 
Rudolph and Destexhe, 2004). These can be so intense in an intact brain that neurones 
undergoing BMO are constantly depolarised in comparison to cells in quiescent 
periods. Whether periods of high background conductance are the sole cause of 
observed up-state activity is hotly debated, with conflicting theories from a number of 
high-profile groups (e.g. Destexhe et al., 2003; Rudolph et al., 2004; Rudolph and 
Destexhe, 2004; c.f. Waters and Helmchen, 2004, 2006) 
 
The differentiation of spontaneous up-state activity caused by periods of differing 
background activity, as opposed to other, more regular oscillations associated with 
such things as sleep or memory formation, was initially made by Steriade et al. (1993), 
in pyramidal cells of certain morphology, usually cells with large dendritic arbours. 
Sanchez-Vives and McCormick (2000) showed that, in the visual cortex of 
anaesthetised cats, up-state activity is initiated in layer V and propagates vertically to 
layer VI and the superficial layers. There are several conflicting theories behind the 
generation and function of these up states. Walters and Helmchen (2004) showed 
using combined patch clamp and electrocorticogram studies that up-state activity is 
co-ordinated throughout the recorded neurones simultaneously, through an increase in 
action potential back-propagation mediated by an increase in the activity of dendritic 
sodium channels and/or a reduction in dendritic potassium channel activity, and 
would appear to also coincide with a marked increase in activity across the cortex. 
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However, Waters and Helmchen (2006) question the requirement of an increase in 
synaptic activity in the generation of up-state activity, citing instead small increases 
coupled with increases in input resistance caused by current rectification. Using short 
hyperpolarising current injections during whole-cell recordings of up-state activity in 
rat neocortical neurones in vivo, the membrane resistance of the recorded cells was 
monitored throughout. During up-state activity the resistance of the recorded neurone 
increased, with a small increase in conductance of 2-10 nS. 
 
In contrast to the assertions of Waters and Helmchen, the Destexhe group (Destexhe 
et al., 2003; Rudolph et al., 2004; Rudolph and Destexhe, 2004; Rudolph et al., 2007) 
have maintained that up-states are generated by periods of intense and co-ordinated 
cortical activity. Their theory is that up-state activity is representative of the behaviour 
of neurones in the intact brains of awake, behaving animals, and so is the most 
accurate representation of a fully functional neurone. Indeed, Cossart et al. (2003) 
have proposed that up-state activity may form the basis of memory retention or 
computational function in neuronal networks, by functioning as “circuit attractors”, a 
proposed method of enabling large collections of simple processing units (i.e. 
neurones) to perform complex computational tasks (Hopfield, 1982). Furthermore, 
Shu et al., (2003a) have demonstrated that barrages of increased excitatory and 
inhibitory activity enhance neuronal responsiveness and increase the accuracy of 
spike-timing. These co-ordinated barrages are thought to be controlled by the actions 
of feedback pathways. McCormick et al. (2003) have suggested that up- and down-
states are the natural result of the extensive recurrent connections in the cortex, with 
inhibitory interneurones playing a crucial role (Sanchez-Vives and McCormick, 2000). 
 
Studies in awake animals have shown that neurones in behaving subjects possess low 
input resistance and a depolarised membrane potential in comparison to quiescent 
cells seen in slices or anaesthetised animals. This would appear to support a much 
higher level of neurotransmitter release in these subjects (Matsumura et al., 1988; 
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Baranyi et al., 1993; Steriade et al., 2001). Furthermore, the technique of resistance 
comparison (by injection of hyperpolarising pulses and application of Ohm’s law) 
used by Walters and Helmchen to propose their “low conductance” up-states, with 
little change in overall synaptic activity, has previously been questioned by the 
Destexhe group (Destexhe et al., 2003) as too unreliable and non-transferable between 
studies or laboratories, due to differences in tissue preparations, electrode properties 
and recording conditions. Further support for the high-conductance theory of up-states 
comes from the use of the sodium channel blocker TTX in in vivo studies. Neurones 
recorded from intact brains in anaesthetised animals displayed, in the presence of 
TTX, resistance and potential characteristics similar to those found in neurones 
recorded from acute brain slices (i.e. a reduced preparation). These results logically 
support the reduced nature of slice preparations, but also rule out any differences in 
membrane potential or resistance characteristics that may have been caused by slice 
preparation, lending further weight to the notion of increased activity leading to up-
states. 
 
Cunningham et al. (2006) proposed an alternative explanation for up-state activity in 
the EC. They suggest that the major drive behind up-state activity is GluR5 containing 
kainate receptors, increasing activity by potentiating GABA and glutamate release 
through action at presynaptic terminals, but also postulate that the oscillations are a 
function of ATP-modulated potassium channels. Blockade of these channels with 
tolbutamide led to the prolongation of “up” phases, whereas enhancing the activation 
of KATP channels with diazoxide led to increased “down” periods. Blockade of KATP 
channels by MgATP slowed the transition between up- and down-state. The results 
suggest that increased activity during up-states leads to rapid depletion of intracellular 
ATP levels, which in turn causes the activation of KATP channels and the termination 
of the up-state. 
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In the studies discussed above, up-state activity is readily observed in vivo due to the 
high level of baseline activity in the intact brain. However, in reduced preparations 
(i.e. brain slices) it is usually necessary to increase activity levels to obtain oscillatory 
behaviour such as BMO and up-states. This can easily be achieved by lowering the 
magnesium concentration in the recording ACSF (e.g. see McCormick et al., 2003; 
Cunningham et al, 2006) to increase activation of pre- and postsynaptic NMDAr, 
increasing release of glutamate and GABA (Jones and Heinemann, 1989; Jones 1994). 
Here, I have used a modified ACSF in acute brain slices to induce up-state behaviour 
in the mEC. The VmD method has been used in an attempt to characterise differences 
in transmission between high-conductance states and quiescent periods. Both up-
states and brief membrane oscillations (i.e. periods of obviously increased potential 
fluctuation that do not lead to spontaneous depolarisations) have been studied with a 
range of drugs. 
 
Methods 
 
EC-hippocampal slices were prepared from juvenile male Wistar rats (40-70g) as 
described in Chapter 2. To induce up-state behaviour, slices were cut in normal ACSF 
without additional ketamine (which was found to reduce the likelihood of up-state 
activity), and stored for 2 hours at room temperature in a modified ACSF after slicing. 
This modified solution contained higher [K
+
]O (3.75 mM) and lower [Mg
2+
]O 
(1.25mM) compared to normal (see Ch. 2), and was used in the majority of 
experiments in this Chapter, with the exception of the Mg
2+
 ramp group. The longer 
recovery time was found to be necessary to obtain reliable up-state behaviour. All 
recordings were made from pyramidal neurones in layer III of the mEC. 
 
A separate group of 6 neurones were subjected to a magnesium ramp, to study the 
effects of decreasing concentration. Recording was started in ACSF with 1.5 mM 
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[Mg
2+
]O, which was then reduced by 0.5 mM every 5 minutes, giving a run of 1.5mM 
to 0.0mM [Mg
2+
]O across the duration of the experiment, until it was nominally zero. 
 
Results 
 
Identification and Classification of Brief Membrane Oscillations 
 
Up-states, where the membrane voltage spontaneously depolarises, often for several 
seconds, are easy to identify and differentiate from epileptiform activity by their 
amplitude, duration and shape, and as such can be identified by eye both during and 
after the recording as obvious depolarisations. However, other events were 
encountered that were obvious increases in the SD of the membrane potential, referred 
to here as brief membrane oscillations (BMO). These BMO are far harder to identify 
post-hoc, and identification involves assessing the entire voltage trace on a second-by-
second basis and comparing membrane voltage fluctuations with the surrounding 
trace, looking for periods of increased variability. Once BMO states have been 
identified, they can be separated from quiescent membrane periods during VmD 
calculations. This gives two readings per cell; one for the normal, quiescent 
membrane state (QMS) and one for the rapid bursts that characterise the BMO. 
 
Characterisation of Up-states 
 
Up-state activity was successfully evoked in a total of 10 cells. Several drugs were 
used to characterise the receptor populations involved in the generation and 
maintenance of up-state activity: the NMDAr antagonist 2-AP5, the AMPAr/KAr 
antagonist NBQX, the GluR5-containing KAr antagonist UBP-302, the gap-junction 
opener trimethylamine, and the gap-junction antagonist carbenoxelone.  
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An illustration of up-state activity, along with an expanded, single up-state showing 
clearly spontaneous synaptic activity, can be seen in Fig. 6.1. Mean baseline values 
for up-state activity were as follows: amplitude = 6.3 ± 1.0 mV, duration = 2.2 ± 0.4 s, 
frequency = 0.22 ± 0.11 Hz. 
  A 
 
 
 
 
 
 
 
 
 
  B 
 
 
 
 
 
 
 
  
 
Figure 6.1: Up-states in a layer III mEC pyramidal neurone. Traces in this and 
subsequent figures show membrane voltage levels obtained through intracellular 
recording from single LIII pyramidal neurones. A: Expanded trace of a single up-
state shows clear spontaneous synaptic activity on the rising edge and plateau of the 
event. B: Up-states exhibit rhythmic activity with a mean frequency of 0.22 ± 0.11 Hz 
 
AMPAr 
 
Up-states in layer III neurones consist of large amplitude depolarisations with 
spontaneous synaptic events superimposed (Fig. 6.1). Since most fast synaptic 
excitation at cortical synapses is mediated by AMPAr, it seemed logical to test for an 
involvement of these receptors in up-state generation so the contribution of AMPAr to 
V 
5 s 
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up-state activity was assessed. When a low concentration (5 µM) of the AMPAr/KAr 
blocker NBQX was perfused, the frequency of up-states slowed from 0.16 Hz to 0.08 
Hz, without significant changes in amplitude. A representative trace is illustrated in 
Fig. 6.2. Upon washout, the frequency of the up-states was restored to control levels. 
 
 
 
Figure 6.2: Effect of NBQX on up-states in layer III. A: In control conditions, these 
up-states exhibited a mean frequency of 0.16 Hz. B: Addition of NBQX (5 µM) caused 
a 50% reduction in frequency, without significant change to up-state amplitude. 
 
NMDAr 
 
NMDAr are tightly regulated by the voltage-dependent block exerted by Mg
2+
. 
Removal of [Mg
2+
]O elicits prolonged epileptiform discharges in EC neurones (Jones 
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and Heinemann 1988, 1989; Jones 1994), so a progressive lowering of [Mg
2+
]O may 
eventually give rise to up-states involving increased activation of NMDAr. When the 
NMDAr antagonist 2-AP5 (30 µM) was perfused (n=3), up-state frequency was 
reduced within 5 minutes. In 2 out of 3 cells, 2-AP5 abolished up-states. Fig. 6.3 
shows a representative trace from one neurone. Whilst the remaining cell showed 
reduced frequency and amplitude, the up-states were not abolished. This suggests that 
NMDAr have more of a role in the generation of up-states than AMPAr. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.3: Effect of NMDAr blockade by 2-AP5 on up-state activity. A: In control 
conditions, up-state behaviour was frequent and regular. B: Addition of 2-AP5 first 
slowed, then abolished, up-state activity in 2 out of 3 cells. The other cell shows 
reduced frequency and amplitude but up-states were not abolished. 
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KAr 
 
GluR5-containing KAr appeared to be crucial to the generation and maintenance of 
up-states in layer III. Application of UBP-302 (20 µM) abolished up-states in all 
tested cells (n=8). Upon wash-out of UBP-302, up-state activity was restored, with a 
similar frequency, but slightly reduced amplitude, compared with control (P>0.05). 
One representative recording is illustrated in Fig. 6.4. Large amplitude up-states 
occurred at highly regular intervals. These were interspersed with less regular and 
smaller amplitude events. Application of UBP-302 abolished both. 
 
 
Figure 6.4: Effects of GluR5 KAr blockade on up-state activity in layer III. A: In 
control conditions up-states have an average frequency of 0.22 Hz. B: After addition 
of 20µM UBP-302, no up-state activity was observed, although baseline membrane 
noise remained at a similar level. C: After 10 minutes wash in drug-free ACSF, up-
state activity spontaneously returned, with similar frequency but slightly reduced 
amplitude. 
 
A 
B 
C 
2 mV 
5 s 
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Gap Junctions 
 
There is much evidence to suggest that electrical synapses (i.e. gap junctions) play a 
major role in the synchronisation of sub-threshold activity in the cerebral cortex (see 
Connors and Long, 2004 for review). Thus, I considered the possibility that gap 
junctions may be involved in synchronisation leading to up-states in the EC. 
Increasing gap junction activity might be expected to increase the synchronisation of 
sub-threshold synaptic events, leading to increased up-states. Conversely, decreasing 
electrical synapse activity might be predicted to reduce network-wide synchrony and 
activity. The role of gap-junctions in up-state activity was investigated through the 
use of trimethylamine (TMA) and carbenoxelone. 
 
 
Figure 6.5: Effect of increased gap junction activity on up-state activity in layer III of 
the mEC. Top trace (A) shows normal up-state activity in a typical cell. After addition 
of 1mM TMA (B), up-state activity increases in frequency, with a slight reduction in 
amplitude. At peak activity, up-state generation under TMA is so frequent that the 
membrane spends more time in a depolarised state than in a resting state. 
 
 
Addition of the gap-junction opener, TMA (1 mM), caused a dramatic increase in the 
frequency (0.15 ± 0.02 Hz to 0.31 ± 0.06 Hz, P=0.03) and duration of up-states, to the 
point where the membrane potential was essentially shifted to a prolonged up-state 
A 
B 
2 mV 
5 s 
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with only occasional periods of normal membrane potential. A representative trace 
from one neurone is illustrated in Fig. 6.5. Washout of the TMA restored up-state 
activity to normal levels. In contrast, the gap junction blocker, carbenoxelone (200 
µM), did not alter the amplitude or frequency of up-states. Thus, it appears that gap 
junction opening can enhance existing up-state generation, but they do not appear to 
be tonically involved in initiating or maintaining activity. 
 
IBg and EBg During Progressive Depletion of [Mg
2+
]O 
 
The up-states described above were induced by lowering [Mg
2+
]O to 1.25 mM 
(compared to 1.5 mM). In addition, a common method of inducing acute epilepsy in 
slices is to record in a Mg
2+
-free environment (e.g. Jones and Heinemann 1988, 1989; 
Jones 1994). The pharmacological experiments above have shown that up-states may 
be modified by AMPAr, NMDAr and GluR5 KAr. In addition, Mg
2+
-free epileptic 
activity has been shown to be blocked by NMDAr antagonists and modified by 
AMPAr antagonists (Jones and Lambert, 1990a, b). VmD measurements (Chapter 4) 
in normal [Mg
2+
]O showed that background inhibition and excitation could be 
modified by blocking NMDAr or GluR5 KAr, which themselves do not feature in the 
VmD estimates. Thus, in the present studies I examined changes in IBg and EBg during 
a progressive lowering of [Mg
2+
]O from 1.5 to 0 mM (Mg-ramp). 
 
Mg
2+
-ramps were obtained in 6 pyramidal neurones in layer III. Initial [Mg
2+
]O was 
1.5mM, and this was lowered in steps of 0.5 mM every 10 minutes until 0 mM 
[Mg
2+
]O was reached. Conductance estimates were performed every 2 minutes. Of 
these neurones, two cells exhibited up-states at 1.5-1.0 mM [Mg
2+
]O, and all cells 
exhibited acute epileptic activity during perfusion with Mg
2+
-free ACSF. 
Conductance measurements were made outside periods of epileptic activity. 
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Figure 6.6: Conductance estimates in decreasing [Mg
2+
]O in layer III mEC pyramidal 
neurones. Control levels are comparable to that found throughout this thesis in layer 
III. A: Stepwise lowering of [Mg
2+
]O causes large rises in both EBg and IBg, however 
the increase in IBg is proportionally much larger. B: This leads to a final I:E  ratio (at 
0 mM [Mg
2+
]O) of 22:1 in favour of inhibition, compared to 4:1 in control conditions 
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Control values were 8.0 ± 1.3 nS for IBg, 2.2 ± 0.4 nS for EBg and I:E ratio was 3.8 ± 
0.3 in 1.5 mM [Mg
2+
]O. Lowering [Mg
2+
]O elicited a progressive rise in both EBg and 
IBg (Fig. 6.6A). IBg increased throughout the Mg
2+
-ramp. However, EBg was 
practically unaltered at 1 mM [Mg
2+
]O, but rose thereafter. Comparing values obtained 
at 1.5 mM [Mg
2+
]O with those in zero [Mg
2+
]O, EBg showed a 3.5 fold increase, 
reaching a final level of 7.6 ± 2.7 nS. IBg was affected to an even greater extent, 
undergoing nearly a 14 fold increase to reach 111.1 ± 33.1 nS in Mg
2+
-free ACSF. 
This was manifest as a large change in I:E ratio, which attained a final value of 21.8 ± 
8.51 in Mg-free ACSF. Changes between 1.5 and 0 mM [Mg
2+
]O were found to be 
significant using ANOVA (PI<0.001, PE=0.016 and PR=0.037). 
 
Changes in the SD of IBg and EBg were also examined. IBg SD increased from an initial 
value of 0.12 ± 0.06 nS in 1.5 mM [Mg
2+
]O to 0.32 ± 0.16, a 2.5 fold increase in 
magnesium free ACSF (Fig. 6.7A). However, the relative change in EBg SD was even 
greater, increasing from 1.8 ± 0.3 pS in 1.5 mM [Mg
2+
]O to 8.1 ± 0.4 pS in Mg
2+
-free 
ACSF. This represents a 4.5 fold increase over the control value. The changes in SD 
indicate increasing synchrony in both excitatory and inhibitory drives onto the 
principal cells. These are likely to be interconnected as it has been shown that 
interneurones can actually synchronise activity in principal cells. Thus, overall 
reduced [Mg
2+
]O causes elevated synchrony in the whole network, and this could be 
involved in the generation of epileptic responses. Neither change, however, was found 
to be significant using ANOVA. 
 
Lowering [Mg
2+
]O had conflicting results on cellular excitability measurements. The 
firing threshold of action potentials was reduced steadily throughout the Mg-ramp 
from 22.3 ± 1.3 mV in 1.5 mM [Mg
2+
]O to 16.2 ± 0.9 mV in zero [Mg
2+
]O, indicating 
increased excitability (P=0.004, t-test). However, the spikes evoked by a 250 ms 
depolarising pulse was not significantly affected by reducing [Mg
2+
]O (2.8 ± 0.7 to 2.1 
± 0.5). 
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Figure 6.7: SD estimates and cellular excitability measurements in Mg
2+
-ramp 
experiments. A: The change in SD estimates is the reverse of that seen in the 
conductance results, as the level of IBg SD increases proportionally less than the level 
of EBg SD. This indicates higher levels of synchrony in both populations, however in 
Mg
2+
-free ACSF the excitatory cells have a proportionally higher degree of 
synchrony compared to the interneurones. B: Cellular excitability measurements 
show conflicting results, with spike threshold falling significantly. C: However, the 
number of spikes per train is also slightly reduced. 
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VmD Measurement of Up-states 
 
In one neurone where a Mg
2+
-ramp experiment was conducted, at approximately 1 
mM [Mg
2+
]O up-states with plateaus long enough (several hundred ms) to obtain 
VmD measurements were observed, allowing estimates of IBg and EBg to be made 
during up-states (Fig. 6.8). 6-8 up-states were analysed at each conductance level. 
VmD conductance values for up-state peaks were 21.5 nS for IBg, and 7.0 nS for EBg. 
This gave an I:E ratio of 3.1 at the plateau of up-states. IBg SD was very high: 1.93 nS. 
EBg SD was close to normal control values, at 6.77 pS. These data suggest that up-
states are periods of high conductance, accompanied by increased synchrony in 
inhibitory populations. The up-state data described during this chapter was largely 
obtained before the VmD method was perfected, so no conductance data is available 
for them. Subsequent experiments were performed using slices taken from rats killed 
by cervical dislocation, as opposed those given ketamine and decapitated. The latter 
group of rats exhibited up-states in most slices, however with the cervical dislocation 
group, used after VmD recordings were made available, up-state activity was almost 
impossible to obtain. 
 
However, cervically dislocated rats did exhibit brief membrane oscillations (BMO) in 
1.25 mM [Mg
2+
]O, which were readily distinguishable from normal quiescent 
membrane states (QMS) as periods of increased membrane potential variability, but 
did not cause up-state like depolarisations. These BMO were studied using the VmD 
method. 
 
Measurement of BMO 
 
VmD analysis of BMO (n=7) revealed extremely interesting results. The fluctuations 
in membrane potential did not involve large increases in overall conductance, but 
were associated with a brief change in I:E ratio. Control conditions in these cells were
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Figure 6.8: VmD measurement of up-states. A: During one Mg-ramp recording, up-
states with plateaus long enough to obtain VmD measurements from were observed. 
The membrane voltage values between the red lines for 6-8 up-states per injected 
current level were pooled and treated as one set of VmD data. B: Values of IBg and 
EBg were both substantially increased, by proportionally equal amounts. C: This led 
to little change in overall I:E ratio. D: The SD of both IBg and EBg is substantially 
increased, suggesting a large increase in synchrony within and between inhibitory 
and excitatory populations. 
Plateau 
500 ms 
2 mV 
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 within the normal range of observations for layer III cells in 1.25 mM [Mg
2+
]O. IBg 
was 4.0 ± 0.5 nS, EBg was 1.1 ± 0.2 nS, and the mean I:E ratio was 3.9 ± 0.3. During a 
BMO, IBg was noticeably reduced to 1.6 ± 0.5 nS. At the same time EBg was increased 
to 2.4 ± 0.8 nS. This gave an I:E ratio of 1.0 ± 0.2 during a BMO (Fig. 6.9). This 
represents a brief change in ratio of almost 4 fold in favour of excitation. The increase 
in EBg was reflected in the SD measurements. Control IBg SD was 0.15 ± 0.04 nS, 
control EBg SD was 1.4 ± 0.2 pS. During a BMO, IBg SD was little altered at 0.19 ± 
0.04 nS, with the SD of EBg showing an upward trend with a nearly 6 fold increase, to 
8.1 ± 5.9 pS. Because of the difficulty in obtaining BMO recordings, n-numbers are 
low. The high S.E.M. of the EBg SD means that it is not a significant change, although 
more experiments may improve the errors. If so, this would indicate that the relative 
synchrony of excitatory activity is greatly increased during these membrane potential 
fluctuations. The changes in I:E ratio and IBg was significant (P<0.05, paired t-test). 
None of the changes in SD were found to be significant. 
 
Effects of Tiagabine on BMO 
 
The fact that BMO appeared to involve loss of background inhibition prompted me to 
study the effects of tiagabine (4 µM, n=4) on their occurrence. Previous experiments 
showed that the GABA uptake blocker caused a substantial increase in IBg. The drug 
abolished BMO in all four neurones. At the same time, it increased IBg from 4.0 ± 0.8 
nS to 8.5 ± 0.9 nS, and left excitatory conductance largely unchanged at 0.9 ± 0.2 nS 
from 1.2 ± 0.3 nS. This led to a final I:E ratio of 9.7 ± 0.8 (vs 3.6 ± 0.4 control). The 
large increase in IBg is likely to be responsible for the abolition of the BMO periods. 
Tiagabine did not significantly change the SD of either IBg or EBg. 
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Figure 6.9: Characterisation of background conductance during brief membrane 
oscillations. A: Example of BMO, indicated by solid black line over trace. Increased 
membrane potential SD can clearly be seen. B: VmD values for control and BMO 
states. IBg is significantly reduced, with a smaller increase in EBg. I:E ratio is 
significantly shifted in favour of inhibition (3.9 vs 1.0). D: Although not significant, 
there is a clear trend in favour of EBg SD increase. IBg SD is not affected. Thus, BMO 
are associated with brief reductions in IBg and increases in the SD of EBg. 
Brief Membrane Oscillation 
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Discussion 
 
Oscillations in cortical networks, associated with changes in background activity, are 
thought to play an important role in the processing of sensory information, memory 
formation and other highly complex computational tasks (Cossart et al., 2003). In this 
Chapter I have characterised two separate oscillatory behaviours, up-states and BMO, 
which would appear to have distinct profiles of background synaptic activity. 
 
Up-states, as outlined in the introduction to this Chapter, have been the subject of 
some debate with regards to the level of synaptic bombardment necessary for their 
generation. Waters and Helmchen (2006) suggest that, due to rectification by voltage 
sensitive channels and associated increases in membrane resistance, only small 
increases in background activity are required for up-state generation. In contrast, the 
Destexhe group (Destexhe et al., 2003; Rudolph et al., 2004; Rudolph and Destexhe, 
2004; Rudolph et al., 2007) maintain that up-states are a result of brief periods of 
significantly increased conductance, with high levels of synchronisation between and 
within neuronal populations. 
 
The VmD data gathered from up-states in this Chapter is in agreement with the latter 
theory. Despite only one neurone being suitable for VmD analysis, the increases in IBg, 
EBg and their respective SDs are clearly associated with up-state events. The I:E ratio 
does not change between baseline and up-state periods, suggesting a proportionally 
equal rise in background excitation and inhibition. The wealth of recurrent 
connections in the mEC leads to close association between inhibitory and excitatory 
populations, with changes in the activity of one having an appreciable effect on the 
other, as seen in earlier Chapters. Thus, a rapid and pronounced increase in EBg would 
precipitate a similar increase in IBg. In a similar fashion to the generation of 
epileptiform activity in the mEC, Sanchez-Vives and McCormick (2000) found that 
up-state behaviour is initiated in layer V and propagates towards the superficial layers. 
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A valuable future study could involve simultaneous VmD measurements from layers 
III and V of the mEC, to investigate possible lamina-specific changes in background 
activity which precede, or coincide with, up-state activity. 
 
Aside from the VmD data, the pharmacological characterisation of up-states 
performed in this Chapter would suggest that GluR5-containing KAr have a crucial 
role in the generation and maintenance of up-state activity. Whole-cell patch clamp 
studies from our laboratory have strongly suggested that GluR5-KAr enhance both 
glutamate and GABA release through action at presynaptic terminals (Chamberlain 
and Jones, unpublished observations). If it is accepted that the increase in background 
activity seen with the VmD method is the driving force behind up-state activity, it 
may be that activation of presynaptic KAr provides a further drive in up-state 
generation.  
 
Figure 6.10: Network connections in the mEC. As before, green triangles represent 
principal cells, and red circles represent interneurones. The wealth of recurrent 
connections (red line) is thought to be an important factor in the generation of up-
state behaviour. Small increases in transmitter release could be boosted through 
activation of GluR5-KAr and/or presynaptic NMDAr, meaning that these receptors 
play a pivotal role in up-state activity. 
  
168 
Further enhancement of transmitter release may come from presynaptic NMDAr, 
explaining the sensitivity of up-states to NMDAr blockade with 2-AP5. Another 
possibility is that up-state activity is sensitive to 2-AP5 due to the role that 
postsynaptic NMDAr play in excitatory transmission in layer V. As discussed above, 
up-states are thought to originate in deeper layers and propagate vertically (Sanchez-
Vives and McCormick, 2000). Our laboratory has shown that a significant component 
of background excitation in layer V is mediated by postsynaptic NMDAr (Berretta 
and Jones, 1996a), the blockade of which may significantly reduce excitatory activity 
in layer V, and reduce the probability of up-state generation and propagation. 
 
The majority of fast excitatory transmission in cortical networks is mediated by 
postsynaptic AMPAr. However, addition of the AMPAr/KAr antagonist NBQX did 
not completely abolish up-state activity in all cells. The effect of NBQX on up-states 
in this Chapter is not clear cut. The abolition seen in 66% of cells, and the reduction 
in frequency seen in the other, may be due to an overall reduction in EBg due to 
AMPAr blockade. However, it may be caused, at least in part, by the antagonism of 
pre- or postsynaptic KAr under NBQX. This could be resolved by further studies with 
more specific antagonists, such as GYKI-53665 (specific AMPAr antagonist) 
although there are few suitable specific antagonists for non-GluR5 containing KAr. 
 
Opening gap junctions with TMA leads to an appreciable increase in the frequency 
and duration of up-state activity. However, reduction of gap junction activity with 
carbenoxelone has no effect on up-states. Thus, it would seem that whilst gap junction 
activity can enhance existing up-states, tonic activation of gap junctions is not 
involved in the normal generation of up-state activity. 
 
The large increases in conductance seen during stepwise reduction of extracellular 
magnesium are not surprising. NMDAr are known to exist both presynaptically and 
postsynaptically at excitatory synapses in the mEC (Berretta and Jones, 1996a, b; 
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Jones and Woodhall, 2005; Yang et al., 2006). Furthermore, NMDAr are known to 
play a large role in the function of GABAergic interneurones (Monyer et al., 1994; 
Glitsch and Marty, 1999; Maccaferri and Dingledine, 2002; Duguid and Smart, 2004; 
Tzingounis and Nicoll, 2004). By reducing the extracellular concentration of 
magnesium, the voltage-dependent blockage of the NMDAr pore by Mg
2+
 ions is 
lessened, and NMDAr mediated depolarisation is more likely. This would increase the 
depolarisation of both the presynaptic and postsynaptic membrane, leading to 
increased release of both glutamate and GABA, and the greater likelihood of action 
potential formation. Thus, since the effects of [Mg
2+
]o reduction take place on both 
sides of the synapse, and would be expected to cause a positive feedback effect on 
transmitter release (i.e. NMDAr activity increases glutamate release, which further 
increases NMDAr activity both pre- and postsynaptically) the rise in activity seen 
during stepwise [Mg
2+
]o reduction is rapid and emphatic. Furthermore, given the 
above-mentioned link between NMDAr and interneurones, the shift in the I:E ratio 
towards inhibition is a predictable response to removal of voltage-dependent Mg
2+
 
blockade of NMDAr. 
 
Decreasing [Mg
2+
]o to 1.25 mM gives rise, in some cells, to brief membrane 
oscillations (BMO). The VmD data from these events suggest that they are distinct 
from up-states, in that there is no overall increase in background conductance. Instead, 
a brief but significant drop in IBg leads to an I:E ratio of approximately 1:1, 
accompanied by an increase in the synchrony of excitatory neurones. 
 
The function of these BMO provides an interesting avenue for investigation. They 
may be associated, precursor events to up-states, that would trigger spontaneous 
depolarisations if conditions were favourable (i.e. greater levels of transmitter release, 
as seen in vivo or with reduced [Mg
2+
]o in vitro). These BMO events are strongly 
reminiscent of sharp wave activity seen throughout the hippocampus and EC in 
behaving animals (Chrobak and Buzsaki, 1994, 1996). These sharp waves are periods 
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of highly co-ordinated activity that are most prominent in the CA1 area of the 
hippocampus (Buzsaki et al., 1983; Buzsaki, 1986; Suzuki and Smith, 1987), but are 
also evident in the deeper layers of the mEC. They have been postulated as a 
mechanism for the transfer of memory traces from hippocampus to EC (Ylinen et al., 
1995). Chrobak and Buzsaki (1994) claim that sharp waves are not evident in the 
superficial layers of the EC and associated retrohippocampal structures, instead 
demonstrating the prominence of a similar but unrelated theta-wave activity in these 
superficial layers in behaving animals. However, the BMO events observed in this 
Chapter are seemingly random, and do not display the highly rhythmic activity 
associated with theta waves, as well as having a far slower frequency. 
 
A possible method for the investigation of these BMO is the combination of VmD 
recording with multi-electrode extracellular, or paired intracellular, recordings. This 
would allow any slice-wide waves to be tracked in real time, which would then give 
an estimation of the direction of propagation, and possible site of origin. 
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CHAPTER 7 
EFFECT OF ANTICONVULSANTS ON BACKGROUND SYNAPTIC 
ACTIVITY 
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Introduction 
 
The effective diagnosis and treatment of various types of epilepsy presents an ongoing 
challenge for physicians and pharmacologists alike. Epilepsy is the most common 
serious neurological condition in the developed world, with a prevalence of 5-10 cases 
per 1000 population. Of these patients, one third will die in a manner related directly 
to their epilepsy (Brodie et al., 1997). The mean duration of epilepsy is 10 years, but 
20-30% of patients will experience lifelong epilepsy. Modern pharmacotherapy 
enables the control of many types of seizures of varying severity. However, 30% of 
patients are, or will become, refractory to any form of pharmacological intervention. 
Of those, a further 30% will be unresponsive to surgical intervention (Sander, 1993; 
Brodie et al., 1997; Kwan and Brodie, 2000). The EC has increasingly become a 
focus of attention for those studying mechanisms of epilepsy, and understanding 
where current treatment regimes fall short. The most common form of epilepsy in 
adults is temporal lobe epilepsy (TLE), accounting for around 40% of seizures in 
adults. Surgical studies have suggested that the success of anterior temporal 
lobectomy or selective amygdalohippocampectomy is directly correlated to the 
amount of EC tissue removed (Fried, 1993). The role of the EC as the “gateway” 
between hippocampus and neocortex implicate it in the propagation of seizures arising 
from hippocampal sclerosis. Indeed, the EC itself has been cited as an initiation point 
for seizures in TLE (Jones and Lambert, 1990a, b; Siegel et al., 1990; Fried, 1993; 
Nagao et al., 1996; Sperling et al., 1996; Schwarcz et al., 2000; Dupont et al., 2001; 
Jones and Woodhall, 2005). 
 
Frontline pharmacotherapy for epilepsy has long been based on empirical results 
rather than rational drug design. As a consequence, the mode-of-action of many 
anticonvulsant drugs is poorly understood. Several common drugs have been the 
subject of debate with regards to their cellular and synaptic effects. Studies in this 
laboratory have used whole-cell patch clamp recording to show that a number of 
  
173 
clinically effective drugs modify the spontaneous release of GABA and glutamate at 
EC synapses. In this Chapter I have used the VmD method to determine how these 
effects relate to global background activity and excitability. 
 
Phenytoin 
 
Used in the treatment of generalised tonic-clonic and complex partial seizures, 
phenytoin has been in use since the 1950s (Mattson et al., 1985; Cunningham et al., 
2000). There is contention concerning its primary mode of action. Many studies have 
suggested that phenytoin acts via blockade of VGSC in a use- and voltage-dependent 
manner (e.g. McLean and MacDonald, 1983; Matsuki et al., 1984; Yaari et al., 1986; 
Tomaselli et al., 1989; Ragsdale et al., 1991; Rogawski and Loscher, 2004; White et 
al., 2007), leading to a reduction of sustained repetitive action potential activity in 
postsynaptic neurones. However, consequence of VGSC blockade might also be 
altered transmitter release. 
 
Previous studies in this laboratory (Cunningham et al., 2000) used whole-cell patch 
clamp studies in the mEC to show that phenytoin could reduce the spontaneous 
release of glutamate but increased release of GABA. Both effects persisted in the 
presence of TTX, showing that blockade of sodium channels was not responsible for 
alterations in release. Phenytoin did not appear to affect postsynaptic glutamate 
receptors (rise time, amplitude and decay time of EPSCs were not affected) so it 
seems likely that it had actions on the release mechanisms at both GABA and 
glutamate synapses. The basis of these effects remains unknown, but they could 
contribute to the anticonvulsant effects of the drug. 
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Ethosuximide 
 
Ethosuximide is the drug of first choice in the treatment of absence seizures. It is 
equally effective as valproate. The prevailing view on the clinical action of 
ethosuximide is that it blocks T-type calcium channels (MacDonald and Kelly, 1994). 
However, as with all anticonvulsants, this is unlikely to be the only factor involved in 
the mode of action of ethosuximide. Coulter et al. (1989a) first showed blockade of 
low-threshold calcium currents (ICaT) by ethosuximide. In the same year a study in 
isolated neurones from the ventrobasal complex of guinea pig (Coulter et al., 1989b; 
Kostyuk et al., 1992), suggested that the action of ethosuximide on ICaT was voltage 
dependent (more pronounced at hyperpolarised potentials). Gomora and colleagues 
(2001) confirmed these findings in cloned human T-type calcium channels, inactive-
state preferential binding by ethosuximide was observed. Other studies suggested that 
persistent Na
+
 channels and Ca
2+
-activated K
+
-channels may be more likely targets for 
the action of ethosuximide (Leresche et al., 1998). Additionally, Löscher and Frey 
(1977) showed that ethosuximide was able to reverse isoniazid-mediated inhibition of 
GAD, suggesting that the drug may have some effects on GABA synthesis. 
 
Gabapentin 
 
Gabapentin was approved for use in antiepileptic polytherapy in 1994. It is a 3-
substituted GABA analogue, and as such was developed on the premise that it would 
exert anticonvulsant effects through mimicking/enhancing GABAergic transmission. 
However, a large consensus suggests that gabapentin has little or no effect on various 
aspects of GABA transmission. 
 
Taylor et al. (1998) discussed a number of proposed mechanisms of the action of 
gabapentin. There is little or no evidence to support direct interaction of gabapentin 
with either GABAA or GABAB receptors, as it does not displace GABA binding 
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(Taylor et al., 1998; Jensen et al., 2002). It does not alter GABA uptake into neurones 
(or glia), nor does it alter electrophysiological responses to GABA (Rock et al., 1993; 
Su et al., 1995). Maneuf et al. (2003) has summarised the efforts to identify and 
purify a “gabapentin binding protein”. This was identified as the α2δ1-2 subunit of the 
VGCC (Gee et al., 1996). No definitive data exist as to the location of these in the EC. 
 
In studies from this laboratory, gabapentin (and the related drug pregabalin) was 
found to reduce both activity dependent and independent glutamate release in the EC. 
The results suggested a dual mechanism of the action of gabapentin. This was 
mediated partly by blockade of P/Q-type VGCCs, and partly by an unknown effect 
downstream of Ca
2+
 entry (Cunningham et al., 2004). 
 
Felbamate 
 
Felbamate was the first of the new generation of anticonvulsants introduced in the 
1990s, having been approved for use in 1993. Its clinical use is now limited as a result 
of rare, but often fatal, side effects such as aplastic anaemia (Pellock and Brodie, 
1997). 
 
The anticonvulsant effects of felbamate have largely been considered to result from 
blockade of NMDA receptors. Kuo et al. (2004) demonstrated that the action of 
felbamate in the blockade of NMDA currents is use dependent, whilst other studies 
have shown that felbamate is specific for receptors composed of NR1a/NR2B 
subunits (Harty and Rogawski, 2000). Recent work from our laboratory has shown 
that felbamate, like other anticonvulsants, reduces spontaneous glutamate release at 
EC synapses. This effect seems to be entirely dependent on blocking the tonic 
facilitatory presynaptic NMDA receptor. In contrast, the reduction of glutamate 
release by phenytoin and gabapentin was independent of presynaptic NMDAr 
blockade (Yang et al., 2007). 
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Felbamate has also been shown to potentiate the action of GABAA receptors in 
cultured neurones, enhancing Cl
-
 current by acting at a site close to, but distinct from, 
the picrotoxin site, and separate from the barbiturate, GABA, benzodiazepine, zinc 
and neurosteroid sites (Rho et al., 1994; Kume et al., 1996; Rho et al., 1997). Further 
investigation showed that the action of felbamate at GABAAr was subunit specific, 
and depended heavily on the right combination of α, β and γ subunits (α1β2γ2S, α1β3γ2S, 
α2β2γ2S and α2β3γ2S) expressed within the GABAA receptor, with no effect or negative 
modulation of other subunit combinations (Simeone et al., 2006). 
 
Valproate 
 
Valproic acid has a long history as an antiepileptic, used to treat generalised and 
partial seizures (Löscher, 1999). Valproate is primarily considered to act as an 
enhancer of GABA (Löscher, 1981), by blocking breakdown through antagonism of 
GABA aminotransferase (Löscher, 1993) or increasing synthesis by increasing 
glutamic acid decarboxylase (GAD) activity (Wikinski et al., 1996). Some have found 
that valproate has a biphasic effect on GABA levels, reducing release at low 
concentration and enhancing release at higher concentrations (Wolf et al., 1988; Biggs 
et al., 1992). Valproate has also been suggested to act upon VGSC to reduce 
repetitive firing in cortical neurones (McLean and MacDonald, 1986; Taverna et al., 
1998). Additionally, some studies suggest a valproate-mediated block of postsynaptic 
NMDA receptors and the displacement of glutamate from AMPA receptors (Wamil 
and McLean, 1991; Zeise et al., 1991; Gean et al., 1994; Kunig et al., 1998). 
 
Work from our laboratory (Cunningham et al., 2003) has shown a reduction in the 
frequency (but not amplitude) of both sEPSCs and sIPSCs (with a greater reduction in 
sEPSC frequency). Both these effects were abolished in the presence of TTX 
suggesting valproate reduces glutamate and GABA release by blocking presynaptic 
VGSC. In addition, the decay time of sIPSCs was increased by valproate, indicating 
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that the drug can potentiate the action of GABAA receptors in the postsynaptic 
membrane. This may occur through interaction with the benzodiazepine site on the 
receptor. 
 
Lamotrigine 
 
Lamotrigine has been approved for use since the mid-1990s. It has been shown to be 
effective in the treatment of partial seizures in patients who are refractory to other 
pharmacotherapies (Goa et al., 1993). Lamotrigine has been suggested to act in a 
similar fashion phenytoin by blockade of VGSC (Miller et al., 1986; Cheung et al., 
1992; Xie et al., 1995; Dichter and Brodie, 1996) and reduction of the repetitive firing 
of somatic action potentials (Calabresi et al., 1999; Salvati et al., 1999). A number of 
studies have suggested that lamotrigine acts largely upon presynaptic sodium channels 
and decreases glutamate release (Leach et al., 1986; Waldmeier et al., 1995, 1996; 
Wang et al., 1996a; Calabresi et al., 1999). Blockade of voltage-gated calcium 
channels (VGCC) has also been suggested to be involved in the action of lamotrigine 
(Wang et al., 1996a, b; Stefani et al., 1997) 
 
Again, previous work in this laboratory (Cunningham and Jones, 2000) has used 
whole-cell patch clamp recordings in the mEC to demonstrate that lamotrigine, like 
phenytoin, decreases spontaneous glutamate release and increases GABA release in 
both the presence and absence of TTX. Thus VGSC block is not a prerequisite for the 
effects of lamotrigine on release. 
 
Methods 
 
Slices were prepared from juvenile male Wistar rats (40-60g) as outlined in Chapter 2. 
Intracellular recordings were obtained from layer III pyramidal cells in the mEC. The 
VmD method was utilised as previously described. After a control period of recording, 
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perfusion was switched to ACSF containing the required anticonvulsant drug. Drug 
perfusion was continued for at least 20 minutes, or until the cell was lost. 
Concentrations of anticonvulsants were chosen to be similar to their therapeutic levels. 
 
Results 
 
Phenytoin 
 
Phenytoin was applied to a total of 9 neurones at two separate concentrations (20 µM, 
n=6, 50 µM, n=3). At 50 µM, effects on conductance and SD values were similar to 
those seen in 20 µM phenytoin. However, action potential amplitude was significantly 
reduced, affecting cellular excitability. Thus, the remaining studies were performed in 
20 µM phenytoin. Control values for the cells tested with 20 µM were: IBg 5.1 ± 0.7 
nS, EBg 1.1 ± 0.2 nS, and I:E ratio was 5.1 ± 0.7. 
 
Addition of 20 µM phenytoin caused a rise in IBg (Fig. 7.1A), to 9.3 ± 1.6 nS. EBg, 
however, was slightly reduced (to 0.6 ± 0.2 nS). This led to a change of ratio in favour 
of inhibition, to 24.6 ± 7.3. Both the change in inhibitory conductance (P=0.01), and 
the increase in ratio (P=0.04), were statistically significant, however EBg was not 
(P>0.05). 20 µM phenytoin appeared to reduce the SD for both IBg and EBg (Fig. 
7.1B), but these changes were not significant (P>0.05), although a trend is evident. 
 
At this concentration, phenytoin had clear, significant effects on cellular excitability 
(Fig. 7.1C-E). Firing threshold increased from 17.1 ± 1.0 mV to 24.3 ± 1.0 mV 
(P<0.001), and the number of spikes generated during a depolarising current step fell 
from 5.3 ± 0.5 to 3.5 ± 0.3 (P<0.001). However, there was no change in action 
potential amplitude. Additionally, during evoked spike trains, phenytoin did not 
significantly change the amplitude of the final action potential in each train, or the 
relative amplitudes of the first and last spikes. 
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Figure 7.1: Effects of phenytoin on background activity and cellular excitability. A: 
Phenytoin (50 µM) causes a significant increase in IBg (5.1 ± 0.7 to 9.3 ± 1.6 nS), with 
no significant change in EBg. This leads to a shift in the I:E ratio in favour of 
inhibition. B: Despite downward trends in the SD of both IBg and EBg, no significant 
change was caused by lamotrigine. C: Spike threshold was significantly increased, 
without affecting action potential amplitude (D). Likewise, the number of spikes per 
250 ms depolarisation was significantly reduced (E). 
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Ethosuximide 
 
The effect of ethosuximide (250 µM) was investigated in a total of 6 neurones. The 
addition of ethosuximide did not dramatically alter background synaptic activity. 
From a control value of 5.8 ± 0.6 nS, IBg increased to 9.1 ± 3.0 nS after 15 minutes 
perfusion with the drug. EBg was hardly affected (1.38 ± 0.16 nS vs 1.15 ± 0.29 nS, 
Fig. 7.2A). Neither change was significant (P>0.05, t-test). However, overall the I:E 
ratio resulting from the combined changes in the conductances, from 4.3 ± 0.3 to 7.6 ± 
1.3, was significant at P=0.03. Ethosuximide also had no significant effect on the SDs. 
 
Despite the weak effect on background activity, ethosuximide did have appreciable 
effects on cellular excitability. Spike firing threshold was increased from 21.6 ± 0.9 
mV to 26.0 ± 1.2 mV (P=0.016), and the number of spikes evoked by depolarisation 
was reduced from 4.8 ± 0.2 to 3.0 ± 0.5 (P=0.003), without effect on the amplitude of 
spikes not significantly affected (P>0.05, Fig. 7.2C-E). 
 
Gabapentin 
 
Gabapentin was tested in 6 neurones, at a concentration of 25 µM. In contrast to many 
of the other anticonvulsant drugs tested, gabapentin had little effect on IBg in these 
neurones. The control level of 4.5 ± 1.3 nS was initially unaltered after 15 minutes in 
gabapentin (4.9 ± 1.3 nS). There was a reduction in EBg (1.1 ± 0.3 to 0.5 ± 0.1 nS), but 
this was still not statistically significant (P=0.12). Although the individual changes 
were not profound, the I:E ratio nevertheless changed from 4.1 ± 0.7 to 8.6 ± 1.9 in 
favour of inhibition, and the change was significant (P=0.04, Fig. 7.3A). Gabapentin 
had no significant effect on the SDs of IBg or EBg (Fig. 7.3B). 
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Figure 7.2: Effects of ethosuximide on background activity and cellular excitability. A: 
Ethosuximide (250 µM) has no significant effect on individual conductances, although 
IBg is slightly increased and EBg slightly decreased. These combine to cause a 
significant shift in I:E ratio towards inhibition. B: SDs of IBg and EBg are not affected. 
C-E: Cellular excitability is decreased, with spike threshold increasing and 
spikes/train decreasing significantly. AP amplitude is not affected. 
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Figure 7.3: Effects of gabapentin (25 µM) on background activity and cellular 
excitability. A: Neither conductance component is significantly altered, however EBg 
shows a clear downward trend. I:E ratio shifts significantly towards inhibition (4.1 ± 
0.7 to 8.6 ± 1.9). B: Conductance SDs are not affected by gabapentin. C-E: As with 
other anticonvulants, cellular excitability is decreased, with spike threshold 
increasing and spikes/train falling. AP amplitude is unchanged. 
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As with ethosuximide, although the changes in IBg and EBg were small, cellular 
excitability was significantly changed by gabapentin. Spike threshold increased from 
19.3 ± 0.8 mV to 23.0 ± 0.3 mV after 15 minutes (P=0.002), with the number of 
spikes evoked by depolarisation falling from 5.2 ± 0.3 to 3.3 ± 0.2 (P=0.001). Overall 
spike amplitude was unaffected (Fig. 7.3C-E). 
 
Felbamate 
 
Felbamate, at a concentration of 100 µM, was tested in 6 neurones. Whilst the change 
was not significant, felbamate was unique amongst the drugs tested in causing a slight 
depression of IBg, although clearly the change was not close to significance (Fig. 
7.4A). EBg also fell, from 2.3 ± 1.3 nS to 0.4 ± 0.1 nS, but again the difference was not 
significant (P=0.17). However, when the I:E ratio was considered, there was a marked 
change from 4.6 ± 1.0 to 15.6 ± 3.5, which proved to be significant (P=0.013.) 
Neither the SD of EBg nor IBg changed significantly in the presence of felbamate. 
 
Again, despite the non-significant overall changes in EBg or IBg, the relative changes 
(i.e. the I:E ratio) proved to be a good predictor of excitability changes. Thus, spike 
firing threshold was raised from 20.3 ± 1.7 mV to 24.4 ± 1.0 mV (significant at 
P=0.02). Similarly, spikes generated per 250 depolarising pulse fell from 5.2 ± 0.4 to 
2.5 ± 0.2 under felbamate (P=0.007). Once again, the overall height of evoked action 
potentials was largely unaffected by the addition of this anticonvulsant (Fig. 7.4C-E). 
 
Valproate 
 
Sodium valproate (500 µM) was perfused for 15 minutes, with a conductance estimate 
made every 5 minutes. Valproate induced a marked elevation in background 
inhibition, with IBg increasing from a control value of 10.2 ± 2.0 nS to 23.1 ± 4.4 nS 
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Figure 7.4: Effects of felbamate on background activity and cellular excitability. A: 
Felbamate (100 µM) had little effect on IBg, and did not significantly affect EBg, 
despite showing a noticeable reduction. Once again, small changes combined to 
significantly change the I:E ratio. B: SDs were not significantly altered in felbamate. 
C-E: Cellular excitability was reduced without changing AP amplitude, with both 
spike threshold and number of spikes per 250 ms depolarisation being significantly 
changed. 
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Figure 7.5: Time-course of valproate action on VmD estimates. A: Over 15 minutes, 
EBg is largely unaffected, being only slightly reduced by valproate (500 µM). IBg first 
falls, then increases significantly. This leads to a significant increase in I:E ratio. B: 
SD estimates show a downward trend, but are not significantly changed. C-E: 
Cellular excitability is significantly reduced, with action potential amplitude 
unaffected. 
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after 15 minutes. Conversely, EBg fell from an initial value of 2.8 ± 0.4 nS to 1.7 ± 0.3 
nS under valproate. These changes were reflected by a change in the I:E ratio, from 
3.6 ± 0.4 to 14.1 ± 3.0. The changes in IBg (P=0.028), EBg (P=0.041) and I:E ratio 
(P=0.01) were all significant (ANOVA). 
 
Examination of the time-course of the valproate (Fig. 7.5A) showed an interesting 
effect. After 5 minutes, IBg was actually depressed, although not significantly so. 
Thereafter it remained close to the control value before increasing sharply after 15 
minutes. In contrast, EBg decreased steadily throughout. 
 
Valproate caused a reduction in the SD of both IBg and EBg. The SD of IBg fell from 
0.6 ± 0.1 to 0.09 ± 0.03 nS after 15 minutes (significant at P=0.003), whilst that of 
EBg fell steadily throughout, and was significantly reduced after 10 minutes (P=0.005) 
before increasing slightly at 15 minutes (Fig. 7.5B). 
 
Finally, valproate had quite marked effects on cellular excitability. The action 
potential threshold rose from 17.8 ± 3.6 mV to 24.2 ± 3.2 mV after 15 minutes 
(significant at P=0.01), whilst the number of spikes generated by the depolarising 
pulse fell from 5.7 ± 1.1 to 0.6 ± 0.5 (P=0.006, t-test). Valproate had no significant 
effect on the amplitude of evoke action potentials (Fig. 7.5D). 
 
Lamotrigine 
 
Lamotrigine was applied at two different concentrations to a total of 8 neurones, 6 
with 20 µM, and 2 at 200 µM. Similar to results in phenytoin, 200 µM lamotrigine 
caused a large reduction in AP amplitude, as well as having a detrimental effect on the 
stability of the baseline membrane voltage. VmD estimates showed similar effects to 
those obtained in 20 µM. During the studies with 20 µM, VmD measurements were 
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Figure 7.6: Time-course of lamotrigine action. A: EBg is not significantly altered 
throughout by lamotrigine (20 µM), but IBg increases throughout, shifting I:E ratio in 
favour of inhibition. B: Although a clear trend is evident, the SDs of IBg and EBg were 
not affected. C-E: As with the other anticonvulsants, cellular excitability was reduced 
without significant effect on action potential amplitude. 
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made every 5 minutes during a 15-minute perfusion period, to follow the time-course 
of the effect of the drug. 
 
Figure 7.7: Spike train frequency, but not amplitude, is reduced by lamotrigine. 
Although the number of spikes in a 250 ms pulse is reduced, the amplitude of the 
action potentials is not affected. Likewise, no use-dependent reduction in spike 
amplitude is evident. 
 
During the application of lamotrigine (20 µM), IBg increased steadily from a control 
value of 5.3 ± 2.0 nS to 13.2 ± 2.6 nS after 15 minutes of drug perfusion. EBg was not 
significantly affected (Fig 7.6A). This led to a marked change in I:E ratio. From a 
control value of 4.0 ± 0.7, the I:E ratio shifted to 17.5 ± 5.0 nS after 15 minutes 
perfusion with lamotrigine. The changes in both IBg (P=0.008) and I:E ratio (P=0.04) 
at 15 minutes were found to be significantly different to control (ANOVA). When SD 
Control Lamotrigine 
200 ms 
10 mV 
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was measured, lamotrigine had no significant effect on the SD of either EBg or IBg, 
despite causing a sharp drop in both levels after only 5 minutes of perfusion (Fig. 
7.6B). 
 
Cellular excitability was markedly affected by lamotrigine. Spike threshold increased 
steadily throughout, from 25.3 ± 3.3 mV to 29.1 ± 3.8 mV after 15 minutes (P=0.014). 
Similarly, the number of spikes generated by a 250 ms depolarising step fell from 5.3 
± 0.8 to 1.3 ± 0.6 after 15 minutes (P=0.011). The amplitude of action potentials was 
unaffected (Fig. 7.6D), and the relative amplitudes of the first and last spikes in a train 
was also unchanged (Fig. 7.7) 
A             B 
 
 
 
 
 
 
 
 
 
 
 
 
 
      C 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.8: Effect of lamotrigine on BMO. A: IBg is reduced, and EBg increased, 
during oscillations. Lamotrigine restores control levels and shifts I:E ratio in favour 
of inhibition, stopping BMO activity. B: SDs are not affected. 
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Lamotrigine was applied to a separate group of cells exhibiting BMO activity (see 
Chapter 6). The addition of lamotrigine (20 µM) caused the abolition of BMO activity 
in all cells. Control values were: IBg = 4.1 ± 0.4 nS, EBg = 0.9 ± 0.1 nS and I:E ratio = 
4.5 ± 0.3. During BMO, the level of IBg fell to 1.23 ± 0.07 nS (P=0.03), whilst EBg 
increased slightly to 1.4 ± 0.3 nS (P>0.05). This gave an I:E ratio of 1.0 ± 0.3 
(P=0.001). During BMO, the SDs of IBg and EBg were not significantly changed. The 
addition of lamotrigine caused a sizable increase in IBg without affecting EBg 
compared to control levels: IBg was 6.0 ± 0.8 nS and EBg was 0.9 ± 0.4 nS (Fig. 7.8). 
 
Discussion 
 
The conclusion from my experiments is that anticonvulsants increase the ratio of IBg 
to EBg, lowering cellular excitability and reducing the probability of action potentials 
firing in the postsynaptic neurone. The VmD estimates of background activity 
(particularly I:E ratio) appear to be good indicators of cellular excitability. All of the 
tested anticonvulsant drugs had significantly shifted the I:E ratio in favour of 
inhibition after 15 minutes. Likewise, cellular excitability was significantly reduced 
by all 6 drugs. Even when changes in IBg and EBg individually are not significant, as 
with ethosuximide, the combined effect of these changes is the significant shift in I:E 
ratio, and subsequently a significant reduction in cellular excitability. However, it is 
clear from other studies, and differences in the background conductance effects seen 
in this Chapter, that the mechanism of action of these drugs varies considerably. It 
may be that, regardless of its effects at the synapse or within the cell, the overall 
efficacy of a drug as an anticonvulsant lies in the changes it makes to network activity 
as a whole. 
 
As stated in the introduction, many studies have suggested that the anticonvulsant 
effects of phenytoin are mediated through use- and voltage-dependent blockade of 
VGSCs (McLean and MacDonald, 1983; Matsuki et al., 1984; Yaari et al., 1986; 
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Tomaselli et al., 1989; Ragsdale et al., 1991; Rogawski and Loscher, 2004; White et 
al., 2007)). However, whole-cell patch clamp studies from our laboratory 
(Cunningham et al., 2000) show that release of both glutamate and GABA is 
modulated by phenytoin by a mechanism that is independent of VGSC activity. 
 
The VmD estimates in phenytoin show an increase in IBg and a decrease in EBg 
relative to control values, although the change in EBg is not significant. Nevertheless, 
I:E ratio is significantly shifted in favour of inhibition. This is in agreement with the 
reciprocal modulation of glutamate and GABA release by phenytoin seen by 
Cunningham et al. (2000). Additionally, at 20 µM, single AP amplitude, and spike 
train amplitude, are unaffected. This suggests that use- and voltage-dependent 
blockade of VGSCs is not a significant factor in phenytoin activity at this 
concentration. The basis of release modulation, and its effects on IBg and EBg, is 
unclear. Dendrotoxin-sensitive K
+
-channels are unlikely to be involved (Cunningham 
and Jones, 2001), however one possibility may be direct interaction with presynaptic 
GABAB receptors, or their associated K
+
-channels (Cunningham and Jones, 
unpublished observations). Certainly, as release is modulated in the presence of TTX 
in our previous patch clamp studies, a significant proportion of the change in 
background activity will be independent of network function. However, since my 
experiments were performed in an intact network, emergent network responses cannot 
be ruled out. 
 
Ethosuximide is a good example of small, insignificant changes in IBg and EBg 
combining to cause a significant change in both I:E ratio and cellular excitablilty. 
Conductance and SD estimates were seemingly unaffected by the addition of 
ethosuximide. However, since IBg was slightly increased, and EBg was slightly 
decreased, these changes combined to lower cellular excitability. 
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The consensus on the mode of action of ethosuximide is as a blocker of open T-type 
Ca
2+
-channels (Coulter et al., 1989a, b; Gomora et al., 2001). Given that the VmD 
method is reliant upon the activity of AMPAr and GABAAr for its estimates of EBg 
and IBg respectively, any observed effects of ethosuximide are likely to be network-
mediated. The action of ethosuximide on VGCC has been suggested to be more 
pronounced at hyperpolarised potentials (Coulter et al., 1989b). In our preparation, 
principal cells generally display a more hyperpolarised resting potential compared to 
interneurones. Thus, ethosuximide may have a more marked effect at excitatory 
terminals than at inhibitory ones, favouring reduction in glutamate release over a 
reduction in GABA release. However, this does not explain the observed increase in 
IBg which causes most of the I:E ratio shift. One possible explanation may come from 
ethosuximide-mediated changes in input resistance and tonic firing rates observed by 
Leresche et al. (1998). This study showed that, at membrane potentials less negative 
than -60 mV, ethosuximide causes an increase in tonic firing in rat and cat 
thalamocortical neurones, possibly due to effects on persistent Na
+
 currents and Ca
2+
-
activated K
+
-channels. In Chapter 3, it was shown that IBg is more dependent upon 
action potential activity than EBg. It may be that the higher levels of tonic firing in 
interneurones are potentiated by ethosuximide, with little effect on principal cells. 
 
Work from our laboratory, and others, has suggested that the primary action of 
gabapentin is the inhibition of glutamate release through direct interaction with 
presynaptic voltage gated calcium channels, with a possible downstream effect that 
reduces the frequency of miniature glutamate-mediated events in the presence of the 
VGSC blocker TTX (Maneuf et al., 2003; Cunningham et al., 2004). There is a 
wealth of evidence to suggest that gabapentin reduces Ca
2+
 influx through blockade 
both of N- and P/Q-type VGCC, but it may preferentially target P/Q-type channels 
(Dooley et al., 2002; van Hooft et al., 2002; Cunningham et al., 2004). However, 
some studies have failed to show any effect of gabapentin subsets of VGCCs 
(Schumacher et al., 1998; van Hooft et al., 2002). Gabapentin is rapidly taken into 
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neurones by the actions of the L-amino acid transporter, leading to an intracellular 
concentration 10-fold higher than that found extracellularly (Welty et al., 1993; Su et 
al., 1995). This suggests that much of its effects on background excitation may be 
mediated by inhibition of release through intracellular mechanisms. 
 
Binding and microdialysis studies have suggested that gabapentin has little effect on 
GABA transmission. Gabapentin is unable to displace GABA from either GABAA or 
GABAB receptors (e.g. see Taylor et al., 1998). Timmerman et al (2000) found that 
gabapentin did not alter extracellular GABA levels in rat subsantia nigra. There is, 
however, evidence that gabapentin blocks presynaptic NMDAr, which would reduce 
the release of both glutamate and GABA (Suarez et al., 2005; Hara and Sata, 2007). 
 
My results show no appreciable change in IBg with gabapentin, with a reduction in EBg 
that is not significant. Taken together, conductance values in gabapentin cause the I:E 
ratio to shift significantly in favour of inhibition, decreasing cellular excitability. 
Although the individual changes are not significant, the VmD results suggest that 
there must be some modulation of release by gabapentin. Considering the evidence 
provided by other studies, the shift in I:E ratio is most likely mediated by a reduction 
of glutamate release. 
 
The action of felbamate is largely mediated through blockade of NMDAr (Harty and 
Rogawski, 2000; Kuo et al., 2004; Yang et al., 2007). Since EBg estimates are based 
on the actions of AMPAr, any effects seen on background excitation estimates will 
most likely be indirect, although some evidence exists to suggest that, at high 
concentrations, felbamate can reduce AMPAr-mediated excitatory events (Pugliese 
and Corradetti, 1996). Recent work from this laboratory has shown that felbamate 
reduces the frequency of sEPSCs through blockade of presynaptic NMDAr (Yang et 
al., 2007). There is evidence that felbamate may be weakly specific for NR2B-
containing NMDAr (Harty and Rogawski, 2000). These have been found on 
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excitatory terminals (Woodhall et al., 2001; Yang et al., 2006) and on interneurones 
(Chen and Reiner, 1996; Szinyei et al., 2003), suggesting that felbamate could reduce 
both glutamate and GABA transmission, through inhibition of glutamate release and 
reduction of NMDAr activity at interneurones, a major driver of their activity (Jones 
and Buhl, 1993; Maccaferri and Dingledine, 2002). However, any reduction of GABA 
release onto principal cells could be mitigated by the benzodiazepine-like action of 
felbamate at GABAA receptors (Rho et al., 1994; Kume et al., 1996; Rho et al., 1997). 
 
The VmD results obtained for felbamate are in agreement with data from other studies. 
The change in EBg, whilst not significant, was appreciably larger than that seen in IBg 
which, uniquely in this chapter, was slightly lower in the presence of the drug 
compared to control. This change in EBg led to a significant change in I:E ratio, 
lowering cellular excitability. The reduction in EBg is most likely due lower glutamate 
release caused by blockade of presynaptic NMDAr, as shown in Yang et al (2007). 
 
Valproate has been suggested to act as an enhancer of GABA transmission through 
increased synthesis or reduced breakdown (Löscher, 1993; Wikinski et al., 1996). 
However, whole-cell patch clamp studies from this laboratory have shown that 
valproate, most probably through antagonism of VGSCs, reduces the release of both 
glutamate and GABA in the mEC (Cunningham et al., 2003). Additionally, valproate 
has been suggested as an antagonist of AMPAr and NMDAr (Wamil and McLean, 
1991; Zeise et al., 1991; Gean et al., 1994; Kunig et al., 1998). 
 
VmD estimates in valproate show slightly reduced EBg with significantly increased IBg 
leading, as with all other anticonvulsants, to an inhibition-favouring I:E ratio and a 
reduction in cellular excitability. The reduction in EBg is likely due to the VGSC-
dependent decrease in glutamate release seen in our previous whole-cell studies, with 
a possible contribution from AMPAr blockade and/or further reduction of glutamate 
release due to blockade of presynaptic NMDAr. Although sIPSCs are reduced in 
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frequency by valproate, their decay time is increased, with no change in amplitude 
(Cunningham et al., 2003). Thus, the overall inhibitory conductance is increased, 
despite the frequency reduction. Additionally, the increase in IBg may lead to further 
reduction of excitatory activity due to network effects. 
 
An interesting point to note is the biphasic effect of valproate in the time-course 
studies. IBg initially decreases, before showing a significant increase. This pattern is 
supported by other studies, which suggest that GABA release is reduced by valproate 
at low concentrations, and enhanced at higher concentrations (Wolf et al., 1988; Biggs 
et al., 1992). 
 
Lamotrigine and phenytoin have similar proposed modes of action (Cunningham and 
Jones, 2000), in that sEPSC frequency is decreased, whilst sIPSC frequency is 
increased, by a VGSC-independent mechanism. The VmD results show a very slight 
reduction in EBg, and a significant increase in IBg. Again, the I:E ratio shifts in favour 
of inhibition in lamotrigine, and cellular excitability is decreased. The lack of change 
in single AP amplitude, or that of spikes on the evoked trains, suggests that VGSCs 
are not significantly blocked by lamotrigine at this concentration. The actions of 
presynaptic VGSCs cannot be ruled out using the VmD method, although 
Cunningham and Jones (2000) suggested the observed effects of lamotrigine are 
largely VGSC independent. 
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CHAPTER 8 
GENERAL DISCUSSION 
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This thesis has validated the VmD method as a means for estimating background 
activity in relation to cellular excitability in the mEC. By using a range of 
pharmacological tools and supporting my pharmacological data with whole-cell patch 
clamp recordings and physiological studies such as layer comparisons, insight into the 
nature of background release and how changes in IBg, EBg and I:E ratio affect the 
excitability of principal neurones has been gained. 
 
Initially, it was important to properly characterise and validate the VmD method in 
our experimental setup. To that end, the first two data chapters focus on the use of 
well-established pharmacological tools to determine how changes in receptor activity, 
the availability of glutamate and GABA at the synapse and VGC blockade affect 
levels of background activity, population synchrony and cellular excitability. The 
VmD calculation incorporates the actions of only AMPA and GABAA receptors, but 
the rich reciprocal connections present within the EC, and the presence of 
autoreceptors that modulate release at the presynapse (e.g. NMDA, KAr) means that, 
within our slices, the addition of a drug is not a straightforward change of activity at 
the postsynaptic membrane. 
 
Encouragingly, the results obtained with receptor antagonists such as NBQX, GYKI-
53665 and bicuculline were as predicted, with most change seen in the conductance 
component that was directly affected (e.g. EBg for NBQX and GYKI) and consequent 
effects on the other component due to, for example, a reduction in excitatory drive on 
to interneurones. The use of drugs that have little or no direct effect on receptors at the 
postsynapse, but alter network activity in some way (e.g. 4-AP, PDC, tiagabine) 
produces more complex effects. However, the VmD data obtained concurred wel with 
previous work from our laboratory and others, especially when taken in conjunction 
with whole-cell patch clamp data, as with PDC and tiagabine. Ideally, future studies 
would utilise patch clamp experiments alongside all VmD experiments. A useful 
avenue for investigation would be simultaneous whole-cell and intracellular recording 
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from two different principal neurones in the same layer of the same slice, so that 
VmD data (and cellular excitability measurements) could be gathered side-by-side 
with a direct measure of EPSC or IPSC activity. This would allow the time-course of 
IBg and EBg changes to be directly correlated with shifts in the amplitude and 
frequency of post-synaptic events. 
 
Some very interesting data came from the comparison of the VmD and patch clamp 
data obtained with tiagabine. Although IBg increased,the frequency of sIPSCs was 
reduced. However, there was a significant increase in sIPSC amplitude and duration 
seen in the patch clamp experiments, suggesting that the VmD estimations depend on 
the total charge transfer, not just the frequency, of the GABAA (and most likely 
AMPA) receptors. Thus, the VmD method is a true measure of integrated 
conductance in these cells. 
 
Another point of note is the notion of specific GluR5 receptor antagonists as possible 
anticonvulsants. If IBg and EBg SD can be taken as an indication of the synchrony of 
the inhibitory and excitatory populations, reductions in SD could indicate a decreased 
propensity for seizure generation. Addition of UBP-302 does not significantly affect 
IBg, EBg or I:E ratio, and does not change cellular excitability. However, there is a 
significant reduction in the SD of IBg, and the SD of EBg exhibits a clear downward 
trend. Thus, it may be that UBP-302, or similar drugs, are ideal anticonvulsants, 
reducing synchrony without compromising other network functions. 
 
The VmD method was further validated by the use of ion channel blockers such as 
Cs
+
, QX-314 and 4-AP. The Destexhe group suggest that estimations of IBg and EBg 
are not significantly distorted by the presence of active currents in the dendrites and 
soma. The lack of change in conductance estimates seen after internal dialysis with 
Cs/QX-314 supports this assertion. The increase in conductance levels seen with 4-AP 
is probably not a result of blockade of A-type K-channels in the soma, but is more 
  
199 
likely due to prolonged depolarisation of the presynaptic terminals, resulting in 
increased transmitter release, due to block of K-channels in the terminals. To further 
test the robustness of the VmD method, other channel blockers could be investigated 
(e.g. IH antagonist ZD-7288). 
 
Our laboratory has long been focussed on lamina-specific differences in the EC, using 
both intracellular and whole-cell recordings to quantify significant differences in the 
frequency and characteristics of inhibitory, excitatory and epileptiform events. The 
bicuculline time-course data obtained in Chapter 5 provides two sets of data, that of 
the normal resting values in our cells, and the lamina-specific differences in 
sensitivity to bicuculline. The baseline values of conductance and SD differ 
noticeably between layers, especially when layers II and III are compared to layer V. 
Given that previous work from this lab has indicated a predominance of inhibition in 
layer II, and greater levels of excitation in layer V, the indication that the I:E ratio in 
layers II and III is approximately 1.5 times greater (i.e. more in favour of inhibition) 
than layer V. Additionally, in layer II the onset of epileptiform activity is delayed 
compared to the deeper layers, and such events are smaller and shorter than those in 
layer III and layer V. 
 
The data obtained with bicuculline support previous assertions from our laboratory 
that layer II is “seizure resistant”, whilst layer V is “seizure sensitive”. An interesting 
further study would be to make simultaneous intracellular recordings from layers II, 
III and V in the presence and absence of bicuculline, so that the onset of epileptiform 
activity could be monitored in terms of synchrony and background activity across the 
layers. Furthermore, the generation and propagation of seizure activity could be 
tracked in real time around the slice. A further alternative would be to use the VmD 
method in one or two simultaneous intracellular recordings, combined with a multi-
electrode array for field potential measurement across the whole slice. This would 
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trace the propagation of epileptiform activity more accurately, whilst still providing a 
measure of background activity in key layers (e.g. II and V). 
 
The two different conductance profiles seen for up-states and BMO suggest that they 
are two discrete phenomena. The up-states seem to be periods of vastly increased 
conductance, with similar I:E ratios to baseline conditions. Conversely, BMO are not 
associated with overall increases in conductance, but show a shift in the I:E ratio in 
favour of excitation. It may be that these events are related, BMO may be precursor 
events to up-states, or “failed” up-states that have not developed properly. The use of 
lamotrigine to abolish BMO suggests that they can be affected in a similar manner to 
epileptiform activity. Further useful investigation could come from patch clamp 
studies of BMO activity. It may be that simultaneous patch clamp and intracellular 
recordings will offer more information about the network basis of these events. Multi-
layer intracellular recordings would provide some information about the laminar basis 
of BMO generation and propagation. 
 
The actions of the anticonvulsants examined in this thesis are thought to vary 
considerably, from reciprocal modulation of glutamate and GABA release to blockade 
of sodium or calcium VG channels. However, their overall effects on transmission 
and excitability are all somewhat similar. IBg is generally increased, and EBg is 
generally decreased. Even if these changes are not significant, they combine to cause 
a significant change in the I:E ratio in favour of inhibition. Furthermore, cellular 
excitability is reduced, to a degree which reflects the change seen in I:E ratio. Thus, it 
may be that the overall network effects of anticonvulsant drugs are far more important 
than their effects at the synapse. 
 
In conclusion, I have validated the VmD method, a novel way to obtain estimates of 
background activity from intracellular recordings, in quiescent slices from rat brain. 
The method has proved to be a useful and powerful way of extracting information 
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from relatively simple electrophysiological recordings to provide insight into the 
functions of cortical networks, and the impact changes in low-level neurotransmitter 
release have on cellular excitability. 
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